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ABSTRACT 
 
In southern Africa, oculocutaneous albinism (OCA) is the most common autosomal 
recessive disease amongst black Africans, occurring with a prevalence of approximately 1 
in 3 900 individuals. OCA occurs in southern African Caucasoids with a frequency that 
reflects the European origins of this population, approximately 1 in 20-30 000. OCA type 1 
is caused by mutations in the tyrosinase gene on chromosome 11q. Tyrosinase mutations 
occur in the Caucasoid population but are extremely rare in black Africans. OCA type 2 is 
caused by mutations in the P gene on chromosome 15q. P gene mutations occur in both the 
black and Caucasoid populations. A sub-type of OCA2 seen in black individuals, brown 
OCA (BOCA), is also caused by mutations at the P gene locus. 
 
A mutation screen was undertaken to identify disease-causing mutations in a group of OCA 
subjects from Sub-Saharan Africa. A common P gene mutation had been identified in the 
black population, a 2.7 kb intragenic deletion, accounting for 78% of P gene mutations in 
this group. No common tyrosinase mutations have been identified to date, in any 
population. A cohort of OCA subjects from South Africa, Lesotho, Zambia and the Central 
African Republic (CAR) were available for study in our laboratory. All subjects were 
screened for the 2.7 kb deletion mutation. Subjects homozygous for this mutation were 
excluded from further study. Subjects where one or two mutations remained to be 
identified were included in a mutation screen (63 blacks and 9 Caucasoids). Depending on 
the clinical categorisation of the type of albinism, subjects were screened for P gene 
mutations only (black OCA2) or were screened for P gene mutations and tyrosinase 
mutations (BOCA, unclassified black OCA and unclassified Caucasoid OCA).  
 
All 72 subjects were screened for P gene mutations and ten putative pathogenic mutations 
were identified. In the group of black OCA2 patients, four mutations which are likely to be 
pathogenic were found: A334V, 614delA, 683insT and 727insG. Mutations were identified 
in four individuals with an unusual hypopigmentation phenotype: E678K was found in the 
homozygous state in an individual from the CAR. A second individual was found to be a 
compound heterozygote for the I370T and the L688F mutations. A third individual was 
found to be heterozygous for the I370T mutation. Three P gene mutations were found in 
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the Caucasoid sample: IVS 14-2 (a→g), V350M and P743L. No further mutations were 
identified in the BOCA sample. The P gene screen comprised 72 subjects, but 40 were 
heterozygous for the 2.7 kb deletion, therefore (144 minus 40 alleles) 104 alleles remained 
to be identified. Identification of 12/104 alleles means that a further 11.5% of the unknown 
P gene mutations are now accounted for. Thirty three of the 72 subjects were included in a 
further mutation screen – at the tyrosinase locus. Four mutations were identified, all in the 
Caucasoid group. Compound heterozygosity was shown in two individuals, one carrying 
the mutations, E294K and A490D and the other, P431T and T373K.  
 
Following mutation analysis of the P gene, it was apparent that a proportion of mutations 
did not lie in the coding region of the gene and it was proposed that some of the remaning 
unidentified mutations might be found in the 5’control or promoter region of the gene. At 
that time, sequence data for the region upstream of the P gene was not known, and so an 
attempt was made to clone the 5’region of the P gene. Two approaches were adopted – a 
bacterial artificial chromosome (BAC) known to contain this region was subcloned; and 
secondly, an inverse PCR experiment was undertaken. Neither experiment was successful 
in generating P gene promoter sequence.  
 
Variation at the P locus was investigated in a second context. This region of chromosome 
15q was implicated as a host susceptibility locus for the infectious disease, tuberculosis 
(TB). A case-control study was undertaken to compare the frequencies of five intragenic, 
polymorphic markers in the P gene: the 2.7 kb deletion, the R305W polymorphism and the 
microsatellite markers, D15S1533, D15S1536 and D15S1537, between a group of black 
South African TB patients from Gauteng and healthy community controls and between a 
group of mixed-ancestry (Coloured) TB patients and healthy controls from the Western 
Cape region. Presence or absence of the 2.7 kb deletion mutation does not appear to 
influence susceptibility to TB in either the black or Coloured population samples studied 
here. The W allele of the R305W polymorphism is significantly (p<0.05) more common in 
the black patient group than in the black control group, suggesting it may be in linkage 
disequilibrium with a disease susceptibility allele. Microsatellite marker analysis showed 
that, in the black population, allele 18 at the D15S1533 locus is significantly (p<0.05) 
associated with susceptibility to TB. In the Cape Coloured population, alleles 20 and 27 at 
the D15S1533 locus, allele 12 at the D15S1536 locus and allele 16 at the D15S1537 locus 
are over represented in the patient group suggesting they may be markers for increased 
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susceptibility to TB. Further, in the Coloured population alleles 12, 13 and 15 at the 
D15S1537 locus showed significant (p<0.05) association with normal controls and may be 
in linkage disequilibrium with protective or resistance alleles.  
 
The results of this study support the proposal of a TB susceptibility locus on chromosome 
15q. OCA-causing mutations have been identified, but many remain elusive. Further 
characterisation of this region will give us a better understanding of the biological 
consequences of variation both within and around the P locus.  
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CHAPTER 1 
INTRODUCTION 
 2
1.1 Introduction 
 
The different groups of humanity have long been an issue of significance with biologists, 
anthropologists, politicians and historians. Human beings have been grouped according to 
their cultural, linguistic, religious and biological differences. Classification of race has 
invariably involved one physical attribute – skin colour. Africans, Asians and Caucasians 
were considered separate entities. Anthropologists spent a great deal of time classifying 
human skull bones into racial groups by measuring the cephalic index, the ratio of length to 
breadth of the skull. The word ‘Caucasian’ derives from the region of the world from 
which it was claimed the skull which best represents the white-skinned people came, 
namely, the Caucasus Mountains in eastern Europe. 
 
The idea that humans are divisible into racially distinct groups has had disastrous effects 
throughout history, perhaps on no continent more obviously so than Africa. To date, only 
maybe 100 genes out of the estimated 20 000 - 25 000 genes in the human genome have 
been shown to be associated with skin colour. The study of murine coat colour genes, more 
easily manipulated in the laboratory, has led to the identification of 127 pigment genes 
(reviewed by Bennett and Lamoreux 2003) and listed on the Albinism Database website, 
http://albinismdb.med.umn.edu/genes.htm). An obvious question arises – do genetic trends 
in skin colour parallel changes in the other tens of thousands of functional genes? DNA and 
protein studies show that differences in skin colour are not accompanied by consistent 
patterns of variation in other functional systems. Humans from different parts of the world 
show distinct patterns of genomic variation, especially at non-coding polymorphic loci, but 
the overall variation is not as great as early anthropologists may have predicted. At the 
molecular level, humans exhibit far less variation than might have been anticipated – the 
homogeneity of the human species is probably due to its relatively recent evolution.  
 
Genetic research on human albinism has been central to many major discoveries in the field 
of human genetics. Albinism provided the first evidence to support the fact that Mendel’s 
law of genetic segregation (first published in 1903) also applies to humans.  
 
Much more recently, one of the human pigment loci (namely, the P gene region on 
chromosome 15q) has become implicated as a region likely to be involved in the complex 
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genetics of host susceptibility to infectious disease. 
 
There is good evidence to support the hypothesis that the origin of modern humans, Homo 
sapiens, lies in Africa. This would suggest that our common ancestors were adapted to a 
hot and relatively dry climate with high levels of ionising radiation from the sun. Early 
humans were presumably darkly pigmented and those who migrated out of Africa had to 
adapt to climatic changes contributing to loss of pigmentation and resulting in the spectrum 
of pigmentary variation found in living peoples today. (This hypothesis has met with 
controversy - light versus dark skin may simply have resulted from a lifting of selective 
pressures for darker skin in Africa and random drift.) Several theories have been put 
forward to explain how and why colder climates were associated with selection for lighter 
skin colour. However, as reviewed by Jablonski (2004), none of them are entirely 
satisfactory.  
 
Temperature and associated high levels of UV radiation have been argued against as being 
the selective agents in skin colour determination; dark skin colour does not protect against 
high temperatures. On the contrary, black colour absorbs more light than lighter colours. It 
has been suggested that dark skin colour protects against the damaging effects of UV 
radiation, the melanin providing a physical block preventing the UV light reaching the 
dermal layers. This would render individuals with a darker skin colour less susceptible to 
developing skin cancer. This may explain why skin cancers, including malignant 
melanoma and squamous and basal cell carcinoma, show an increased incidence with 
increased exposure to the sun, and are more prevalent in lightly pigmented individuals than 
darkly pigmented individuals. However, these types of cancers usually kill the individual 
only after reproductive age, making it an unlikely selective factor for skin colour in the 
context of climate. Diamond (2005) comments that this may be over-simplistic on the 
scientists’ behalf as it ignores three very important historical human social structures – the 
long dependence of offspring on parents for learning and social status, the large 
contribution of hunter-gatherer grandmothers to their grandchildren and the dependence of 
a clan or village on its elders for knowledge in a preliterate society. 
 
A second hypothesis concerns the ability of skin to synthesize vitamin D (Jablonski and 
Chaplin, 2000). Vitamin D is synthesized by the body in the presence of UV light. It is 
possible that the excessive amount of sunlight present in the tropics would lead to an over-
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production of vitamin D by the body. The increased amount of melanin present in dark 
skinned individuals acts as a block to the UV light, reducing the level of radiation that can 
penetrate the skin. In cloudy climates, the presence of large amounts of melanin in the skin 
would be disadvantageous, as the pigment would block the already low levels of UV 
radiation, and inhibit vitamin D synthesis. Lack of vitamin D leads to poor bone 
development in children and permanent skeletal deformation, a condition known as rickets. 
In this way, the colder, cloudier climates of Europe would have selected for a lighter skin 
colour.  
 
A third hypothesis involves the B vitamin folate. This vitamin, essential to health and 
especially important during early embryonic development, undergoes photolysis in the 
presence of excessive sunlight. It would then follow that individuals should be darkly 
pigmented to prevent UV breakdown of folate (Jablonski and Chaplin, 2000).  
 
Jablonski and Chaplin (Jablonski 2004, Chaplin 2004, Jablonski and Chaplin 2000) argue 
that skin colour is determined by a combination of these factors – skin colour in a certain 
climatic region will evolve as a compromise between skins light enough to allow sufficient 
UV penetration for vitamin D synthesis, but dark enough to prevent excessive folate 
destruction (discussed in Diamond 2005). 
 
While natural variation in skin colour obviously exists, the genes involved in pigment 
production have been found by looking at the ‘unnatural’ state - the absence or abnormal 
presentation of pigmentation. The study of coat colour in mice has provided a wealth of 
information to the field. Lack of pigmentation is termed albinism. Within the human 
condition, a range of severity is observed. Individuals affected with oculocutaneous 
albinism (OCA) type 1 or type 2 have a very severe phenotype, with little or no pigment 
production. Individuals affected with rufous oculocutaneous albinism (ROCA), classified 
as OCA type 3, have a very mild phenotype and are often unaware that they have any 
abnormality. The genes for OCA1 and OCA2, tyrosinase and P respectively, have been 
extensively studied due to the fact that mutations at these loci cause such significant 
pathology.  
 
The genes for ROCA (tyrosinase related protein1) and a fourth type of OCA, OCA4 
(membrane-associated transporter protein) have been identified. The genetics of other 
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single gene disorders e.g. Waardenburg Syndrome, Hirschsprung Disease, Hermansky-
Pudlak Syndrome and Chediak-Higashi Syndrome have also been elucidated. These are 
multi-systemic disorders, where hypopigmentation is just one of the clinical phenotypes. 
 
1.2 Plan of the thesis 
 
Chapter 1 comprises a review of the literature and includes the aims of this project.  
Chapter 2 presents the subjects involved in this study and describes the methodologies 
used. As this project involved two lines of research, the results and discussion for each part 
will be presented together for the sake of clarity. Chapter 3 comprises the results of the first 
part of the project, namely the search for pathogenic mutations in albinism subjects, and 
will include a discussion of these results. Chapter 4 comprises the results of the second part 
of the project, namely the investigation of the P locus as a possible TB susceptibility locus, 
and will include a discussion of these results. Concluding remarks are made in Chapter 5.    
 
1.3 Melanogenesis 
 
By definition, albinism is distinguished from other hypopigmentation disorders by the 
presence of eye involvement in affected subjects. Melanin is required during embryonic 
development for the normal development of the eye. Optic dysfunction is caused by 
abnormalities in the fovea (the fovea is hypoplastic), misrouting of the optic fibres, 
nystagmus and strabismus. Foveal hypoplasia leads to a marked reduction in visual acuity. 
Individuals with albinism typically have a visual acuity in the range of 20/200 to 20/100. 
Misrouting of the optic tract is one of the most striking characteristics of the albino eye 
(Creel et al. 1978). 
 
In the biological spectrum there are five main pigments: hemoglobins, chlorophylls, 
carotenoids, flavanoids and melanins. Melanins are insoluable and have essentially defied 
analysis by classical techniques. Melanins are found throughout the plant and animal 
kingdoms, and fall into three major categories. Eumelanins are the brown and black 
pigments, pheomelanins are the red and yellow pigments, and plants contain certain brown 
and black pigments derived from phenols and catechols. 
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Pigment formation in mammals takes place in highly specialised cells called melanocytes, 
which contain unique cytoplasmic organelles, the melanosomes. Melanocytes are large, 
dendritic cells found in the dermal layer of the skin.  Melanogenesis is a metabolic process 
whereby the substrate tyrosine is converted into the pigment, melanin. Both the amino acid, 
tyrosine (the precursor) as well as melanin (the end-product) are stable compounds, but the 
intermediates of melanogenesis are mostly unstable, reactive substances. These melanin 
intermediates are toxic to the cell and this is why melanin biosynthesis does not take place 
in the cytoplasm of the cell, but rather must occur in a membrane-bound organelle, the 
melanosome. If tyrosinase is erroneously compartmentalised by the cell, melanogenesis 
taking place at an incorrect location in the cell could lead to cell damage and death. Several 
key steps need to be achieved for normal melanogenesis: tyrosine must be taken up and 
compartmentalised within the melanosome, the melanosomes must synthesize and store the 
melanin, and the melanosomes must be successfully transferred through the dendrites from 
the melanocyte to the surrounding keratinocytes. One melanocyte will feed 36 
keratinocytes. The keratinocytes, containing their melanin packages, will gradually move 
toward the surface of the skin, contributing to skin pigmentation. In hair bulbs, the 
melanosomes are transferred into the growing hair shaft. Thus, overall skin and hair 
pigmentation is determined by the size and shape of the melanosome, the type, amount and 
ratio of eu- to pheomelanin contained in the melanosomes that are transferred from the 
melanocytes (reviewed by Hearing, 1998). 
 
Melanogenesis is dependant on the activity of the enzyme tyrosinase. Tyrosinase becomes 
activated through a glycosylation process that occurs in the Golgi-associated endoplasmic 
reticulum (Mishima and Imokawa 1983). The glycosylated enzyme is then transported, in 
coated vesicles, to the pre-melanosome. Here, tyrosinase catalyses the initial step in the 
formation of melanin – the formation of DOPAquinone from tyrosine. A third, 
downstream, catalytic activity of tyrosinase has been shown (Korner and Pawelek, 1982), 
namely, the oxidation of dihydroxyindol. Two other regulatory enzymes in the 
melanogenic pathway have been described, the tyrosinase-related proteins 1 and 2 (TYRP1 
and TYRP2).   
 
TYRP1 possesses dihydroxyindol carboxilic acid (DHICA oxidase) activity (Kobayashi et 
al. 1994). TYRP2 was shown to have DOPAchrome tautomerase (DT) activity isomerizing 
DOPAchrome to DHICA (Tsukamoto et al. 1992). TYRP1 has been shown to be 
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associated with the production of eumelanin rather than pheomelanin in human melanoma 
cell lines (DelMarmol et al. 1993) and is thought to facilitate the specific distal step in the 
production of brown-black pigments by oxidation of DHICA before the polymerisation 
takes place. The melanogenic pathway is depicted in Fig.1.1.   
 
 
 
 
 
Eumelanogenesis results from the transformation of DOPAquinone to leucodopachrome 
and subsequent oxidation reduction reactions catalysed by post-DOPA oxidase regulators. 
Pheomelanogenesis begins with the conjugation of DOPAquinone to cysteine or 
glutathione  which is converted to the final pheomelanin product via a series of chemical 
reactions. The relative amounts of eu– and pheo-melanin produced in an individual is 
determined by their genotype as well as the cellular environment. 
 
Figure 1.1 Schematic representation of the melanin biosynthesis pathway. 
Enzymes involved in the pathway for which the genes have been identified are 
encircled to highlight their point of action (Hearing 1998).  
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1.3.1 Extracutaneous melanocytes 
 
Melanocytes in the skin and the bulb region of the hair follicles of higher vertebrates and 
primates are responsible for making pigmented melanosomes which are transferred to the 
skin and hair keratinocytes and thereby give colouration to the epidermis and the hair shaft. 
Melanocytes have been found to occur at certain other sites, namely the eye, ear and 
leptomeninges of the brain. These populations of melanocytes are not identical to 
cutaneous melanocytes, but are morphologically and functionally similar (reviewed by 
Boissy 1998a). 
 
Ocular melanocytes occur in the uvea and the retina of the eye and appear to be essential 
for the complete embryonic development of the neural retina and the neuronal network to 
the visual centre of the brain. They function to absorb light as it passes through the 
photoreceptor cells and also to transfer nutrients and waste to and from the retina. 
Melanocytes of the eye complete the process of melanisation shortly after birth and then 
remain melanogenically inactive throughout the life of the individual. 
 
Otic melanocytes are found primarily in the connective tissue of the inner ear and in the 
cochlea (Meyer zum Gottesberge 1988). These melanocytes appear to function in the 
development of the endolymph fluid and it is proposed that melanin serves to protect 
against noise and/or toxin-induced damage by absorbing excess sound waves and toxins, 
preventing subsequent damage to hair cells (Barrenas and Lindgren 1990, Conlee et al. 
1986).  
 
The meninges covering the medulla oblongata and the upper cervical cord are pigmented 
due to the presence of melanocytes in this tissue (Goldgeier et al. 1984). As with the 
melanocytes of the uvea and the retina, these cells are melanogenically inactive in the 
adult. The function of the melanocytes in the leptomeninges is not clear. 
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1.4 Racial differences in skin architecture 
 
The difference in the dark skin colour of Negroid and Australian aboriginal individuals, the 
intermediate skin colouring in Asians and Amerindians, and the lighter skin colouring of 
Caucasoids, is not attributable to a higher density of melanocytes in the darker skinned 
races. Rather, melanocyte distribution in the skin is consistent among different racial 
groups, but the type and distribution of melanosomes in the keratinocytes show distinct 
variation (Szabo et al. 1969). The melanosomes in the keratinocytes of Caucasoids and 
Asians are usually grouped together - they are seen in clusters which are surrounded by a 
membrane. Also, a granular substance is seen within the membrane-bound structure, 
between the melanosomes. In Asian skin, the melanosomes are more densely packaged 
within the membrane and there is less granular substance observed. In Negroid 
keratinocytes however, the melanosomes are larger and do not aggregate, but occur 
individually. Further, there are many more melanosomes in Negroid skin and they are also 
more melanised (i.e. darker) (See Fig 1.2.). The same situation is seen in aboriginal skin, 
with more melanosomes, larger in size and individually dispersed (Mitchell 1968). 
Interestingly, it has been shown that the normal racial distribution of melanosomes in 
keratinocytes can be altered by non-genetic factors such as ultraviolet light (Toda et al. 
1972). Following exposure to a single dose of longwave radiation and application of 
trimethyl psoralen (a photosensitising chemical), skin biopsies taken from the 
hyperpigmented areas of Caucasoid skin showed non-aggregated melanosomes that were 
significantly larger than those in control tissue biopsied from the same individual.  
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1.5 Types of albinism 
 
Albinism comprises a number of inherited disorders affecting normal pigmention. Lack of 
pigmentation may be localised to the eye (ocular albinism, OA) or may be seen in the eye, 
skin and hair (oculocutaneous albinism, OCA). While albinism was initially thought to be 
caused by different mutations in one gene, it is now apparent that the genetics of albinism 
are complex and the disorder shows locus heterogeneity. To date, nine types of OCA and 
four types of OA are described (summarised in Table 1.1). Type 1 OCA comprises 
disorders involving mutations in the tyrosinase gene (TYR) on chromosome 11, rendering 
TYR non-functional and therefore this type of albinism was initially referred to as 
tyrosinase-negative OCA. Mutations resulting in a complete lack of tyrosinase activity 
cause OCA type 1A (OCA1A). Mutations resulting in residual tyrosinase activity cause at 
least two additional types of OCA, OCA1B (yellow OCA) and OCA1MP (minimal 
pigment OCA). OCA1TS results from mutations which render the tyrosinase enzyme 
temperature sensitive. Type 2 OCA is a slightly milder phenotype and tyrosinase activity is 
normal (tyrosinase-positive OCA). OCA2 results from mutations in the P gene on 
Figure 1.2 Diagramatic representation of a dendritic melanocyte transferring mature 
melanosomes to surrounding keratinocytes in the dermal layer of the skin (Sturm et al. 
1998). The figure shows that skin colour differences between the races result from the 
number, type, level of melanisation and distribution of melanosomes within the 
keratinocytes. 
 
 
 11
chromosome 15. Brown OCA (BOCA) is also linked to the P locus, and is therefore a 
subtype of OCA2.  Red or rufous OCA (ROCA), OCA type 3, is caused by mutations in 
the TYRP1 gene on chromosome 9. More recently, a new form of human OCA has been 
described, OCA type 4. The gene involved is MATP (human chromosome 5), the human 
homologue of the mouse underwhite gene. (The gene symbol for MATP is now SLC45A2.) 
An autosomal dominant form of OCA has also described. Two distinct forms of X-linked 
OA (OA1 and OA2), an autosomal recessive form (OA3) and ocular albinism with 
sensorineural deafness have been described. 
 
 
TYPE OF ALBINISM INHERITANCE LOCUS CHR OMIM* No 
OCA1   TYR 11q14-21 203100 
   - OCA1A (tyrosinase-negative) autosomal recessive TYR   
   - OCA1B (yellow OCA) autosomal recessive TYR   
   - OCA1MP (minimal pigment) autosomal recessive TYR   
   - OCA1TS (temp sensitive) autosomal recessive TYR   
OCA2 (tyrosinase-positive) autosomal recessive P 15q11-13 203200 
   -BOCA autosomal recessive P   
OCA3 (ROCA) autosomal recessive TYRP1 9p23 203290 
OCA4 autosomal recessive MATP 5p 606574 
Autosomal dominant OCA autosomal dominant unknown  none 
OA     
   - OA1 (Nettleship-Falls) X-linked OA1 Xp22 300500 
   - OA2 (Aland Island eye disease) X-linked CACNA1F Xp11 300600 
  AROA autosomal recessive  6q13-15 203310 
  OA and deafness autosomal recessive TYR and 
MITF 
11q14-21; 
3p14-12 
103470 
*OMIM reference number = Online Mendelian Inheritance in Man 
(www.ncbi.nlm.nih.gov) 
OCA2 is by far the commonest form of albinism worldwide, due essentially to its high 
frequency in sub-Saharan Africa. OCA2 is the most common autosomal recessive genetic 
condition in black populations of sub-Saharan Africa (illustrated in Figure 1.3).  
Table 1.1. Types of albinism 
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Figure 1.3 Photograph of the rock star, Bono, visiting a school in Lesotho (TIME April 2, 
2007). In this picture, 27 random black high school students are captured on film, one of 
whom happens to be affected with albinism – an illustration of how common this disorder 
is amongst southern African black individuals. 
 
(In other parts of Africa, sickle cell anaemia is the most common autosomal recessive 
disease, carrier numbers having reached such high frequencies due to heterozygote 
advantage in the presence of endemic malaria.) 
The overall frequency of OCA in many population groups is about 1 in 20 000 (Witkop et 
al. 1989). The frequencies of the different types of OCA as they occur in given population 
groups is given in Table 1.2. OCA2 is far more common in black populations of African 
origin than in Caucasoid populations. 
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Table 1.2. The estimated prevalence of albinism in different population groups. 
 
TYPE POPULATION PREVALENCE REFERENCE 
OCA2 African   
 Cameroon 1 in 35 000 Aquaron 1990 
   - Bamileke, Cameroon 1 in 7 900 Aquaron 1990 
 Nigeria 1 in 5 000 Barnicot 1952 
   - Ibo, Nigeria 1 in 1 100 Okoro 1975 
 South African blacks 1 in 3 900 Kromberg & Jenkins 1982 
 Tanzania 1 in 1 400 Luande 1985 
 Zimbabwe 1 in 4 200 Lund 1996 
 European   
 Northern Ireland 1 in 10 000 Froggatt 1960 
 Norway 1 in 9 650 Magnus 1992 
 American    
 USA Caucasoid 1 in 36 000 Witkop et al. 1989 
 USA African-American 1 in 10 000 Witkop et al. 1989 
 USA Amerindian   
   - Zuni Indians 1 in 240 Witkop et al. 1972 
   - Hopi Indians 1 in 227 Woolf and Grant 1962 
 USA Brandywine isolate 1 in 85 Witkop et al. 1972 
OCA1 USA Caucasoid 1 in 39 000 Witkop et al. 1989 
 USA African-American 1 in 28 000 Witkop et al. 1989 
BOCA South African blacks Unknown Manga et al. 2001b 
ROCA South African blacks 1 in 8 500 Kromberg et al. 1990b 
OA1 General 1 in 50 000 O’Donnell and Green 1989 
 
1.5.1 Tyrosinase related albinism (MIM 203100) 
 
Worldwide, the second most common form of albinism after OCA2 is OCA1. This type of 
albinism is caused by a loss of function of the enzyme tyrosinase. The condition was first 
diagnosed using the classic hair-bulb assay (King and Witkop 1976): the tyrosinase enzyme 
is localised to the melanocytes, thus the hair-bulb of a freshly plucked hair provides the 
most accessible tissue source. The hair-bulb is incubated in a high concentration tyrosine 
solution. Tyrosine (the precursor of melanin biosynthesis) will move into the hair-bulb and 
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if tyrosinase is present, melanin will be synthesised. A positive hair-bulb assay thus 
indicates the type of albinism is OCA2, while a negative result indicates OCA1. (Some 
forms of OCA1 with residual TYR function will show pigmented hair bulbs.)  Molecular 
testing is now the method of choice to confirm a clinical diagnosis and to categorise the 
type of OCA. Individuals with OCA1 present at birth with marked hypopigmentation, the 
skin is milky-white, the hair white and the eyes light blue. The eyes may become a darker 
blue over a number of years, the skin may appear to gain colour over time, but never gains 
the ability to tan and will burn on exposure to the sun. Pigmented lesions like nevi, freckles 
or lentigines are rarely observed on the skin. 
 
1.5.1.1 OCA1A: Tyrosinase-negative OCA 
 
Individuals with OCA1A have no pigment in the skin, hair or eyes at birth, and 
pigmentation does not occur over time (see Fig 1.4). The ultrastructure of the melanocyte 
and the melanosomes is normal, but melanosomes do not reach maturity. Melanocyte 
distribution in the appropriate tissues is normal. 
 
 
 
 
Figure 1.4 A Caucasiod individual affected with OCA1. Eye abnormalities are a 
phenotypic presentation, distinguishing albinism from hypopigmentation. 
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1.5.1.2 OCA1B: Yellow-mutant OCA 
 
This type of albinism is caused by tyrosinase mutations which do not render the enzyme 
completely non-functional, so-called ‘leaky’ mutations. Some residual tyrosinase activity 
(5 - 10%) is apparent in the eye and most obviously, the hair. The hair becomes yellow in 
colour due to the production of pheomelanin. This type of albinism was first described in 
the Amish population of Indiana (Nance et al. 1970). Affected individuals show the 
extreme hypopigmentation present at birth characteristic of OCA1, but pigment will begin 
to accumulate during the first decade of life and the hair colour will become light yellow or 
blond by adolescence (the phenotype may closely resemble very fair individuals of 
Scandinavian origin). Affected individuals with near-normal amounts of skin and hair 
pigmentation may be erroneously diagnosed as having OA. There is a great degree of 
variability in the phenotype caused by different mutations resulting in more or less residual 
tyrosinase activity.  
 
1.5.1.3 OCA1MP: Minimal-pigment OCA 
 
This type of OCA1 is very similar to OCA1A with a severe hypopigmentation phenotype, 
but minimal pigment is seen to accumulate in the iris of the eye in the first decade of life. It 
is not certain whether or not this phenotype warrants a distinct classification, but evidence 
of a mouse phenotype would support such a distinction: an allele at the murine c locus 
(c44H) results in residual tyrosinase activity and the accumulation of pigment in the eye 
only. This murine phenotype is termed dark-eyed albinism. The other possibility is that this 
phenotype falls into the range of yellow OCA, but the tyrosinase enzyme has even less 
activity than in yellow OCA. Affected individuals are often born with pigmented irides (or 
pigment will accumulate during the first decade) but the skin and hair is completely white. 
The hair may develop a slight yellow colour with time. So-called ‘Platinum OCA’ is most 
likely the same phenotype. From studies of hair-bulb tyrosinase activity in the obligate 
heterozygote parents of affected individuals, it would appear that OCA1MP results from 
compound heterozygosity for a severe OCA1 mutation (OCA1A or OCA1B) and a less 
severe mutation (King and Olds 1985). 
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1.5.1.4  OCA1TS: Temperature-sensitive OCA 
 
The phenotype of this type of albinism is most obvious in the Siamese cat and the 
Himalayan rabbit where the body is hypopigmented but the extremities (the nose, ears, tail 
and paws) are pigmented. The tyrosinase enzyme is functional only at the slightly lower 
temperature present at the extremities and looses its function at the higher body 
temperature. A case has been documented in humans, but the condition is rare (King et al. 
1991). The proband described in this study presented at birth with a phenotype consistent 
with that of OCA1A. However, at the time of puberty, the hair on her arms became light 
brown in colour and the leg hair turned dark brown. The hair on her head remained white, 
as did the skin, and the eyes remained blue. Analysis of tyrosinse activity in this individual 
showed that the enzyme lost its catalytic activity above 35oC. Ultrastructural analysis of 
melanocytes in hair-bulbs taken from scalp hair and then from leg hair showed that stage I 
and II melanosomes were present in melanocytes from the scalp, but stage III and IV 
melanosomes were present in the melanocytes of leg hair follicles. 
 
1.5.2  P gene related albinism (MIM 203200) 
 
1.5.2.1  OCA2 
 
OCA2 is caused by mutations at the P locus on chromosome 15q. A somewhat milder 
phenotype than OCA1 is seen in individuals with OCA2: the eyes are usually pigmented 
(blue-grey or light brown in colour) and pigment will accumulate in the hair over time 
(pheomelanin) giving it a straw-coloured appearance. The skin is creamy white and cannot 
tan (see Fig 1.5). Patches of pigmentation may also develop on the sun exposed regions of 
the skin (freckles, nevi and lentigines). The ultrastructure and distribution of the 
melanocytes is normal (Witkop et al. 1973). 
 
Black individuals in sub-Saharan Africa affected with OCA2 may present with an 
interesting phenotype. Approximately 61% of these OCA2 individuals will develop 
ephelides (Kromberg et al. 1989). Ephelides are darkly pigmented patches, similar to large 
freckles.  
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They are dendritic in conformation, with a central area of pigmentation and finger-like 
projections (see Fig 1.5). Ephelides are not present at birth, but develop from the second or 
third years of life. Ephelides usually only appear on the sun-exposed regions of the skin 
(the face, neck, forearms and hands), suggesting that they develop in reaction to UV light 
exposure. Individuals who develop ephelides seem to be protected, to some extent, against 
radiation damage caused by the sun since they have fewer skin cancers early in life 
(Kromberg et al. 1989). 
 
If more than one member of a family is affected with OCA2, they will either all develop 
ephelides or none of them will develop ephelides (Kromberg et al. 1989). This observation 
has led to the hypothesis that the development of ephelides has a genetic basis and is not a 
random occurrence. Initially it was proposed that the nature of the mutation in individuals 
who develop ephelides might be similar to the mutation in the pun mouse (Ramsay et al. 
1992). By this model, the OCA2 mutation would show a localised reversion to wild-type in 
the area comprising the ephelus, and normal pigment production could occur. However, 
with the elucidation of the common African OCA2 mutation (Durham-Pierre et al. 1994), 
the 2.7 kb deletion mutation, and its subsequent description in the homozygous state in 
 
Figure 1.5 The OCA2 phenotype with and without ephelides. The individual on the left is a 
black individual affected with OCA2. This individual has not developed ephelides despite 
age and sun exposure. The boy on the right is a black individual affected with OCA2 who 
has developed ephelides. 
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OCA2 individuals with ephelides (Stevens et al. 1995), it is now obvious that this is not the 
molecular mechanism which allows for the development of the ephelides phenotype.  
 
1.5.2.2  BOCA: Brown OCA 
 
It was originally presumed that this type of albinism occurred only in black Africans and 
African-Americans, but Caucasoid individuals with this form of albinism have been 
described (King et al. 1980, 1985a). Amounts of eumelanin in the skin and eyes are 
reduced but not absent. The phenotype in affected individuals from the black population is 
one of light brown skin, darker coloured hair and light brown or grey eyes (see Fig 1.6). 
Affected individuals present with the same ocular defects as seen in other types of 
albinism. The Caucasian phenotype was described as being essentially similar to OCA2, 
with white skin and golden blond hair. At the time the gene defect involved in BOCA was 
not known. The brown locus has been identified in humans, and BOCA is linked to the P 
locus on chromosome 15q (Manga et al. 2001b). Thus OCA2 and BOCA are allelic, with 
BOCA possibly being caused by milder mutations in the P gene. As these conditions are 
caused by mutations at the same locus, it is possible to have individuals affected with either 
BOCA or OCA2 in the same family. 
 
 
 
Figure 1.6 A black family with three children affected with albinism, one affected with 
BOCA and two with OCA2. The boy on the left is affected with the slightly milder BOCA 
phenotype. Two sibs have classic OCA2, while the oldest sister (background) and father 
(right) are unaffected. 
 19
If parents have children some of whom are affected with BOCA and some of whom are 
affected with OCA2, then one parent at least needs to be affected with BOCA. In the 
family photographed above, it must be assumed that the mother was affected with BOCA, 
carrying one severe and one mild P gene mutation. The father is normally pigmented, but a 
carrier of OCA2, therefore carrying one severe P gene mutation.  
 
Molecular P gene mutation analysis in 10 BOCA individuals showed 9 to be compound 
heterozygotes for the severe 2.7 kb deletion mutation and another unidentified mutation 
(Manga et al. 2001b). Despite extensive further mutation analysis, a second P gene 
mutation could not be identified in any individual. Haplotype studies showed several 
BOCA-associated haplotypes exist, making a second common mutation unlikely, although 
the haplotypes could be divided into two core groups, suggesting a limited number of P 
gene mutations give rise to this phenotype (Manga et al. 2001b). It is proposed that the 
second mutation in these individuals is likely to be a milder, ‘leaky’, mutation.  
 
Boissy et al. (1996) described an African-American patient with the BOCA phenotype. On 
melanocyte culture, it was found the cells contained no detectable amounts of TYRP1 
using various anti-TYRP1 probes. Mutation analysis showed the patient was homozygous 
for a 1 bp deletion in exon 6 of the TYRP1 gene. These authors (Boissy et al. 1996) 
concluded that this mutation affects the ability of the TYRP1 gene to interact with 
tyrosinase, leading to dysregulated tyrosinase activity which promotes the synthesis of 
brown melanin as opposed to black melanin. This paper classified BOCA as OCA type 3 
(in agreement with the discussion above); however, this patient having a different gene 
affected, TYRP1 as opposed to P, has led to some controversy.    
 
1.5.3  Other forms of albinism 
 
1.5.3.1  OCA3 (Rufous OCA, MIM 203290) 
 
Rufous oculocutaneous albinism has been described in the native population of Papua New 
Guinea (Walsh 1971), families in the northwest of Puerto Rico (King et al. 1978, 1986) and 
black Africans (Kromberg et al. 1990). Individuals with ROCA have a reddish-bronze skin 
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colour, ginger coloured hair (which is lighter in colour than the skin) and the eyes are blue 
or brown (see Fig 1.7).  
 
 
 
 
 
Figure 1.7 A black individual (right) affected with ROCA standing next to a normally 
pigmented individual. 
 
 
The visual anomalies of OCA3 are often mild but nystagmus and misrouting of the optic 
tract have been described in certain individuals (Kromberg et al. 1990), lending support to 
the delineation of this phenotype as a form of OCA. The prevalence of ROCA in southern 
Africa is approximately 1 in 8 500 (Kromberg et al. 1990). ROCA is caused by mutations 
at the tyrosinase-related protein 1 (TYRP1) locus, and two common mutations have been 
described (Manga et al. 1997). The nonsense mutation, S166X, and a second mutation, 
368delA, account for 45% and 50% respectively, of ROCA chromosomes in southern 
Africa. 
 
1.5.3.2  OCA4 (MIM 606574) 
 
Due to the observation that certain individuals with OCA were not found to have either 
TYR or P gene mutations, it was proposed that other form/s of OCA may exist (Passmore et 
al. 1999). Researchers in the laboratory of Murray Brilliant chose the human homologue of 
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the mouse gene, underwhite (uw), as a good candidate for being involved in another form 
of human albinism, and cloned the gene at the mouse uw locus (Newton et al. 2001). The 
mouse uw gene encodes a protein that is predicted to span a lipid bilayer and shows highest 
homology to sucrose-transporter proteins found in plants. The gene has been renamed matp 
(for membrane-associated transporter protein). The human homologue was subsequently 
identified through database searches and alignments (Newton et al. 2001).  
 
The human gene, MATP (now called SLC45A2), is located on chromosome 5p. A group of 
102 individuals with hypopigmentation were screened for mutations in the MATP gene. 
Mutations were identified in one individual, of Turkish descent. His phenotype most 
closely resembled that of an OCA2 individual but he had no detectable P gene mutations. 
A study of 75 unrelated albinism patients in Japan revealed that 18 of them (24%) carried 
MATP mutations, making this the most common locus for tyrosinase-positive OCA in 
Japan (Inagaki et al. 2004). A study on 176 German patients with albinism identified 5 
individuals (3%) with OCA4 (Rundshagen et al. 2004). Like the P protein, MATP has been 
shown to have 12 transmembrane domains and is also predicted to function as a 
transporter. Work in mice has shown that tyrosinase is synthesised at normal levels in 
uw/uw melanocytes, but activity levels are only about 20% of that found in wild-type 
melanocytes (Costin et al. 2003). Further, in individuals with OCA4, melanocytes secrete 
melanosomes which are mostly immature. These authors propose that tyrosinase 
processing and trafficking to the melanosome is disrupted by the aberrant MATP 
transporter and that the tyrosinase enzyme is abnormally secreted from the melanocytes in 
the early stage melanosomes.  
 
1.5.3.3  Autosomal dominant OCA 
 
While families have been described where albinism seems to be segregating as an 
autosomal dominant trait (Bergsma et al. 1974, Fitzpatrick et al. 1974), it is not certain 
whether this is a true form of OCA. The family described by Bergsma et al. showed 
affected parents and children, but normal grandparents. The albinism in this family is 
possibly exhibiting a pseudo-dominant pattern of inheritance (King et al. 1995). The other 
family (Fitzpatrick et al. 1974) does not meet the most definitive criterion for OCA as there 
is no eye involvement. 
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1.5.3.4  Ocular albinism 
 
Ocular albinism (OA) is far less prevalent than either OCA1 or OCA2. While the 
phenotypic manifestation is hypopigmentaion of the eye, ultrastructural changes of the skin 
and hair are present. 
 
X-linked recessive ocular albinism (OA1, MIM 300500)  
 
This type of albinism is also called Nettleship-Falls ocular albinism. Affected males show 
all the ocular features of albinism (Charles et al. 1993) with the eyes being blue to brown in 
colour. The skin and hair are normally pigmented. Heterozygous females do present with 
clinical features in 80% of cases (Charles et al. 1992) with pigment changes in the eye 
being apparent. This is due to X-chromosome inactivation patterns. In certain cases, 
heterozygous females will present with the ocular albinism phenotype, presumably due to 
non-random X-inactivation. The melanocytes in OA are normal, but abnormalities in the 
melanosomes are evident: very large melanosomes are present in the melanocytes, not only 
of the iris and retina, but also in the skin and hair follicles. The presence of these “giant 
melanosomes” in multi-systemic organs suggests this disorder may in fact be a type of 
OCA, with major manifestations in the eye. The gene for X-linked OA was mapped to 
Xp22.3-22.2 (Schnur et al. 1991) and has subsequently been cloned (Bassi et al. 1995). 
 
X-linked recessive ocular albinism (OA2, MIM 300600) 
 
A large kindred from the Aland Islands was described (Forsius and Efiksson 1964) with 
males affected with a type of OA considered distinct from OA1. Patients presented with the 
severe eye anomalies characteristic of OA1 as well as myopia, astigmatism and 
colourblindness. Female carriers did not exhibit the complete pigment deficiency 
characteristic of OA1. Van Dorp et al. (1985) showed there was no misrouting of the optics 
pathways in affected males. A study by Hawksworth et al. (1995) on a Welsh pedigree 
with X-linked congenital nystagmus and manifestation in some females, proposed a clinical 
diagnosis of either Aland Island eye disease (AIED) or congenital stationary night 
blindness. The genes for both conditions had been previously mapped to proximal Xp, 
leading these authors to suggest these might be the same disease. Molecular analysis of a 
Finnish family with AIED identified mutations in the CACNA1F gene which maps to 
Xp11.23-11.22 (Wutz et al. 2002). 
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Autosomal recessive ocular albinism (OA3, MIM 203310) 
 
Four families were described (Witkop et al. 1978) where males and females were equally 
affected with ocular albinism. Several isolated cases of affected females were also 
described. Affected individuals present with ocular albinism and normal cutaneous 
pigmentation. All the cases described to date have been amongst Caucasoids, the clinical 
phenotype has not been found in black African or African-American subjects (King et al. 
1995). It has been proposed that the locus for AROA lies on chromosome 6q13-q15 (Rose 
et al. 1992). These authors studied a dysmorphic boy who had the features of OA and was 
found to carry a cyotogenetic deletion of chromosome 6q. Ultrastructural analysis of the 
cutaneous melanocytes showed an absence of giant melanosomes. It is thus debatable 
whether this individual had OA or not, the hypopigmentation may be simply part of the 
chromosome abnormality syndrome.  
 
Like autosomal dominant OCA, it is thus still debatable whether this is a true distinct form 
of albinism, and the clinical manifestations observed may be due to mild or leaky 
mutations in either tyrosinase or the P gene. A 7 year old girl of northern European origin, 
initially thought to have AROA, was investigated at the molecular level and found to be a 
compound heterozygote for two P gene mutations (Lee et al. 1994a), lending support to the 
latter theory.  
 
Ocular albinism with sensorineural deafness (MIM 103470) 
 
Lewis (1978) described 7 affected males and 5 affected females in a large pedigree of 
Caucasian origin. Patients presented with classic OA plus deafness. In a family initially 
presented by Bard (1978) and then later further investigated by Morell et al. (1997), sibs 
with heterochromatic irides were described, as well as an individual with a prominent white 
forelock, characteristic of Waardenburg syndrome. Morell et al. (1997) undertook 
molecular analysis in this family and found affected individuals to show an apparent 
‘digenic’ pattern of inheritance – the phenotype resulting from mutations in 2 distinct 
genes. Patients were heterozygous for a mutation in the MITF gene (which, when mutated, 
causes Waardenburg syndrome) and either heterozygous or homozygous for a variant in the 
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tyrosinase gene, R402Q. This TYR polymorphism is known to be associated with reduced 
enzyme activity (Tripathi et al. 1991).  
 
1.6 Other hypopigmentation disorders 
 
Melanocytes are embryonically derived from the neural crest. Melanoblast cells will 
migrate out of the dorsal surface of the neural tube along its entire length, and migrate to 
several target sites of the developing embryo. Melanoblasts will migrate to areas in four 
organ systems: the skin, the eye, the ear and the brain. Melanoblasts move to the basal 
epithelium of the epidermis and the hair bulbs in the skin, to the uveal tract of the eye, to 
the stria vascularis, the vestibular organ and the endolymphatic sac of the ear, and the 
leptomeninges of the brain. Once at these sites the melanoblast will differentiate into the 
melanin-producing cell, the melanocyte. Melanocytes in adult tissue rarely divide or 
migrate. Further, while melanocytes in the skin and hair bulbs remain melanogenically 
active, those in the extracutaneous sites become melanogenically inactive for the life of the 
individual. As many gene products are made and used by the melanocyte as it differentiates 
and migrates to its target site, there are consequently numerous points at which a mutation 
in a given gene may disrupt the normal melanogenesis process and lead to a 
hypopigmentation disorder. 
 
1.6.1 Neural Crest Defects 
 
Since the time that Darwin observed deafness in white, blue-eyed cats a complex picture 
has emerged of the association between embryonically derived neural crest cells and the 
presence of melanin pigmentation. Mutations affecting the early stages of melanoblast 
migration result in failure of these cells to reach their target tissue and the disorders which 
result present with de-pigmented lesions which contain no melanocytes.  
 
1.6.1.1 Waardenburg Syndrome (WS1 and WS2: MIM 193500; WS3 MIM 148820)  
   
 Individuals with Waardenburg syndrome present with patches of cutaneous 
depigmentation, which are variable in size and number. The irides of the eye are partially 
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or unilaterally different in colour and deafness, of varying severity, results from the 
reduction or absence of melanocytes in the cochlea. Mutations in the PAX3 gene lead to 
Waardenburg syndrome type 1 and type 3. PAX3 maps to human chromosome 2q35-37.3 
(Tassabehji et al. 1992, Hoth et al. 1993). These disorders are inherited as autosomal 
dominant traits. Interestingly, homozygotes present with a more severe phenotype than the 
heterozygotes, suggesting a dosage effect of the gene product. The PAX3 gene encodes a 
transcription factor with three functional domains mediating DNA binding, and a 
transcription activation site (Walther et al. 1991, Wilcox et al. 1992). In some cases, but 
not in most, Waardenburg syndrome type 2 is caused by mutations in the micropthalmia-
associated transcription factor gene, MITF, (Hughes et al. 1994, Tassabehji et al. 1994) on 
human chromosome 3p12. WS2 patients who do not carry MITF mutations have mutations 
in some, as yet undiscovered, gene/s. MITF is the human homologue of the mouse 
micropthalmia locus. The MITF protein functions as a transcription factor and has been 
shown to bind to tyrosinase and TYRP1 (Yasumoto et al. 1995), activating these proteins. 
In this way MITF is thought to upregulate melanin synthesis. In the mouse, mutations 
affecting different functional domains dictate whether the disease is inherited in a recessive 
or a dominant fashion. In the human system, all MITF mutations show an autosomal 
dominant mode of inheritance. 
 
1.6.1.2 Hirschsprung Disease (MIM 142623) 
 
 Hirschsprung disease presents with congenital megacolon resulting from the absence of the 
neural crest derived cells in the smooth muscle of the intestinal wall. In a proportion of 
cases, hypopigmentation occurs together with heterochromatic irises and deafness. The 
disease shows locus heterogeneity as the phenotype can arise from mutations in several 
different genes, operating alone or in combination with each other (see OMIM or 
GeneCards for overview). However it appeared that clinically mutations at one locus were 
neither necessary nor sufficient to cause disease. Carrasquillo et al. (2002) conducted a 
genome-wide scan looking for areas of linkage disequilibrium due to common ancestry in a 
cohort of Mennonite families. They identified 3 areas of susceptibility – on chromosomes 
10q11, 13q22 and 16q23. They showed the gene at 13q22 is EDNRB and the gene at 10q11 
is RET. Mouse crosses between ret null and ednrb mice showed non-complementation and 
joint transmission. Also, joint transmission of RET and EDNRB alleles in affected 
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Hirschsprung disease patients lead these authors to suggest an epistatic effect between the 
two loci leading to disease presentation.  
 
1.6.1.3 Piebaldism (MIM 172800) 
 
Piebaldism is an autosomal dominant disorder characterised by white patches of skin 
(predominantly on the face, chest and abdomen) and hair, which entirely lack melanocytes. 
The distinctive phenotype allowed this disorder to be one of the first genetic traits 
recognized to exhibit autosomal dominant inheritance (Morgan 1786 as cited in Spritz 
1992). Pedigrees have been described where a proportion of the affected individuals also 
present with deafness (Reed et al. 1967, Comings and Odland 1966 as cited in Spritz and 
Beighton 1998) but this is not common and it is generally held that the defects in this 
condition are essentially cosmetic. Like vitiligo, the patches of affected skin are 
characterised by a reduction in the number of melanocytes, down to complete absence. 
Mutations in the KIT gene on chromosome 4q12 have been shown to result in piebaldism 
(Fleischman et al. 1991, Giebel and Spritz 1991b, Spritz et al. 1992). The murine 
phenotype of piebaldism is “dominant white spotting”. The KIT protein functions as a 
plasma membrane receptor. After binding with the ligand, the receptor initiates a chain of 
events which upregulate melanocyte proliferation (Spritz et al. 1994). Different types of 
mutations lead to milder or more severe phenotypes, as do mutations in different positions 
in the gene (Spritz et al. 1992, reviewed in Boissy and Nordlund 1997). Certain 
heterozygous missense mutations have a “dominant negative” effect in that the mutant 
dominant allele interferes with the action of the wild-type allele resulting in as much as a 
75% loss of normal receptor function (Spritz et al. 1992 a and b). 
 
1.6.2 Organelle Defects 
 
 After the melanoblasts leave the neural crest and migrate to specific target sites, they will 
complete their differentiation. Here defects within the melanocyte resulting in an inability 
to produce pigment result in oculocutaneous albinism (OCA). A further group of disorders 
involve not only defective melanin production by the melanosome, but also abnormal 
organellogenesis in other cell types. Disorders of cytoplasmic organelles are exemplified 
by Hermansky-Pudlak syndrome and Chediak-Higashi syndrome. 
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1.6.2.1 Hermansky-Pudlak Syndrome (MIM 203300) 
 
 The Hermansky-Pudlak syndrome (HPS) is characterised by three distinguishing 
phenotypes: oculocutaneous albinism, bleeding diathesis due to a deficiency in the platelets 
and a lysosomal ceroid storage disease. Three different organelles (melanosomes, platelet 
dense granules and lysosomes), in different cell types, are seen to be affected. Melanocytes 
in the hair and skin are normal, but lack fully developed melanosomes, only stage I and II 
melanosomes are found. The disorder was found to be particularly common in two 
inbreeding population isolates, one in the Swiss Alps and the other in Puerto Rico. (HPS is 
probably the most common single gene disorder in Puerto Rico with an estimated carrier 
frequency of 1 in 21 due to founder effect (Wildenberg et al. 1995). These populations 
were used in the mapping of the first locus for HPS to chromosome 10q23 (Fukai et al. 
1995). The gene at this locus has since been cloned (Oh et al. 1996). It has been shown that 
the syndrome shows locus heterogeneity as it can be caused by mutations in several genes, 
seven loci have been identified to date (HPS1 – HPS7), all mapping to different 
chromosomes. 
 
1.6.2.2 Chediak-Higashi Syndrome (MIM 606897) 
 
The Chediak-Higashi syndrome (CHS) is a rare autosomal recessive disorder characterised 
by incomplete oculocutaneous albinism, recurrent and severe infections, a bleeding 
tendency and enlarged granules in many cell types. Most patients die in childhood. Giant 
inclusion bodies in peripheral blood cells are diagnostic of the disease, and melanocytes 
contain giant hypomelanotic melanosomes (about five times their normal size). These large 
melanosomes cannot be transferred to the keratinocytes. The gene for CHS has been cloned 
in human (Barbosa et al. 1996, Nagle et al. 1996) and mouse (Barbosa et al. 1996, Perou et 
al. 1996). The human CHD locus is on chromosome 1q43 and is the homologue of the 
murine beige locus. 
 
1.6.3 Acquired hypopigmentation defects 
 
Many agents – chemical, pharmacological, infectious – may induce areas of 
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hypopigmentation on the skin and/or hair. Two conditions, namely leprosy and 
tuberculosis, will be discussed due to their relevance to this study. 
 
1.6.3.1 Leprosy (MIM 246300) 
 
In 1882 Robert Koch identified the tubercule bacillus, Mycobacterium tuberculosis, and 
this became established as the ‘typical’ mycobacterium. In the time following this 
discovery, other mycobacteria were described and these were consequently classed as 
‘atypical’ mycobacteria. There are 10 species of atypical mycobacteria described 
(discussed by Meyers 1991) which cause infections of the skin. One of these organisms is 
the bacterium, M. leprae.  
 
M. leprae causes leprosy, a chronic disease affecting the cooler parts of the body: the skin, 
upper respiratory tract, superficial portions of peripheral nerves and the testes. Skin lesions 
are the earliest manifestation of the disease, and these lesions are often hypopigmented. In 
tuberculoid leprosy, a subtype of leprosy, these lesions have sharply demarcated edges and 
they range in size from 1 cm in diameter to lesions that cover an entire area of the body, 
e.g. a cheek or thigh. Major clinical symptoms are also observed in the nervous system. In 
lepromatous leprosy, appropriate immune responses from the body fail, and bacteria spread 
through the skin to the peripheral nerves. Deeper tissues do not become affected because 
bacteria reproduce optimally at temperatures between 27°C and 30°C. Pain in the 
peripheral nerves is experienced with a loss of sensation, usually in the hands and feet. 
Leprosy affects approximately 15 million people worldwide (World Health Organization), 
a large number (50%) of whom live in Africa and India. Leprosy is an infectious disease 
spread most commonly by skin-to-skin contact, nasal secretions, mother’s milk and 
possibly placental transmission from the mother to the fetus. Interestingly, animals have 
been found affected with leprosy, and the bacteria isolated from three different animal 
species is indistinguishable from the human pathogen. Naturally acquired leprosy has been 
described in armadillos in Louisiana and Texas, in a chimpanzee from Sierra Leone and in 
a mangabey monkey from West Africa. The armadillo population in Louisiana has received 
special attention, with up to 10% of the wild population being infected with leprosy. 
Susceptibility of the armadillo is probably due, in large part, to the temperature of the 
central body portion of the animal which is 32-35°C.  
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Like tuberculosis, susceptibility to leprosy has been shown to have a genetic component. 
The disease will only manifest clinically in a small subset of individuals who have been 
exposed to the pathogen. Familial aggregation is evident, such that distribution of the 
disease among sibs is not random. A case study undertaken in Papua New Guinea (Shields 
et al. 1987) found that the disease showed family clustering even though the social unit of 
the population was the community and not the family. A study by Kaur et al. (1997) looked 
at two polymorphic loci in a sample of individuals from New Dehli. These two loci are on 
human chromosome 2q31-33, a region showing synteny to the area of the mouse genome 
where the Bcg locus is found. The murine Bcg locus influences susceptibility to 
intracellular parasites. An allele of one of these loci, the 104 bp allele of the CTLA4 locus, 
was not found in any of the leprosy patients studied (N=25), leading these authors to 
conclude that the 104 bp allele is correlated with host resistance to developing leprosy, and 
absence of this allele may be a possible risk factor for the disease. Using a cohort of 
families with affected sib-pairs from south India, Siddiqui et al. (2001) found significant 
linkage (lod score=4.09, p=0.00002) to chromosome 10q13. Mira et al. (2003) described a 
genome-wide search for susceptibility loci to leprosy in a southern Vietnamese population 
and found a susceptibility locus on chromosome 6q25.  
 
1.6.3.2 Tuberculosis 
 
While hypopigmented patches in leprosy have been well documented, infection with the 
mycobacterium M. tuberculosis has, very interestingly, also been shown to alter cutaneous 
pigmentation. A field doctor working in Nigeria observed that African patients infected 
with tuberculosis (TB) presented with a ‘relative hypochromia’, particularly of the face 
(Pearson 1978, Pearson 1989).  Melanocytes in the face are twice as numerous per square 
millimeter of skin, as compared to any other part of the body, hence it follows that a 
change in melanin concentration would be more apparent in the face/cheeks. Scientific 
investigation showed that the hypochromia was significantly different when TB patients 
were compared to a control group of individuals, matched for ethnicity, socio-economic 
background, sex and age. Re-pigmentation resulted upon successful treatment of the 
tuberculosis (within 3-6 weeks of commencement of antibiotic therapy).  
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Many genes have now been described which may work singly but probably work in 
combination with each other, to determine susceptibility to TB. Gene variants at loci such 
as HLA, NRAMP1, Vitamin D receptor and the mannose-binding protein (MBL2) have all 
been investigated for a possible role in TB susceptibility (discussed further at the end of 
this chapter).  
 
1.7 Mouse pigment loci 
Several mouse coat colour mutations were documented as early as the late 19th century. 
Initially, mice were bred purely for aesthetic purposes, and the breeder’s hobby known as 
the “mouse fancy” was established. Scientific experiments on the genetics of coat 
pigmentation began in the first two decades of the 20th century. Early genetic experiments 
looked at mouse coat colour because of the obvious phenotype available for analysis. 
Consequently, a wealth of knowledge is now available and the genetics of pigmentation is 
the best understood complex developmental system in the mouse. To date, at least 127 loci 
affecting coat colour in the mouse have been described (reviewed by Bennett and 
Lamoreaux, 2003). Only about 60 of these genes have been cloned and all of them appear 
to have human orthologues. Six of those most relevant to the present study are reviewed 
below: 
 
1.7.1 The pink-eyed dilution locus (p) 
 
Mutations at the pink-eyed dilution (p) locus in mice cause a hypopigmentation phenotype 
affecting both the coat and the eyes. The pink-eyed dilution phenotype is one of the oldest 
described mouse variants and is caused by mutations at the p locus. The p locus is located 
on mouse chromosome 7 (a region showing synteny to human chromosome 15q). At least 
100 alleles are known to occur at this locus but many of these did not arise spontaneously 
and are radiation-induced deletions (Lyon et al. 1992). Mutations at this locus result in a 
range of phenotypes in the mouse, ranging from slightly lighter coat colour with dark eyes, 
to the classic white (albino) mouse with pink eyes. The gene at the p locus has been cloned, 
and is termed the p gene (Gardner et al. 1992). The human homologue, the P gene, is 
responsible for the oculocutaneous albinism type 2 (OCA2) phenotype (Rinchik et al. 
1993) and will be discussed below in further detail.   
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1.7.1.1 The pun allele 
 
One of the mutant alleles at the p locus is the spontaneously arising pink-eyed unstable 
(pun) variant (Melvoid 1971, Gondo et al. 1993). The pun allele constitutes a 70 kb head-to-
tail duplication of genomic DNA within the p gene. The duplication includes exons 6-18, 
with breakpoints in introns 5 and 18 (Oakey et al. 1996) and results in a larger mRNA 
transcript and a non-functional protein. Unlike other p alleles, this mutation is associated 
with a very high reversion frequency. The pun allele exhibits the highest reversion rate 
reported in mammals (discussed in Brilliant et al. 1991). Up to 3.5% of offspring from the 
cross of two pun homozygous mice will show patches of wild-type coat colour (Melvoid 
1971) (See Fig 1.8).  
 
 
This phenotype is due to somatic reversion of the mutation - the duplicated sequence is lost 
in the cells where pigment can be produced. Tandem head-to-tail duplications (but not 
inverted duplications) allow for the loss of one of the duplicated copies by homologous, but 
unequal cross-over during meiosis. 
 
1.7.2 The agouti (a) locus 
 
The agouti mouse shows a characteristic hair banding pattern: alternate bands of black and 
yellow along the hair shaft. The mouse agouti locus (a) has been mapped to chromosome 2 
and the gene cloned (Bultman et al. 1992). The gene spans 18kb of genomic DNA and the 
 
Figure 1.8.  The pun mouse. Dark patches of coat colour represent areas of spontaneous 
reversion to wild type. 
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4 exons encode a mRNA transcript of 0.8 kb. The gene is not expressed in melanocytes. 
The agouti protein acts as a ligand for the melanocyte stimulating hormone receptor 
(MC1R), resulting in competitive inhibition between the agouti protein and melanocyte 
stimulating hormone (MSH). Over 18 alleles at this locus have been described, the wild 
type allele (A/A) gives the typical banded pattern while the homozygous mutant mouse 
(a/a), nonagouti, has only black hair. There is a lethal yellow allele (Ay) that when present 
in the heterozygous state (Ay/a) results in an all yellow coat, but is lethal in the 
homozygous state (Ay/Ay). Heterozygosity of the Ay allele is associated with obesity and 
sterility. The Ay mutation is not within the coding region of the agouti gene. Rather, the 
phenotype results from a DNA structural alteration that disrupts a gene, raly, which is 
located 5’ to the agouti locus. On Ay chromosomes, the coding sequence of the raly gene is 
deleted and the agouti locus is placed under the control of the raly promoter, resulting in 
deregulated over-expression of the agouti gene (Michaud et al. 1993). These authors 
suggest that the homozygous lethality in Ay/Ay mice may be due to lack of raly expression 
in the developing embryo as opposed to aberrant agouti expression. It should be noted that 
the alleles at this locus exert an effect on the phenotype only in the hair follicles. The type 
of pigment produced at other locations in the body is always eumelanin, regardless of the 
agouti genotype.  
 
1.7.3 The albino (c) locus 
 
The albino locus was thought for a long time to be the structural gene for the enzyme 
tyrosinase, a key catalytic enzyme in the melanin pathway. In 1987, Kwon et al. showed 
that tyrosinase cDNAs mapped to the c locus (Kwon et al. 1987), and it was subsequently 
shown that mutations in the coding region of Tyr inactivate the protein (Shibahara et al. 
1991). Inactivation of tyrosinase leads to complete loss of all pigment production in the 
melanocyte, and the phenotype is a completely white coat colour. 
 
During the 1980s when researchers were attempting to clone the tyrosinase gene, two 
proteins with high homology to tyrosinase were isolated as incidental findings. The 
melanocyte-specific gene products tyrosinase, b-locus protein and dopachrome tautomerase 
were all cloned by screening melanocyte cDNA expression libraries with antibodies raised 
in rabbits against hamster tyrosinase (Kwon et al. 1987, Jackson 1988, Jackson et al. 
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1992). While tyrosinase is the only enzyme absolutely necessary for melanin production, 
the other two modify the kind and amount of melanin produced. The genes are located on 
three different chromosomes and show an overall amino acid sequence identity of 
approximately 40%. It is proposed that the three genes arose from an ancient triplication 
event and sufficient time has passed such that the only nucleic acid identity seen is that 
which is required for amino acid identity (Jackson et al. 1992). The sequence homology 
between these three genes is a useful tool for mutation detection; if a given residue is 
conserved between the three proteins, it is likely to be functionally important and variation 
at this point potentially pathogenic. 
 
1.7.4 The brown (b) locus 
 
A clone that was initially isolated as a candidate for tyrosinase (Shibahara et al. 1986) was 
subsequently mapped to the brown locus on mouse chromosome 4 (Jackson 1988). The 
murine b-locus protein is homologous to the human melanocytic glycoprotein, gp75 
(Halaban and Moellmann, 1990). The brown locus protein was termed tyrosinase-related 
protein-1 (Tyrp1). Mutations at this locus do not eliminate pigmentation, but result in a 
mouse with a brown coat colour. The non-mutated Tyrp1 brown locus is essential for black 
eumelanin production. The function of tyrp1 remains controversial. It has been proposed to 
function in the context of hydrogen peroxide elimination (Halaban and Moellmann, 1990). 
H2O2 is probably produced as a by-product of the initial steps of melanogenesis when 
tyrosine is converted to melanin precursors. If the H2O2 is not removed, it can destroy the 
precursors as well as melanin itself. Subsequently it was shown that the b-protein has 
dopachrome tautomerase activity (Winder et al. 1994), converting dopachrome to DHICA 
rather than DHI. The product of the slaty locus had already been shown to have 
dopachrome tautomerase activity (Tsukamoto et al. 1992) (see below), and the question 
immediately arose as to why the melanocyte would require two enzymes with the same 
activity. Winder et al. (1994) suggest that since DHI is far more cytotoxic than DHICA, the 
cell may require the activity of two proteins capable of converting dopachrome to DHICA. 
Alternatively, they propose that tyrp1 and tyrp2 may have different functions within the 
conversion process, one catalysing the conversion of dopachrome to quinone methide, the 
second converting quinone methide to DHICA. 
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1.7.5 The slaty (slt) locus 
 
The enzyme dopachrome tautomerase was named tyrosinase related protein 2 (tyrp2) and 
was mapped to the slaty locus on mouse chromosome 14 (Jackson et al. 1992). The 
enzyme catalyses the tautomerisation of dopachrome to 5,6-dihydroxyindole-2-carcoxylic 
acid (DHICA) rather than conversion to 5,6-dihydroxyindole (DHI). The slaty variant is a 
point mutation, resulting in the amino acid substitution, arg194gln (Jackson et al. 1992). 
The slaty phenotype is a slate grey coat colour, lighter than the wild type black coat. Mice 
homozygous for the slaty mutation show a reduction (3 to 4-fold) in dopachrome 
tautomerase activity (Tsukamoto et al. 1992, Jackson et al. 1992), thus the mutation down-
regulates enzyme activity but does not abolish it. 
 
1.8 Human pigment loci 
 
The genes directing the formation, transport and distribution of the specialised melanin 
containing organelles, the melanosomes, can collectively be referred to as the pigmentation 
genes (Sturm et al. 2001). The first of these genes was identified through mapping the loci 
which resulted in mouse coat colour variants, and subsequently, genes have been identified 
through molecular characterisation of human inherited hypopigmentaion disorders (e.g. 
OCA1 and OCA2). The process of melanin production involves stimulation of the 
melanocyte by the hormone alpha-melanocyte stimulating hormone (α-MSH). The α-MSH 
will bind to the melanocortin-1 receptor (MC1R), previously called the melanocyte 
stimulating hormone receptor (MSHR), which lies in the melanocyte membrane, and 
stimulation of the MC1R will induce melanosome maturation with subsequent transference 
of pigmented melanosomes to surrounding keratinocytes in the skin. The MC1R also 
controls switching of the melanin type produced by the melanosomes – red/yellow or 
brown/black pigments may be produced. The crucial catalytic enzyme, tyrosinase, is active 
in both pheomelanosomes (producing red/yellow pigments) and eumelanosomes 
(producing the brown/black pigments), while the latter also require the activity of the 
tyrosinase-related proteins 1 and 2 (TYRP1 and TYRP2) to produce the darker melanins.  
 
A critical determinant of tyrosinase activity is intramelanosomal pH and this is thought to 
be controlled by the action of the melanosomal-membrane protein, the P protein. The 
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interaction of tyrosinase, TYRP1, TYRP2 and P proteins (together forming the 
melanogenic complex) is not clearly understood.  
 
1.8.1 Melanocortin 1 receptor (MC1R) 
In mice, the relative amounts of pheomelanin and eumelanin produced is essentially under 
the control of two loci – extension and agouti. The extension gene is expressed in 
melanocytes and produces the melanocortin 1 receptor (Mc1r) protein. Mc1r is stimulated 
by the binding of α-MSH or ACTH (Mountjoy et al. 1992), both of which induce 
melanogenesis (eumelanin production) and darkening of the skin. A number of alleles are 
described, the dominant allele (E) results in black (wild-type) coat colour, the recessive 
allele (e) results in a yellow coat colour when present in the homozygous state. While 
mutations in this gene lead to a lack of eumelanin production in the skin and hair, this is 
not the situation in the eye: e/e mice are able to produce eumelanin in their retinal 
melanocytes.  
While wild-type Mc1r protein leads to eumelanin production, the murine agouti protein, on 
the other hand, acts as an antagonist of Mc1r, preventing binding of MSH and thereby 
preventing eumelanin production. In this situation, the default melanogenic pathway, i.e. 
pheomelanin production, operates in isolation.  
 
The human homologue of extension, MC1R, maps to chromosome 16q24 (Magenis et al. 
1994). As evidence exists that variation at the MC1R locus leads to coat colour variation in 
mice, the human homologue has been investigated for variants that may lead to normal 
pigmentation variation in humans. It has been shown that sequence variation at the MC1R 
locus is present in red haired, fair skinned individuals of British ancestry (Valverde et al. 
1995). John and Ramsay (2002), investigating a group of red-haired individuals in South 
Africa (white, European descent) found all individuals to be either homozygous or 
compound heterozygotes for MC1R mutations, supporting the theory that variation at this 
locus is recessive with respect to the phenotype and two mutations are necessary (although 
not sufficient) to result in red hair and pale skin. Other population groups have also been 
investigated, namely, black Africans, Chinese and Indians (Rana et al. 1999), with Africans 
and Indians showing very little sequence variation at the MC1R locus and a single variant, 
Arg163Gln, being present at a high frequency (70%) in East and Southeast Asian 
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population groups. In contrast to the findings of Rana et al. (1999), John et al. (2003) 
looked at two black African populations, namely sub-Saharan Negroids and the San 
bushmen, and found variation in the MC1R gene in both population groups. These authors 
propose that selection has occurred at this locus in Africans and the MC1R gene has likely 
played a role in maintaining the dark skin colour of these population groups.  
 
King et al. (2003b) have identified 8 Caucasoid patients with OCA2 who have red hair 
(and not the typical yellow/blond). Molecular analysis revealed that all 8 individuals carry 
two P gene mutations, resulting in the OCA2 phenotype, and 6 out of the 8 individuals 
carry additional mutations in the MC1R gene, resulting in the red hair phenotype. This is 
thus an example of a second locus modifying the OCA2 phenotype in humans, and is 
different to rufous albinism in Africans. 
 
1.8.2 Human agouti signalling protein (ASIP)  
 
The human homologue of the murine agouti locus was cloned using an interspecies DNA-
hybridisation approach (Kwon et al. 1994). The human gene is 85% identical to the mouse 
and encodes a 132 amino acid protein. The human agouti gene maps to chromosome 
20q11, and is closely linked to the MODY (maturity onset diabetes of the young) locus. It is 
interesting to consider the function of human agouti signalling protein, since there is no 
equivalent human phenotype to the murine wild type banding pattern of the hair shaft. The 
human protein is not expressed in melanocytes. Rather, the gene is expressed in adipose 
tissue, testis, ovary and heart, and at lower levels in liver, kidney and foreskin.   
 
1.8.3 The tyrosinase family 
 
Three genes are presently known to form the tyrosinase gene family: TYR, TYRP1 and 
TYRP2. Their mouse homologous loci are c (albino), b (brown) and slt (slaty), respectively. 
These genes code for proteins with very similar amino acid sequence, all three being 
recognised by tyrosinase antiserum. It is possible these genes were formed from a common 
ancestral gene and have diverged over evolutionary time. 
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1.8.3.1 Tyrosinase (TYR) 
 
Tyrosinase is the crucial enzyme of melanin biosynthesis, acting as a catalyst in the 
formation of DOPAquinone from tyrosine (the rate limiting step in melanin production) 
and then at least once more in the biosynthetic pathway. Homozygous mutations at the c 
locus in mice produce a white coat colour. Tyrosinase cDNA was first cloned in 1987 
(Yamamoto et al.) by screening a mouse melanocyte cDNA library using mouse tyrosinase 
antiserum. Human tyrosinase cDNA was subsequently cloned by screening a human 
melanocyte cDNA library with hamster tyrosinase antiserum (Kwon et al. 1987). Using in 
situ hybridization, the human TYR locus was mapped to chromosome 11p14-21 (Barton et 
al. 1988). Both the human and mouse genes span more than 50 kb of genomic DNA, and 
contain 5 exons (Giebel et al. 1991b). Tyrosinase mRNA analysis revealed a high 
percentage (41%) of transcripts which are alternatively spliced (Porter et al. 1991). The 
original mouse cDNA cloned by Yamamoto et al. (1987) was actually missing exon 3. 
Most of the alternate transcripts exclude important functional domains and do not translate 
into functional tyrosinase protein. A second locus to which tyrosinase cDNA hybridizes is 
located at human chromosome 11p11.2-cen (Barton et al. 1988, Giebel et al. 1991). This 
locus contains only exons 4 and 5 of the tyrosinase gene and does not produce any 
detectable transcription product and is assumed to represent a tyrosinase pseudogene. 
 
Deletions, nonsense, missense, frameshift and splice site mutations in TYR are all found to 
be associated with OCA type 1, with these mutations distributed throughout the gene (see 
the albinism database for a comprehensive listing). A number of missense mutations are 
clustered around the second copper binding region located toward the 3’region of the gene. 
 
1.8.3.2 Tyrosinase related protein 1 (TYRP1) 
 
Mutations at the b locus produce a brown coat colour in mice. The brown locus cDNA was 
initially cloned during a differential hybridization experiment using mouse melanoma cells 
and mouse neuroblastoma cells, and the cDNA (termed pMT4) was thought to be 
tyrosinase (Shibahara et al. 1986). When the real tyrosinase cDNA was cloned, it was 
shown that pMT4 was encoded at another pigment locus. This second locus was mapped to 
mouse chromosome 4 and termed a tyrosinase related protein (trp), and later designated 
tyrp1 (Jackson 1988, Jackson et al. 1990).  
 38
The mouse genome contains a tyrp1 pseudogene, but there is no evidence suggesting the 
human genome contains a pseudogene (Shibahara et al. 1991). Numerous alleles at the 
brown locus in the mouse have been described (reviewed by King et al. 1995). The cDNA 
of the human homologue, TYRP1, was cloned (Cohen et al. 1990) and mapped by in situ 
hybridisation to chromosome 9p23 (Murty et al. 1992). The brown locus in the mouse, as 
well as its’ human homologue, TYRP1, are structurally different from tyrosinase, 
containing 8 exons and spanning 15-18 kb of genomic DNA (Shibahara et al. 1986, Shibata 
et al. 1992).  The gene product is a glycoprotein with a molecular weight of 75 kDa, and is 
sometimes referred to as gp75. The protein is a transmembrane protein, localized to the 
melanosome (the same as the P protein). Gp75 is a protein found in abundance in 
melanoma cell lines, but is not observed in non-pigmented (amelanotic) melanoma cell 
lines (Tai et al. 1983). 
 
1.8.3.3 Tyrosinase related protein 2 (TYRP2) 
 
The only known mutant allele at the slaty locus, slt, results in a dark gray/brown coat 
colour in the mouse when present in the homozygous state. The product of the mouse slaty 
locus and the human homologous locus, TYRP2, is the enzyme DOPAchrome tautomerase 
(DT). The slt mutation does not abolish DT activity, but down regulates function such that 
homozygous mice show a three- to four-fold reduction in DT activity in melanocytes 
(Jackson et al. 1992). The mouse cDNA was first cloned, essentially by accident, during 
experiments to clone the tyrosinase cDNA using tyrosinase antibody (Jackson 1988, 
Jackson et al. 1990). The human homologue was mapped to chromosome 13q31-q32 by 
fluorescent in situ hybridisation (Sturm et al. 1994). A subsequent paper by the same group 
(Sturm et al. 1995) showed that TYRP1 and TYRP2 are larger than TYR and that TYRP2 is 
larger than TYRP1. These authors suggest that TYRP1 was derived from a TYR duplication 
event and then TYRP1 itself was duplicated to give rise to TYRP2.   
 
1.8.4 The P gene 
 
After TYR, the P locus on chromosome 15q is the second major pigment locus in the 
human genome. 
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1.8.4.1 Cloning the gene at the OCA2 locus 
 
OCA1 was known to be caused by a defect in the enzyme tyrosinase, and is hence known 
as tyrosinase-negative (ty-neg) OCA. The gene, TYR, was cloned in 1987 (Kwon et 
al.1987). The biochemical defect in OCA2 (or ty-pos OCA: the tyrosinase enzyme 
functions normally in individuals with this type of albinism) was not known and so 
localisation of the gene proceded via classic linkage studies and the candidate gene 
approach. Jenkins et al. (1990) reported the exclusion of 57% of the genome after a 
genome-wide screen using random polymorphic markers. Subsequently, following the 
candidate gene approach, Ramsay et al. (1992) looked at the PWS/AS region on 
chromosome 15q. PWS and AS are distinct clinical syndromes mapping to 15q11-13, but 
they both show a hypopigmentation phenotype in a number of cases. Further, the co-
existence of PWS and AS with albinism had been documented (Phelan et al. 1988, Wallis 
and Beighton 1989, Weisner et al. 1987). Through positive linkage scores to markers at the 
D15S10 locus, it was shown that the OCA2 locus mapped to chromosome 15q11.2-q12 
(Ramsay et al. 1992). This region of human chromosome 15 shows synteny to mouse 
chromosome 7 which harbours two pigment loci, pink-eyed dilute (p) and tyrosinase (c). 
The c locus was excluded as a candidate for the ty-pos locus (Colman et al. 1993) and it 
was proposed that the human homologue of the p gene was the most likely candidate for ty-
pos OCA (Ramsay et al. 1992).  
 
The murine p protein, as well as its human homologue, P, were cloned (simultaneously by 
two groups: Gardner et al. 1992, Rinchik et al. 1993). Analysis of human P cDNA 
sequence revealed a protein of 838 amino acids with 12 putative transmembrane domains. 
Database searches showed that the P protein sequence showed highest homology (21%) to 
an E.coli tyrosinase-specific transport protein (Rinchik et al. 1993) and these authors 
proposed that the P protein might be a component of the melanosomal membrane and 
function as a transporter of tyrosine into the melanosome. The mouse p protein constitutes 
833 amino acids, with the same 12 hydrophobic domains which could span a lipid bilayer 
(Gardner et al. 1992). 
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1.8.4.2 P gene mutations cause OCA2 
 
At the time of cloning of the mouse p protein, ten different p alleles were studied - in six of 
these the homozygous mutant showed either an aberrant size mRNA (eg. pun and pJ) or 
undetectable levels of p mRNA (eg. p6H, p25H and p - the original mutant allele). Rinchik et 
al. (1993) described a patient with PWS and OCA2 and showed, by Southern blotting, that 
this patient had homozygous deletions of a region of chromosome 15q which included the 
PWS region as well as the P gene locus, whereas in 15 other PWS/AS patients who did not 
have OCA homozygous deletions that included both regions (PWS/AS and P) were not 
observed. It was proposed that defects in a single gene, namely P, were likely to result in 
the OCA2 phenotype in man and mouse. 
 
Lee et al. (1994a) investigated four patients, three with OCA2 (one of whom also had 
PWS) and a fourth with a milder form of albinism, autosomal recessive ocular albinism 
(AROA). These patients were screened for tyrosinase (TYR) as well as P gene mutations. P 
gene mutations were identified in all four patients, showing that mutations at the P locus 
give rise to a range of clinical phenotypes (OCA2, OCA2 associated with PWS and 
AROA). Further evidence for P mutations being responsible for the OCA2 phenotype was 
provided by Durham-Pierre et al. (1994) who described an intragenic deletion of the P 
gene in OCA2 individuals from a Brandywine family - an inbreeding population isolate in 
Maryland, USA (see below).   
 
1.8.4.3 A common P gene mutation 
 
In a study by Durham-Pierre et al. (1994), OCA2 individuals from three different 
population groups were studied: the Brandywine Maryland isolate (originally described by 
Witkop et al. 1972), African-Americans and black Africans. An intragenic deletion 
mutation of the P gene was found in a Brandywine family. The mutation is a 2.7 kb 
deletion which completely removes exon 7 of the P gene. The deletion corresponds to 
nucleotides 699-859 (amino acids 216-270) of the human P cDNA sequence, and results in 
a premature STOP codon and truncation of the P polypeptide, rendering a non-functional 
protein. Four unrelated African Americans with OCA2, two Africans (one from Cameroon 
and one from Zaire), as well as 15 Caucasians with OCA2 from 8 families were screened 
for the deletion - all four African-Americans and the two Africans were found to be 
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heterozygous for the deletion while none of the Caucasoids carried the deletion allele 
(Durham-Pierre et al. 1994). The authors proposed an African origin for this mutation, its 
prevalence in the African-American population resulting from a founder effect in the USA, 
or alternately the allele may be prevalent in west Africa from where the African-American 
population derives. The latter scenario has since been shown to be correct. 
 
A screen of 73 unrelated southern African blacks with OCA2 revealed that the 2.7 kb 
deletion mutation accounted for 78% of OCA2 mutations in this population, confirming 
that the deletion is in fact common in Africa (Stevens et al. 1995, Stevens et al. 1997). In a 
smaller study comprising 13 OCA2 individuals, a similar frequency (77%) was observed 
for the allele in OCA2 individuals from Tanzania (Spritz et al. 1995). The 2.7 kb deletion 
mutation is also common in the Cameroon, where it accounts for 65% of mutant OCA2 
alleles, and the highest frequency reported to date is in Zimbabwe where the deletion 
comprises 92% of mutant alleles (Puri et al. 1997). 
 
1.8.4.4 Other P gene mutations 
 
Apart from the 2.7 kb deletion mutation, no other common mutations have been described 
for the P gene. Numerous other mutations have been reported, most occurring within 
individual patients or families (Lee et al. 1994a and b, Spritz et al. 1995, Lee et al. 1995, 
Spritz et al. 1997, Kerr et al. 2000). Recently, a P gene mutation, specific to the Native 
American population group, the Navajo, has been described (Yi et al, 2003). The mutation 
is a 122.5 kb LINE-mediated deletion of the P gene and its carrier frequency in this 
population is approximately 1 in 20.  
 
1.8.4.5 Structure of the P locus 
 
The P protein is 838 amino acids with 12 putative transmembrane domains (Rinchik et al. 
1993). Database homology alignment showed the structural arrangement was similar to that 
of proteins lying within a membrane and facilitating the transport of small organic 
molecules across the membrane (Rinchik et al. 1993). It was subsequently shown in the 
mouse that the membrane to which the 110-kDa p protein localises is the melanosomal 
membrane (Rosemblat et al. 1994); the melanosome being the melanocyte-specific 
organelle in which melanin biosynthesis occurs. Lee et al. (1995) characterised the 
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molecular organisation of the human P genomic locus. The locus spans at least 250 kb of 
genomic DNA (as determined by the group of phage clones that spanned the coding 
sequences of the locus) but may be as large as 600 kb (this upper limit being determined by 
the fact that the entire P locus is contained within two YAC (yeast artificial chromosome) 
clones, one containing P exons 1 - 22 (this YAC, YAC 93C9, contains an insert of 370 kb) 
and another containing P exons 3 - 25 (this YAC, YAC 149A9, contains an insert of 400 
kb and the region of overlap between the two YACs is approximately 170 kb). These two 
YACs give further information regarding the orientation of the locus - YAC 149A9 (the 
YAC containing the 3’ end of the P gene) maps proximal to YAC 93C9, indicating that the 
P gene is orientated 3’ - 5’ with respect to the centromeric end of 15q, i.e. the human P 
gene is transcribed off the reverse strand. (This is not the situation in the mouse, where the 
p gene is transcribed 5’ - 3’ with respect to the centromeric end of chromosome 7). 
 
The P gene consists of 25 exons, the first of which is non-coding (that is, exon 1 is 
transcribed into mRNA but is not translated as part of the protein sequence). The DNA 
sequence of exon 19 contains an in-frame STOP codon (TGA) which, when translated 
leads to a truncated and non-functional protein. Exon 19 is alternately spliced and is only 
present in a small percentage of P mRNA (Rinchik et al. 1993), ensuring the bulk of P 
mRNA is translated into full length P protein, which excludes amino acid residues coded 
for by exon 19. The P gene harbours several sequence polymorphisms in both coding and 
non-coding regions, scattered throughout the gene. 
 
Although the P gene is located within the PWS/AS region on chromosome 15q and was 
therefore initially thought to be imprinted (Gardner et al. 1992), neither the human nor the 
mouse loci are subjected to imprinting phenomena, and individuals heterozygous for P 
mutations are normally pigmented, irrespective of the parent of origin of the mutant allele. 
 
1.8.4.6 Family of P-like proteins 
 
At the time the P protein was cloned and sequenced (Rinchik et al. 1993), researchers 
reported the human P protein showed homology to an E.coli tyrosinase transport protein, 
tyrP. These findings were not supported by subsequent database searches by the same 
authors (Lee et al. 1995). Instead they identified what was termed a novel family of P-like 
proteins which function as membrane transporters of small molecules. At this time P-like 
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proteins were identified searching the NBRF-PIR protein sequence database using the 
BLAST (Altschul 1990) program. Five proteins showing significant homology to P were 
identified: the Arsb proteins of Staphylococcus aureus and Escherichia coli, the E.coli 
Nhab Na+/H+ antiporter protein, the Mycobacterium leprae 38L protein and the mouse p 
protein. The 38L protein of M.leprae is a cell membrane protein and shares 40% identity 
(57% similarity) over its 429 amino acid length with the human P protein, suggesting the 
two proteins may serve a common function. 
 
Homology alignments are extremely useful for defining amino acid residues which are 
conserved over evolutionary time. If an amino acid at a given position is conserved across 
species, it is a clue that variation at that point in the protein cannot be tolerated, and 
indicates the importance of that residue in maintaining normal function of the protein. 
Thus, if during a screen for mutations in a gene, an amino acid variation is detected, the 
amino acid change is more likely to be pathogenic if it occurs at a position where the 
residue is conserved. Looking at amino acid conservation between species is an important 
tool in assessing the significance of an amino acid substitution mutation. 
 
1.8.4.7 Function of the P protein 
 
The function of the P protein remains unclear. The protein is membrane-bound, being 
localised to the melanosmal membrane (Rosemblat et al.1994). It was initially proposed 
that the P protein might function as a transporter of tyrosine, the precursor of melanin 
biosynthesis, into the melanosome (Rinchik et al. 1993). It was subsequently shown that 
the P protein is not a significant transporter of tyrosine (Rosemblat et al. 1994). Further 
database homology searches showed that the human P protein is a member of a family of 
proteins which function as membrane transporters of small molecules (Lee et al. 1995). 
While it has still not been ascertained what the P protein transports across the melanosomal 
membrane, this transport function has been shown to be necessary for maintaining an 
acidic pH within the melanosome (Puri et al. 1998). Tissue culture experiments 
demonstrated that mouse cell lines deficient for p were almost never acidic and did not 
contain the tyrp1 protein. The cellular pH affects the activity of tyrosinase, the enzyme will 
only function in a low pH environment. These authors (Puri et al. 1998) therefore propose 
that the p protein mediates ionic transport which serves to maintain an acidic pH within the 
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melanosome; and further, the incorrect pH may interfere with the assembly of the 
melanogenic complex as demonstrated by the lack of  tyrp1 protein.  
 
1.8.5 ASIP, MSH, MC1R and the pheomelanin/eumelanin switch 
 
Ian Jackson proposed a model as to how the melanocyte undergoes the 
pheomelanin/eumelanin switch (Jackson 1993): pheomelanin production in the melanocyte 
is the default pathway in the absence of MSH. If MSH is present and binds to its receptor, 
then the melanocyte switches to eumelanin production. The agouti protein prevents MSH 
binding to MC1R, negating the influence of the MSH. In this way the presence of the 
agouti protein results in pheomelanin production only. The agouti mouse shows alternate 
black and yellow bands on the hair shaft, the black bands are wild type colour and the 
yellow bands result from expression of the agouti locus. Mutations at the agouti locus 
would result in a black coat colour. Mutations at the MC1R locus would lead to the 
inability of MSH to bind its receptor; in this scenario the default pheomelanin pathway 
would be in place and the eumelanin switch could not occur, resulting in the all yellow coat 
colour. Experimental evidence supports this hypothesis: when human melanocytes in 
culture were incubated together with high levels of ASIP (human agouti signalling protein) 
it was found that ASIP blocked the stimulatory effects of MSH on cAMP accumulation, 
tyrosinase activity, TYRP1 levels and melanocyte proliferation (Suzuki et al. 1997). These 
findings suggest that the role of ASIP in humans is actually similar to that of the agouti 
protein in mice, the proteins playing a regulatory role in pigmentation. 
 
1.8.6 The role of pigment genes in normal pigment variation in humans 
 
A vast body of knowledge exists regarding coat colour genes in the mouse (with 127 loci 
now known to affect pigmention), 68 of these have known human homologues. These 
genes must be seen as candidates for playing a role in normal pigment variation (Hoekstra, 
2006). 
 
As discussed (section 1.1), human skin colour was originally dark and has over 
evolutionarily time become lighter with increased geographical distance from the equator 
(Relethford, 1997). Most human populations have become fixed for brown hair and eye 
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colour with phenotypic variation being found amongst individuals of European descent. 
 
Variants associated with normal variation in humans have been described at 9 loci to date. 
Online Mendelian Inheritance in Man (OMIM) has ascribed the symbols SHEP1-9 for 
these loci (SHEP for skin/hair/eye pigmentation). SHEP1 phenotype variation is associated 
with genotypic variation in the P gene, SHEP2 with variation at the MC1R locus, SHEP3 
with variation at the TYR locus, SHEP4 with variation at the SLC24A5 locus, SHEP5 with 
variation at the SLC45A2 locus, SHEP6 with variation at the SLC24A4 locus, SHEP7 with 
variation at the KITLG locus, SHEP8 with SNPs on chromosome 6p25.3 and SHEP9 with 
polymorphisms in the 3’untranslated region of the ASIP gene. Variation at the P locus will 
be discussed in greater detail below. 
 
A recent paper (Sulem et al. 2007) describes a huge genome wide association search for 
variants associated with skin, hair and eye variation in an Icelandic and a Dutch population. 
The findings of these authors supported previously described associations found in the P 
gene, MC1R and TYR and found further variants in SLC24A4, KITLG and on 6p25.3. 
 
1.8.6.1 Variants in the P gene influencing normal pigment variation 
 
The first mapping experiments looked for the locus for brown eye colour (BEY2), and 
found strong linkage of BEY to chromosome 15q11-q12 in 832 families in the Copenhagen 
area (Eiberg and Mohr, 1996). This study further showed linkage of brown hair colour 
(HCL3) to markers in the same region, leading these authors to suggest that the P gene 
might be a strong candidate for brown eye and hair colour. These findings were supported 
by later studies (Frudakis  et al. 2007, Posthuma et al. 2006) also showing brown versus 
blue-green eye colour and brown hair colour to be linked to the P gene locus. The P gene 
plays a role in determining normal variation of eye and hair colour between population 
groups (Sturm and Frudakis, 2004).  
 
Duffy et al. (2007), undertook a twin study in an Australian population (largely therefore of 
European descent) and found three separate polymorphisms in intron 1 of the P gene to be 
associated with blue eye colour: The three SNPs, located closely and tightly linked, are T/C 
(rs7495174), G/T (rs4778241) and T/C (rs4778138). The TGT haplotype was found to be 
strongly associated (present in 90.5% of alleles in individuals) with blue eye colour. The 
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TGT/TGT diplotype was found in 62.2% of subjects of European descent, as opposed to 
7.4% in individuals of African ancestry, a finding consistent with the recessive nature of 
lighter pigment phenotypes. The authors suggest that this haplotype may be seen as 
diagnostic for eye colour. They further suggest that the position of these variants - in the 5’ 
regulatory region of the P gene – may alter the temporospatial expression of the gene, 
resulting in the phenotype changes. 
 
An Icelandic study (Sulem et al. 2007) also detected these three SNPs, but a fourth variant, 
rs1667394, showed even stronger association for blue versus brown eyes. The rs1667394 A 
allele was most frequent in blond haired and blue eyed individuals, being present at a 
frequency of 80-90% in northern European populations. This SNP is found 200kb 
downstream of the P gene, lying in intron 4 of HERC2. The intronic sequence variation 
within HERC2 is unlikely to affect HERC2 expression itself, but may well affect P gene 
expression, thereby producing phenotype changes in pigmentation. Alternatively, the 
HERC2 variant may be linkage disequilibrium with a functional variant within the P gene 
itself (Sulem et al. 2007). 
 
1.9 The P gene environment 
 
Besides the P gene itself, neighbouring regions on human chromosome 15q (and the 
syntenic regions on mouse chromosome 7) are proving interesting candidates in the 
aetiology of the hypopigmentation phenotype.   
 
1.9.1 Proximal to P: The Prader-Willi Syndrome/Angelman Syndrome region 
 
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are non-allelic, inherited 
disorders caused by genetic abnormalities of imprinted genes on chromosome 15q11-q13. 
Imprinting refers to a category of non-Mendelian inheritance where a gene is expressed 
differently, depending on whether it was inherited from the male or female parent. 
Following fertilisation, a somatic cell will know which parent the imprinted region came 
from, leading to parent-of-origin specific gene expression (Sapienza 1990). PWS is caused 
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by a loss of expression of gene/s of the paternally inherited chromosome 15, while AS is 
caused by a loss of maternal gene expression.   
 
1.9.1.1 Deletions in the PWS/AS region 
  
Different molecular mechanisms can lead to AS and PWS, but each results in loss of 
parent-of origin (imprinted) gene expression. In the majority of cases (70-75%), patients 
have a cytogenetic deletion of chromosome 15 from bands q11-q13 (reviewed in Glenn et 
al. 1997). This represents a region of approximately 4 Mb of DNA which includes the P 
gene at its’ telomeric end (see Fig 1.9).   
 
 
 
 
 
 
 
 
Figure 1.9 Schematic representation of human chromosome 15q11-q13. Region of 
chromosome 15q showing the centromere (cen), telomere (tel), certain genes and markers 
the two proximal and one distal breakpoint region associated with PWS and AS (green 
curvy lines) and the position of duplicated repeat units related to HERC2 associated with 
these breakpoint regions (open black circles). The presence of these large, duplicated 
structures at either end of 15q11-q13 suggests a simple mechanism of chromatid 
misalignment during meiotic recombination. Imprinting status is indicated in colour: loci 
showing expression of the paternal allele are shown in blue, maternal allele expressed, 
pink; nonimprinted genes and markers are shown in black. The black arrows indicate the 
direction of transcription of the P gene and of HERC2. (Adapted from Ji et al. 1999 and 
Nicholls 1999.) 
 
 
1.9.1.2  Uniparental Disomy in the PWS/AS region 
 
Uniparental disomy (UPD) is the next most common cause of PWS (see OMIM reference 
numbers 176270 [PWS] and 105830 [AS]). In PWS patients with UPD, the individual 
inherits two maternal alleles, but no paternal allele for the region of chromosome 15. Since 
the second, totally normal, but also maternally derived copy of chromosome 15 cannot 
complement the missing paternal chromosome, this shows that the maternally inherited 
 
      I             II                                                  III 
             Proximal                    Distal 
cen tel 
ZNF127 SNRPN  IPW        UBE3A                   P   HERC2 
PWS                        AS                    OCA2 
D15S24 D15S18 
 48
PWS genes are normally silent and the paternally inherited genes are normally expressed. 
The converse is true in AS, where patients with UPD have inherited two paternal alleles 
and no maternal complement of this region of chromosome 15.  
 
1.9.1.3  Imprinting mutations in the PWS/AS region 
 
The remainder of cases are caused by point mutations within a single gene or mutations 
within a specialised region called the imprinting center (IC). In AS, the involvement of a 
single gene has been proposed and this gene is UBE3A (Kishino et al. 1997, Matsuura et 
al. 1997). A family was described with an isolated deletion of the UBE3A gene (Burger et 
al. 2002). The mutation caused AS when inherited through the female germline but not 
PWS when paternally inherited. These findings support the hypothesis that loss of UBE3A 
expression off the maternally inherited chromosome is sufficient to cause AS, and that this 
gene is not involved in PWS. In PWS it is likely that at least two genes are involved, 
making this a contiguous gene syndrome. In about 5% of PWS and AS cases, patients have 
no deletion mutation and no UPD, but they do show abnormal methylation patterns of the 
imprinted region. Thus, PWS patients have a maternal methylation pattern on their 
paternally derived chromosome, and AS patients carry a paternal methylation pattern on 
their maternally inherited chromosome (Nicholls et al. 1994). About half of all imprinting 
cases have a microdeletion involving the 5’ region or the first exon of a gene in the region 
called SNRPN (Dittrich et al. 1996, Saitoh et al. 1996). The region defined by the 
microdeletions has been termed the IC, and mutations in this region seem to block the 
resetting of the correct imprint as a cell passes through the germline of the parent of the 
affected individual.  
 
1.9.1.4  Clinical presentation of PWS and AS 
 
PWS and AS are clinically distinct syndromes. PWS patients present with neonatal 
hypotonia and failure to thrive, hyperphagia becomes apparent at 18-36 months and leads 
to severe obesity. Patients are mildly retarded. Hypogonadism and small hands and feet 
also characterise this condition (Holm et al. 1993). AS patients are severely mentally 
retarded, with little or no speech development. This syndrome is also known as “happy-
puppet syndrome” due to the characteristic happy disposition, protruding tongue, ataxic 
movement disorder and hyperactivity (Williams et al. 1995). Interestingly, about 50% of 
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both PWS and AS patients are hypopigmented (noticeably more fair in skin and hair colour 
than their parents). Before the gene for OCA2 was cloned, it had been suggested that a 
pigment gene might lie on proximal chromosome 15q. In 1986, Butler et al. described a 
cohort of patients in which those exhibiting hypopigmentation carried deletion mutations as 
opposed to other (then, as yet undescribed) types of mutations. Also, approximately 1% of 
PWS and AS patients are affected with oculocutaneous albinism (Wallis and Beighton 
1989, Rinchik et al. 1993). These observations led to this region being included in a search 
for the OCA2 locus, using the candidate gene approach (Ramsay et al. 1992). 
  
1.9.1.5  The hypopigmentation phenotype  
 
In a study of 28 PWS patients (Spritz et al. 1997), 15 (54%) were classified as 
hypopigmented. Seventeen of the 28 patients carried a deletion which included the P gene. 
Of the deletion patients, 14 (82%) were scored as hypopigmented. Thus, there were 3 
patients with a deletion that did not include the P gene; one of these patients was 
hypopigmented. Of the 8 non-deletion patients, none were scored as hypopigmented. These 
findings show there is a high correlation between hemizygosity for the P gene and 
hypopigmentation in PWS. In contrast, it should be noted that partial deletions of the P 
gene which are associated with OCA2, do not result in hypopigmentation in heterozygotes 
(Rinchik et al. 1993, Durham-Pierre et al. 1994, Lee et al. 1994a).  
 
Spritz et al. (1997) make three suggestions as to how the hypopigmentation phenotype may 
come about in PWS and AS. Firstly, the P gene promoter region may contain functional 
polymorphisms that down-regulate P function; when the intact P allele carries these 
polymorphism/s, reduced transcription occurs off the normal allele. Arguments against this 
hypothesis include the observation that there is no common polymorphism haplotype of the 
intact P allele amongst hypopigmented individuals (Spritz et al. 1997) and further, if the P 
promoter region did contain polymorphisms with functional significance, then OCA2 
heterozygotes carrying a P mutation on one chromosome and a functionally significant 
polymorphism on the other chromosome, would also show hypopigmentation, but this is 
clearly not the case.  
 
Secondly, there may be a second, as yet undescribed pigment gene in this region of 
chromosome 15 that is being deleted together with P in certain PWS and AS patients. This 
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second gene may lie very close to P, or it may even lie within the P gene itself, being 
transcribed as an alternate transcript. (The P gene is large and it is feasible that it may 
contain several other genes.) Mouse data do not support this hypothesis - mice 
heterozygous for large P gene deletions do not show a hypopigmentation phenotype 
(Johnson et al. 1995). This is not to say that a second putative pigment gene could not have 
been introduced into this region after the mouse-human evolutionary divergence.  
 
Thirdly, it has been noted that the maternal and paternal chromosome 15 homologues 
associate with each other in the region of 15q11-q13 during late S-phase (LaSalle and 
Lalande, 1996). These authors suggest that this may help in bringing about allele specific 
transcription, as occurs in this region. In PWS and AS patients, this physical chromosome 
15 homologue association was found to be disrupted, especially in deletion patients. Since 
there are both imprinted and non-imprinted genes in this region, the control of gene 
expression is complex and when a deletion disrupts this organisation, the normal 
expression pattern of both imprinted and non-imprinted genes may be affected. 
Consequently, the intact P allele may show reduced expression. 
 
The question of why certain PWS and AS patients show a hypopigmentation phenotype is 
an important one in the context of OCA2. Answers to this question will be directly 
applicable to questions concerning partial/intermediate OCA phenotypes (examples to be 
presented in chapter 2 and termed ‘unclassified black OCA’ in this study). Further, it is 
important always to bear in mind the complexity of the physical genomic region in which 
the P gene lies. 
 
1.9.1.6  The hyperpigmentation phenotype 
 
It is interesting to note that a patient with a duplication of 15q11.2-q14 has been described 
(Akahoshi et al. 2001). The woman presents with clinical manifestations of proximal 15q 
trisomy and hyperpigmentation. Cytogentic interphase fluorescence in situ hybridization (I-
FISH) analyses confirmed that the P gene is present in three copies in this woman.  
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1.9.2  Distal to P: The HERC2 locus 
 
1.9.2.1  The PWS/AS deletion breakpoints 
 
As discussed, most cases of PWS and AS result from a deletion on proximal chromosome 
15q. The frequency of PWS and AS is similar – approximately 1 in 15 000. This indicates 
that a deletion mutation is equally as likely to arise during male gametogenesis as it is 
during female gametogenesis. The frequencies of PWS and AS are also similar across all 
populations groups, as would be expected for chromosome disorders which arise de novo 
in each affected patient and where the parents are genotypically normal.  By implication 
then, the genetic make-up of the region is predisposing to the deletion event. The 
breakpoints indicate an underlying instability, a genetic ‘hotspot’ for recombination. 
 
It has been shown that most (90%) of the PWS/AS deletions have clustered breakpoint 
regions. The distal breakpoint is between the P locus and the marker D15S24 (Knoll et al. 
1989), while there are two proximal breakpoint regions, region II lies between D15S18 and 
ZNF127 and region I lies between D15S18 and the centromere (Christian et al. 1995) (see 
Fig.1.9). About 60% of the deletion patients (class II) show a proximal deletion breakpoint 
in region II, while 40% (class I patients) show a deletion breakpoint in region I. 
 
1.9.2.1.1  Other diseases caused by chromosome rearrangements 
 
Several other human diseases, e.g. alpha(α)-thalassaemia, Duchenne muscular dystrophy 
(DMD), steroid sulfatase (STS) deficiency, Charcot-Marie Tooth type 1A (CMT-1A) and 
haemophilia A (Factor VIII deficiency) often arise from large chromosome 
rearrangements. e.g. deletions, duplications or inversions. Deletions at the α-globin locus 
have clustered 3’ breakpoints and often involve homologous recombination events between 
the duplicated α-globin genes (Nicholls et al. 1987). Homologous recombination between 
Alu sequences leads to deletions as well as duplications at the LDL receptor locus 
(Lehrman et al. 1985). It was found that the common 1.9 Mb deletion of the STS locus 
occurred through homologous recombination between low-copy repeated sequences called 
S232 elements, which are situated at either end of the deletion on Xp (Yen et al. 1990). 
Also, CMT-1A is associated with a 1.5 Mb region tandem duplication of chromosome 
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11p11.2-p12 (Pentao et al. 1992). This 1.5 Mb region is flanked by a sequence called 
CMT-1A-REP which is proposed to be a large, complex repeat element of 17 kb (Pentao et 
al. 1992). The molecular aetiology of haemophilia A in approximately 50% of the affected 
males is a large (~500 kb) inversion on Xq which disrupts the Factor VIII gene. The 
inversion occurs by homologous recombination between low-copy repeat elements, one in 
intron 22 of the gene and either of two homologues located 500 kb distal (Lakich et al. 
1993, Naylor et al. 1993). 
 
Clearly, there is evidence that large, low-copy repeat elements predispose to recurring 
rearrangements (Lupski 2007). 
 
1.9.2.2.  Identification of low-copy repeat elements at PWS/AS breakpoint junctures 
 
In order to identify repeat sequences within the chromosome 15q11-q13 interval, Buiting et 
al. (1990) isolated several clones from the region by microdissection. One of these clones 
(MN7), when used as a probe, detected multiple restriction fragments which had been 
mapped to 15q11-q13 and 16p11.2 by somatic cell hybrid analysis and in situ hybridisation 
(Buiting et al. 1992). By PCR, it was determined that there were 4 or 5 MN7 loci spread 
over a large distance within 15q11-q13. Further, the MN7 probe detected several cDNAs 
that mapped to both 15q and 16p. The authors suggested that MN7 was part of a low-copy 
repeat element that contains an expressed sequence. By Southern hybridisation, a low-copy 
repeat element (END repeat) that occurs specifically at the proximal (II) and distal 
breakpoint regions was identified (Amos-Landgraf et al. 1999). A 100bp section of the 
repeat unit was found to have 98% identity with a database EST, supporting the earlier 
proposal by Buiting and colleagues that the repeat formed part of an unidentified gene. 
 
1.9.2.3  The mouse p6H allele  
 
The region of the mouse genome syntenic to human chromosome 15q11-q13 is a region on 
Mus musculus chromosome 7 (Mmu7). In the human, the distal PWS/AS breakpoint lies 
immediately distal of the P gene. Therefore, the distal breakpoint homologous region in the 
mouse must lie close to and proximal to p on Mmu7. Many deletions at the mouse p locus 
have been induced by radiation mutagenesis. The radiation-induced mutation, p6H, is a 
large deletion which includes the p gene and extends proximally on Mmu 7 (see Fig 1.9). 
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Mice homozygous for p6H deletions exhibit a hypopigmentation phenotype (due to loss of 
the p locus) plus three other phenotypes: runtiness, a nervous jerky gait and male sterility 
with female semi-sterility (Hunt and Johnson 1971, Handel et al. 1987, Lyon et al. 1992). 
Using complementation analysis, Rinchik et al. (1995) showed that the neurologic and 
fertility abnormalities were likely to be due to dysfunction at a single locus, jdf-2 (juvenile 
development and infertility-2). In the literature this locus is also referred to as the rjs 
(runty, jerky, sterile) locus.  
 
1.9.2.4  The gene associated with the PWS/AS breakpoints as well as the jdf-2 mouse 
phenotype: HERC2 
 
By positional cloning, the gene at the murine jdf-2/rjs locus was cloned (Lehman et al. 
1998). The cDNA is exceptionally large (>15 kb) and the predicted protein contains several 
motifs including three RCC-1 (Regulator of Chromosome Condensation-1)-like repeats and 
a HECT (homologous to the E6-AP carboxyl terminus) domain. RCC-1 is a gene which has 
been mapped to human chromosome 1p36.1 (Nishimoto et al. 1994) and its product is an 
abundant, nuclear, DNA-binding protein which acts as a guanine nucleotide exchange 
factor (GEF). 
 
Approaching the issue from a different angle, Ji et al. (1999) cloned the gene which 
contains the transcribed low-copy repeat element that is associated with the breakpoint 
region of the PWS/AS deletions. The gene is called HERC2 as it contains a HECT domain 
and RCC-1 motifs. It is related to HERC1, a gene encoding a GEF protein. HERC2 is the 
ancestral gene, and the human genome contains duplicated, but truncated, copies of the 
gene which comprise a family of low-copy repeats. The mouse homologue, Herc2, is 
present only as a single copy gene in the mouse genome and is the gene at the jdf-2 locus. 
Herc2 mutations have been shown to be responsible for the phenotype in three different 
ethylnitrosuria (ENU)-induced jdf2 mouse mutants (Ji et al. 1999).  
 
1.9.2.5  Herc2 may play a role in pigmentation 
 
Walkowicz and colleagues (1999) have characterised a further 19 jdf2 mutations (13 were 
radiation-induced and 6 were ENU-induced mutants). Of special interest here are the 
alleles p12DTR, p39DSD and p103G. p12DTR is an interstitial deletion which results in loss of  
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5 kb from the coding sequence of Herc2. Both p39DSD and p103G are not deletion alleles, but 
rather show abnormal size restriction fragments on Southern analysis, indicating a 
rearrangement event. The rearrangement in p39DSD is confined within Herc2 itself, lying in 
the 3’ region of the gene. p103G shows a DNA rearrangement extending from the 3’ end of 
Herc2 into the interval between 3’ Herc2 and the 5’ end of the p gene (see Fig.1.10). 
 
 
 
Figure 1.10 Map of mouse chromosome 7 showing the region containing the 3’ end of 
Herc2 and the 5’region of the p gene, plus intervening sequence. Orientation relative to the 
centromere (cen) and telomere (tel), as well as direction of transcription (green arrows) of 
the genes is shown. Positions of certain radiation-induced p mutations are indicated below 
the map: the deletion p12DTR is represented by a red line and the intervals in which the 
rearrangements present in p39DSD and p103G are found, are represented as blue boxes. 
(Adapted from Walkowicz et al. 1999). 
 
 
Notably, while none of these mutations include the p gene, all three alleles lead to a 
hypopigmentation phenotype in the homozygous state: p39DSD and p103G are mottled 
mutations (light coloured patches of fur against a black background) and the allele p12DTR 
shows an intermediate albino phenotype with moderately diluted coat colour and dark pink 
eyes (Russell et al. 1995). 
 
1.10  Psychosocial aspects of albinism 
 
In the black population of South Africa the prevalence of OCA2 is 1 in 3900 (Kromberg 
and Jenkins, 1982). At the largest black hospital in South Africa, Chris Hani Baragwanath 
cen                                              tel 
5’                                             Herc2                           3’                         5’    p       3’ 
p12DTR 
 
p39DSD 
 
p103G 
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Hospital in Soweto, just outside Johannesburg, a baby with albinism is expected to be born 
every two months (Kromberg et al. 1987b). Because albinism is so common in South 
Africa it is essential that the society develops an appreciation of the problems and issues 
surrounding this condition. 
 
1.10.1  Social attitudes 
 
The striking phenotypic difference between black individuals affected with albinism and 
their population group, as opposed to white individuals affected with the same condition, 
has possibly led to the black individual having to deal with greater problems of social 
adjustment. In the African context this situation is compounded further by ethnic beliefs 
and myths. A study involving 35 South African black individuals with OCA2 (Kromberg 
and Jenkins, 1984) found that the subjects, aged between 13 and 21 years, had a positive 
body image and, contrary to what may have been expected, claimed to be less ashamed of 
their physical appearance than did the matched control group without albinism. Individuals 
with albinism were found to suffer from psychosomatic ailments such as sweaty palms and 
headaches. This group also felt that gaining employment would be a problem, and while 
individuals with albinism seemed to be accepted in the community, positive attitudes rarely 
extended to include marriage. 
 
1.10.2  The mother-child bond 
 
Since the mode of inheritance of OCA is autosomal recessive, the birth of an affected baby 
is usually a shock to the parents as there is often no family history of the condition. 
Mothers are frequently depressed and unhappy. This manifests in a delayed mother-child 
bonding and mothers are often reluctant to breast-feed their babies as they look so different 
to themselves (Kromberg et al. 1987b). Babies with albinism were found to exhibit delayed 
milestones (sitting, crawling, walking). This may be a factor of lack of maternal 
involvement in the early months of the baby’s life, combined with the physical problems an 
infant with albinism would experience due to poor eye-sight. Vision is very important for 
the infant’s ability in learning to control body movements and developing a perception of 
the surroundings in which they find themselves (Kromberg et al. 1987b). It was found that 
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maternal attachment tended to normalise by the time the infant was approximately nine 
months of age. 
 
1.10.3  Myths and superstitions 
 
The occurrence of albinism in Africa has been documented over historical time (reviewed 
by Kromberg 1990) and myths have often surrounded those affected with albinism. Both 
positive and negative associations have been documented. Myths surrounding the birth of a 
baby with albinism include punishment for bad behaviour of the parents, the mother 
conceived during menstruation or ate undesirable food-types while pregnant (Kromberg 
1990). Mythology from central and northern Africa holds that babies with albinism might 
be the result of a Negress-gorilla or Negress-water spirit mating (Pearson et al. 1913 as 
cited in Kromberg et al. 1987b). On the other hand, the birth of a baby with albinism might 
be due to the mother being touched by a spirit or receiving a good-luck sign from the 
spirits. Certain communities associate the condition of albinism with the affected individual 
having increased spiritual or religious powers (Kromberg 1990) although this is probably 
not a widely held belief and affected individuals themselves do not appear to claim superior 
spiritual powers (Kromberg 1984). A common belief is that people with albinism do not 
die, they simply disappear - the death myth (Kromberg 1984). The origin of this myth is 
not known, but it has been suggested that because infanticide of babies born with albinism 
was practiced, especially in rural areas in the 19th century mothers who had left their babies 
in the bush to die would tell people that the baby had ‘disappeared’. Another explanation 
may be that, since individuals with albinism were conceived by spirits, they were thought 
not to be fully human and therefore could not die (Kromberg et al. 1987a). 
 
1.10.4  The issue of whiteness in the African context 
 
Black individuals with OCA2 are never perceived socially as ‘white’ by their community, 
they may be ostracised for their physical appearance, but this is more a factor of how 
different they look from their normally pigmented population group and not because this 
population attributes any political significance to their being ‘white’. In the Sudan 
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individuals with albinism were referred to as ‘danedio’ which means ‘white’ and not 
‘toulako’ which means ‘white man’ (Kromberg 1990). 
1.10.5  Prenatal diagnosis 
 
The option of prenatal diagnosis for albinism was first put forward in 1981 by Haynes and 
Robertson. These workers looked at scalp samples from 12 aborted fetuses (not affected 
with OCA) between 16 and 20 weeks gestation. Fetal melanocytes were studied by 
histochemistry and electron microscopy (EM) in order to ascertain development of the 
melanosomes. A normal fetus will exhibit fully pigmented melanosomes (stage IV) as early 
as 16 weeks gestation, the occurrence of OCA in the fetus will be demonstrated by the 
incomplete development of melanosomes (stage II). Using this technique it would be 
essential to obtain hair bulb and scalp skin biopsies from the fetus by fetoscopy as melanin 
is not present in amniotic cells, but only in melanocytes, making amniocentesis unhelpful 
(Taylor 1987). 
 
The first prenatal diagnosis for albinism was performed in London in 1983 (Eady et al. 
1983). The procedure was undertaken for a couple from the Middle East who had one 
normal child and one child affected with albinism. Fetal scalp samples were obtained from 
the fetus by fetoscopy at 20 weeks gestation and analysed by EM. Stage II melanosomes 
were observed, but no stage III or IV melanosomes. The fetus was diagnosed as being 
affected with albinism and the parents elected to terminate the pregnancy. 
 
The techniques involved in prenatal diagnosis were then extended to include the dopa 
reaction test, useful in diagnosing tyrosinase-negative OCA in a fetus (Gershoni-Baruch et 
al. 1991). To test the feasibility of this test as a tool in prenatal diagnosis, the dopa reaction 
was performed on skin samples taken from fetuses aborted between 12 and 30 weeks 
gestation (for reasons not related to albinism). The dopa reaction in hair bulbs of normal 
fetuses gave a positive result from week 17 (no hair follicles were seen in scalp samples 
obtained before 17 weeks). This study supported earlier findings that pigmented 
melanocytes were only present in hair bulbs after 16-17 weeks gestational age. Further, 
skin biopsies taken from the back and thigh showed that pigmentation was not seen in the 
epidermis at any gestational age studied. Gershoni-Baruch et al. (1991) used EM studies in 
conjunction with the dopa reaction test to exclude albinism in a fetus by showing stage IV 
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melanosomes and a positive dopa reaction in hair follicles. In a family where the type of 
albinism was tyrosinase-negative (OCA1), a dopa reaction test would give a definitive 
result as to the status of the fetus. 
 
If the type of albinism present in a family is known and the locus causing the albinism has 
been identified, then the prenatal diagnostic method of choice would be DNA linked 
marker analysis. This method avoids the more invasive procedure of fetoscopy - fetal DNA 
may be derived from amniocytes or chorionic villus sample (CVS) material. This option 
however, requires the availability of DNA from an affected individual in that family. The 
majority of OCA mutations are rare, usually specific to a given family. Consequently, 
direct detection of a common mutation in a fetus is not often an option. The notable 
exception is OCA2 in black African individuals. In this population group, one common 
mutation (the 2.7 kb deletion) accounts for up to 78% of OCA2 chromosomes (Stevens et 
al. 1995; 1997), making it a feasible scenario that both parents are carriers of this specific 
mutation. In this case, direct mutation analysis in the fetus is diagnostic. 
 
The laboratory in which this thesis was carried out offers albinism molecular diagnostic 
services, including prenatal diagnosis in families where this is feasible. Worldwide, 
laboratories offering prenatal and other diagnostic testing for OCA can be found at 
GeneTests (www.genetests.org). 
 
 59
 
1.11  Host-related genetic background and susceptibility to the infectious disease 
tuberculosis 
 
 
“We have to inquire whether persons living habitually in the same 
environment and with practically the same risk of infection have 
the same chance of developing phthisis whatever be their stock.”  
(Pearson 1912) 
 
 
1.11.1 History of tuberculosis 
 
It is not known when humans first became afflicted by tuberculosis (TB), but available 
evidence suggests that the disease predates written records and has been prevalent for 
several centuries. It is thought that M. tuberculosis, the causative agent for TB in humans, 
derived from M. bovis, which causes TB in cattle and other animals, as well as in humans. 
Cattle first became domesticated in the Neolithic period which is also the same period that 
shows the earliest evidence of TB in humans. Between 7000 B.C. and 4000 B.C. in the 
Middle East, it is thought cattle were first domesticated and milking of cattle began. 
Therefore transmission of the mycobacterium to humans may have been through injestion 
of infected meat or by drinking milk from infected cows. A skeleton found in a Neolithic 
cemetery near Heidelberg in Germany (dating to about 5000 B.C.) had deformities 
characteristic of spinal tuberculosis – collapse and fusion of the thoracic vertebrae leading 
to a hunchback appearance. Although these skeletal lesions are in keeping with a diagnosis 
of TB, they are not sufficient evidence to confirm a diagnosis. The earliest conclusive data 
come from skeletal remains found in Egypt dating to between 3700 B.C. and 1000 B.C. 
The mummy of a 5 year old child showed evidence of pulmonary and vertebral TB. This 
was confirmed by the identification of acid-fast bacilli (M. bovis or M. tuberculosis) on 
microscopy of material taken from vertebral bone (Zimmerman 1979).  
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1.11.2 The introduction of tuberculosis into South Africa 
 
While tuberculosis has been present in Europe and Asia for millennia, it is a relatively new 
disease in southern Africa. Although written records do not exist prior to the late 19th 
century, it is assumed that the disease did not occur with any significant prevalence in the 
native populations of southern Africa prior to the era of European colonisation. South 
Africa was first colonised by the Dutch in 1652, with the purpose of setting up a station in 
the Cape to provide fresh provisions for trade ships sailing between Europe and Asia. 
Several waves of immigration followed (including British, French and German) and over 
the course of the next 300 years, southern Africa found itself completely under European 
control.   
 
It appears that the spread of TB to the native peoples of southern Africa was initially 
determined by their degree of contact with Europeans. In the early 19th century TB became 
problematic amongst the Khoikhoi (Hottentots) peoples, who lived in the south-western 
areas of South Africa which were colonised early. The San (Bushmen) were ravaged by TB 
following European contact. These groups may be seen as ‘virgin soil’ for tuberculosis 
disease, with individuals having no acquired resistance to the pathogen. Tuberculosis also 
appears to have become established early among the Coloured peoples living in the south-
western Cape. Bantu-speaking black Africans, living in the interior of the country, 
remained unaffected for longer. It is thought that low levels of endemicity were present 
amongst the Zulu in Natal and the Xhosa in the Ciskei prior to the 20th century (Packard 
1989). 
 
The discovery of diamonds in 1867, and gold in 1886, in the area around Johannesburg 
(now known as Gauteng), created a demand for cheap labour which led to the development 
of a migrant labour system, drawing black workers from not only within South Africa’s 
borders, but also from neighbouring countries. Miners worked in close proximity to each 
other in hot and moist conditions, were housed in over-crowded compounds and generally 
had a poor diet. High tuberculosis mortality rates in black mine workers ensued. To further 
aggravate the situation, mines adopted a policy of terminating workers’ contracts once they 
developed the disease and repatriating them to their homelands. This practice played a key 
role in disseminating the disease to the rural areas. The mining industry also led to rapid 
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industrialisation, with simultaneous urbanisation and the socio-economic problems which 
follow.  
 
Anti-tuberculosis drugs were introduced in the 1950s, after which a sharp decrease in 
mortality rates was noted. However, incidence rates continued to increase. Factors such as 
over-crowding, unemployment and poverty continue to contribute to the high incidence of 
tuberculosis in this country. 
 
1.11.3  Clinical tuberculosis 
 
Tuberculosis, an infectious disease, is caused by the human pathogen, Mycobacterium 
tuberculosis. The disease affects approximately 2 billion people worldwide (this is about 
one third of the world’s population) and results in about 2 million deaths per year, making 
it the infectious agent that claims more lives than any other worldwide (Frieden et al. 
2003). TB, once thought to be controlled, has reinstated itself as a major health problem, 
particularly in developing countries. The gravity of the situation led the World Health 
Organisation (WHO) to declare tuberculosis a global emergency in 1993. Poor TB control 
measures have led to the emergence of multi-drug resistant disease, the Mycobacterium 
bovis bacille Calmette-Guerin (BCG) vaccination has limited efficacy and the AIDS 
pandemic have all contributed to increased susceptibility and the dramatic increased 
incidence of clinical TB. 
 
A two-step process in progression to TB disease takes place. Firstly the individual will 
become infected with M. tuberculosis. Clinically, the reaction to this initial infection 
usually goes unnoticed. In an individual with a healthy immune system, the bacterium will 
lie dormant. The second step, clinical TB, will only result following the 
immunosuppressive effects of factors like malnutrition, another infectious disease, 
alcoholism or diabetes. The time period between infection and disease can therefore vary 
from weeks to a lifetime, although the risk of disease is highest in the first year following 
infection, declining as time proceeds (Comstock 1982).  
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1.11.4  Selection and infectious disease – Malaria as the classic example 
 
Population studies have shown that infectious diseases can act as selective agents with 
respect to a populations’ genetic structure, strongly influencing allele frequencies at a given 
locus. The best known example is that of the relationship between the infectious disease, 
malaria and the human genetic haemoglobinopathies - sickle cell anaemia and thalassemia - 
where heterozygotes for globin gene mutations have a selective advantage in the presence 
of malarial disease. Malaria has established itself as ‘the strongest known force for 
evolutionary selection in the recent history of the human genome’ (Kwiatkowski 2005). 
 
Sickle haemoglobin (HbS) is a variant of the HBB gene (which encodes β-blobin). This 
variant has arisen independently in different areas and is maintained at a frequency of 
approximately10% in many malaria endemic areas (Flint et al. 1998). That is, 1 in 10 
individuals are carriers of the sickle cell trait in these areas, making this the most striking 
example of heterozygote advantage in human genetics. HbS homozygotes are affected with 
sickle cell disease, but HbS heterozygotes have a 10-fold reduced risk of suffering severe 
malaria (Hill et al. 1991). 
 
1.11.5  Host genetics and infectious disease 
 
It has long been noted that certain infectious diseases have a ‘heritable’ component and that 
different individuals respond very differently following exposure to a given infectious 
agent. Up until the latter part of the 19th century, diseases such as TB and leprosy were 
believed to be inherited disorders. 
 
While infectious diseases themselves are obviously not heritable, susceptibility or 
resistance to certain infectious agents has now clearly been demonstrated for a number of 
diseases. Early evidence came from incidents like those which occurred in Lubeck, 
Germany, where infectious Mycobacterium tuberculosis was accidentally administered to a 
group of individuals – some of whom never developed TB disease, others developed the 
disease but recovered, while in others the infection proved fatal. In the 1980s, 
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haemophiliacs accidentally given HIV infected blood, showed great variation in their 
progression to AIDS and AIDS-related illness. 
 
While these examples demonstrate how the individual’s genetic background may influence 
susceptibility to disease, host susceptibility may also be seen at a population level. A West 
African tribe, the Fulani, appear to be far more resistant to malaria than any of their 
immediate neighbours (Modiano 1996). In the USA, all the occupants of a nursing home 
were exposed to the TB pathogen and it was noted that patients of different ethnic 
backgrounds were differently affected – individuals of African American origin were more 
susceptible and were at greater risk of developing TB disease than were their white 
counterparts (Stead et al. 1990). 
 
1.11.6  Molecular genetic tools to study host susceptibility to infectious disease 
 
The basic strategies available in studies of genetic association (in decreasing order of 
confidence) are: 
• Twin studies (comparing disease concordance in monozygotic versus dizygotic 
twins) 
• Family linkage studies (looking for association of the occurrence of TB in family 
members with the inheritance of a particular genetic marker) 
• Case-control studies (comparing individuals with TB to control individuals) 
• Anecdotal reports (family or ethnic clusters of TB suggesting increased 
susceptibility)  
 
As the human genome project and the allied pathogen genome mapping projects have come 
to completion, a new approach to studying host-pathogen interactions has become available 
to the scientist. Infectious disease can be considered a complex genetic trait with many host 
genes all having small, but additive or interactive effects on the phenotype. Two main 
strategies are available when looking for areas of disease susceptibility/resistance in the 
host genome: genome-wide scanning with micro satellite or SNP markers to identify 
regions of the genome involved (‘positional cloning’) and secondly, the candidate gene 
approach which would look for association between the function-related candidate genes in 
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the host genome and disease susceptibility. 
 
1.11.6.1 Genome wide screens 
 
Chromosome 17q 
 
In humans, the first example of gene mapping looking for a locus involved in infectious 
disease susceptibility was undertaken in large Brazilian pedigrees where susceptibility to 
schistosome infection appeared to be segregating as a Mendelian trait (Marquet et al. 
1996). Using a genome scan approach and linkage analysis, a single major susceptibility 
locus on chromosome 5q31-33 was identified. A subsequent study in Brazil (Blackwell et 
al. 1998) looking at multi-case families for TB, leprosy and leishmaniasis, found a 
significant (P=0.01) association of TB susceptibility to the locus 17q11.2-q12. 
 
Another two-stage study was undertaken using 16 Brazilian multi-case TB families (Miller 
et al. 2004). These authors found association with chromosomal regions 10p26.13, 11q12.3 
and 20p12.1. No association was found for the 17q locus earlier described by Blackwell et 
al. (1998), but the small sample size of the Miller study should be kept in mind. 
 
A large case-control study was undertaken looking at 4 candidate genes within the 17q11.2 
region using patients from Mexico and Korea (Flores-Villanueva et al. 2005.) An 
association was found for one gene: an A→G polymorphism in the promoter region of 
MCP-1 (monocyte chemoattractant protein-1) was found to confer increased risk for 
developing TB in both the heterozygous (AT) and homozygous (GG) state, in both 
population groups. 
 
Chromosomes 15q and Xq 
 
The second attempt to map a human susceptibility locus for TB, using a large-scale family-
based genome scan, was undertaken by Bellamy et al. (2000). Using linkage analysis of 
affected sib-pairs, Bellamy et al. (2000) looked at 92 affected sibling pairs collected in the 
Gambia and South Africa. All individuals were typed for 299 microsatellite markers found 
throughout the genome. Seven chromosomal regions showed maximum LOD scores >1, 
and these regions were then fine-mapped using a further 22 markers. Fine mapping 
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involved typing a second set of 82 affected sib-pairs and their parents. Results showed only 
two regions of the human genome, namely, chromosome 15q (LOD score=2.00) and 
chromosome Xq (LOD score=1.77) gave LOD scores suggestive of linkage. While these 
LOD scores do not achieve the levels of significance recommended for a genome-wide 
linkage scan (LOD>3), the authors argue that this is probably a reflection of the small 
sample size used here being insufficient to detect linkage for genes contributing to a 
complex disease phenotype. When mapping complex disease traits, single gene mapping 
strategies need to be adapted or reconsidered, as many genes are now involved, having 
small but additive or interactive effects on the phenotype. 
 
Chromosome 8q   
 
Most recently, a genome-wide scan using 96 multi-case TB families from Morocco 
(Baghdadi et al. 2006) found strong linkage to a single genomic region – on chromosome 
8q12-q13. While this locus was not associated in all families, a particularly high 
association was observed in families where at least one parent was affected, leading the 
authors to suggest that predisposition at this locus is inherited in an autosomal dominant 
fashion. Baghdadi et al. (2006) suggest that, while TB susceptibility can result from the 
many-genes-with-small-additive-effects scenario, it can also result from certain 
susceptibility genes have large and dominant effects.    
 
1.11.6.2  Candidate genes 
 
Several genes that play a role in the human host’s immunological response to infection by 
mycobacteria have been studied, looking for different alleles or polymorphisms that may 
exist which could cause subtle changes in function of the protein, leading to individual 
variation in susceptibility to TB. The polymorphic human leukocyte antigens (HLA) were 
the first proteins to be studied and subsequent work has been done on cytokines and pattern 
recognition receptors. 
 
Human leukocyte antigens (HLA) 
 
HLA alleles have been found to be associated with susceptibility to several different 
infectious diseases including malaria, HIV progression and hepatitis B and C persistence 
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(reviewed by Hill 2006). Two classes of HLA are defined – class I antigens, HLA-A, B and 
C and class II antigens, HLA-DR, DQ and DP. 
 
Earlier studies looked at class I antigens and a meta-analysis, combining many of the 
results from these studies, by Kettaneh et al. (2006) concluded that there was no significant 
association of HLA class I alleles with TB susceptibility. They did find however that the 
HLA B13 allele has a protective effect. 
 
The same meta-analysis showed for class II alleles that at the DR locus, DR3 and DR 7 are 
protective, DR8 is a susceptible allele and DR2 gave borderline results as a susceptibility 
allele (Kettaneh et al. 2006). 
 
The HLA class II antigens, DR, DQ and DP receive more attention – the DR2 antigen has 
11 alleles and many reports, some finding association and some not, have been published 
(reviewed by Takiff 2007). For the DQ locus, a significant association was found for 
DQB1*0503 with TB susceptibility in a Cambodian population (Goldfeld et al. 1998). This 
allele was found in the TB patient group only and in none of the 107 control individuals, 
leading the authors to suggest that this allele could have a near Mendelian effect in this 
population. 
 
Cytokines and cytokine receptors 
 
Cytokines and their receptors are further elements of the immune system, thought to be 
important in controlling mycobacterial infections. Cytokines, e.g. tumour necrosis factor 
(TNF), interferon-γ (IFN-γ) and the interleukins (IL-1, IL-8, IL-10 and IL-12) have been 
investigated. TNF variation has shown no association with either susceptibility or 
resistance to TB in studies from India (Selvaraj et al. 2001), Cambodia (Delgado et al. 
2002) and Turkey (Oral et al. 2006). Published studies looking at INF- γ are inconclusive, 
with results differing for different populations studied. 
Much the same scenario exists with contradictory results from studies on IL-12 and the IL-
12 receptor as well as IL-1B. IL-1 gene polymorphisms are not associated with TB in 
Gambians (Bellamy et al. 1998), Gujarati Indians (Wilkinson et al. 1999) and Cambodians 
(Delgado et al. 2002). In the Cambodian study, an association for the -1082 polymorphism 
of the IL-10 promoter with TB susceptibility was reported. A Japanese study found 
 67
homozygosity for a certain haplotype of the IL-12 receptor gene to be associated with TB 
susceptibility (Akahoshi et al. 2003). 
 
Vitamin D receptor 
 
Before the availability of antituberculosis drugs, the disease was treated with high doses of 
vitamin D, leading to the thinking that vitamin D is an important factor in immunity to 
M.tb. As synthesis of vitamin D3 is dependant on the skin’s exposure to UV light, it was 
postulated that darker skin races could synthesise less vitamin D and this may be one 
reason why more pigmented races are allegedly more susceptible to TB, especially those 
living in less sunny climates (Wilkinson et al. 2000). The effects of vitamin D are exerted 
by interaction of vitamin D and the vitamin D receptor (VDR). Numerous polymorphisms 
in the gene for the VDR have been found, but work on TB associations focuses on four of 
these - polymorphisms that either create or destroy four different restriction enzyme sites: 
Fok I, Taq I, Bsm I and Apa I and the alleles are designated F/f, T/t, B/b and A/a, with the 
uppercase letters denoting presence of the restriction site (Bornman et al. 2004).  
 
Pattern recognition receptors 
 
One of the first lines of defence of the human immune system is the recognition and 
subsequent uptake of a pathogenic microorganism by macrophages and dendritic cells. On 
the surface of these phagocytic cells are different types of pattern recognition receptors 
which bind to different patterns on the pathogens in order to promote phagocytosis and 
activate the signalling pathway of cytokine production, antigen presentation and the 
development of the immune response. Pattern recognition receptors of interest in TB 
susceptibility are toll-like receptors, the macrophage mannose-binding lectin (MBL) and 
the dendritic-cell-specific intercellular adhesion molecule-3, designated DC-SIGN.  
 
1.11.6.3 Candidate genes studied in the SA population 
 
Mannose binding lectin 
 
Mannose-binding lectin (MBL) is a serum protein which forms part of the immune 
pathway. MBL, on binding to ligands present on the pathogen, activates the complement 
cascade. Three mutations in the human MBL gene have been described, all of which cause 
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low levels of the protein to be produced by the liver. The effect of low levels of MBL on 
susceptibility has been studied in several population groups, with contradictory results. In 
the South African Coloured population it was found that polymorphic alleles causing lower 
levels of MBL were associated, not with TB susceptibility, but with TB resistance, these 
alleles having a protective effect, especially against TB meningitis (Hoal-van Helden et al. 
1999).  
 
DC-SIGN 
 
Dendritic-cell-specific intercellular adhesion molecule is a protein present on macrophages 
that recognises pathogens and is a major receptor for M.tuberculosis on dendritic cells 
(Tailleux et al. 2003). Two promoter region variants (-871G and -336A) have been 
identified in the gene encoding DC-SIGN, CD209. These two variants have been found to 
be associated with a lower risk of developing TB in the South African Coloured population 
(Barreiro et al. 2006). These authors investigated the frequency of the -871G protective 
allele in three other populations, Asians, Europeans and black Africans. Presence of the G 
allele was found in 21% of Asians, 38% of Europeans but was absent in Africans. Barreiro 
et al. (2006) propose that this could be a contributing factor to the increased susceptibility 
of this ethnic group. 
 
INF-γ 
 
A SNP in position +874 (T→A) of the INF-γ gene was studied and it was found that the 
‘A’ allele, thought to down-regulate protein transcription, was more common in SA 
Coloured TB patients and the ‘T’ allele was more common in controls (Rossouw et al. 
2003). 
 
SLC11A1 (NRAMP1) 
 
Both SLC11A1 (NRAMP1) and SLC11A2 (NRAMP2) were investigated in the SA 
Coloured population (Hoal et al. 2004). The (GT)9 allele of the (GT)n dinucleotide repeat in 
the 5’ region of  SLC11A1 was found to be significantly more common in controls than in 
patients, suggesting this is a protective allele. No associations between TB susceptibility 
and variation at the SLC11A2 were found. 
 
 69
 
HLA class II 
 
Lombard et al. (2006) looked at HLA-DRB1 and HLA-DQB1 polymorphisms in the 
Venda population. DRB1*1302 and DQB1*0301were found to be susceptibility alleles in 
this black population group. Interestingly, these particular alleles have been found to be 
protective with respect to malarial and hepatitis B and C persistence. 
 
VDR 
 
The vitamin D receptor restriction enzyme alleles have been studied in the Venda 
(Lombard et al. 2006) and the Cape Coloured population (Babb et al. 2007a). In the Venda, 
the haplotype F-b-A-T significantly protected against TB. In the Coloured population, the 
Apa I ‘AA’ and the Taq I ‘TT’ or ‘Tt’ genotypes were found to be predictive of a faster 
response to antituberculosis chemotherapy. 
 
SP110 
 
The human homologue of the mouse Ipr1 gene, SP110, was investigated. No significant 
association was found between TB susceptibility and any of the 8 polymorphisms studied 
(Babb et al. 2007b). 
 
1.11.6.4 Mouse genetic susceptibility studies 
 
Nramp-1 (SLC11A1)  
 
The first example of gene identification of a host susceptibility gene by positional cloning 
was the cloning of the murine natural resistance-associated macrophage protein 1 gene 
(Nramp-1) (Vidal et al. 1993). It was known that a locus in the mouse conferred resistance 
to intracellular infections such as Leishmania, Salmonella and the BCG strain of 
Mycobacterium bovis. The Nramp-1 gene was amenable to a positional cloning strategy 
given that the phenotype of the mice (either resistant or susceptible to infection) was 
clearly distinguishable in the F2 and backcross progeny. Resistant and susceptible inbred 
mouse strains showed Mendelian inheritance patterns, with resistance being almost 
completely dominant. The human homologue of Nramp-1, SLC11A1, was identified 
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(Cellier et al. 1994) and currently there are four polymorphisms used in TB association 
studies. A meta-analysis (Li et al. 2006) analysing data from 17 different studies concluded 
that, although the association of SLC11A1 with TB was not found in all studies, there 
seems to be sufficient evidence that some of the variants exert a mild effect on 
susceptibility.   
 
Ipr1 (SP110) 
 
A specific mouse strain, C3HeB/FeJ, shows extreme sensitivity to M. tuberculosis. A 
second murine susceptibility locus was identified (Kramnik et al. 2000) and termed sst1, 
for super susceptibility to TB. The gene was subsequently cloned and called Ipr1 
(intracellular pathogen resistance 1). In searching for the human homologue, the closest 
protein identified was SP110, which is only 41% identical to Ipr1. Tosh et al. (2006) 
looked at variation in the SP110 gene in three African countries, the Gambia, Guinea-
Bissau and the Republic of Guinea. Results showed that 3 of the 20 SNPs tested were 
associated with TB in one or the other of these populations, but results were not consistent. 
A study from Ghana (Thye et al. 2006) found no association between SP110 variation and 
TB susceptibility as did a study by Babb et al. (2007) in the South African population. 
 
1.11.7  Mendelian susceptibility to mycobacterial diseases 
 
A rare but very important group of patients comprises individuals who are hyper 
susceptible to mycobacteria, contracting infections in childhood or early adolescence. 
Disease in these patients is caused not by M. tuberculosis, but by BCG following 
vaccination (Petrini 2006). Presumably these individuals would be susceptible to  
M. tuberculosis as well, but were simply exposed to BCG first.  
 
Mutations may either cause complete absence of gene product or may cause reduced levels 
of protein product. Infection in children with complete deficiency is generally fatal, being 
resistant to all forms of antibiotic therapy. Prognosis for patients with partial deficiencies is 
good, with affected individuals surviving into adulthood (Casanova et al. 2002, Ottenhoff  
et al. 2005, Fernando et al. 2006). 
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The genetic defects in many of the affected patients/families have been identified and are 
defining the human immunological response essential for controlling mycobacterial 
infections. The mutations are heterogeneous, often occurring in the children of 
consanguineous parents. Mutations are inherited in a classic Mendelian fashion, most 
commonly autosomal recessive, but autosomal dominant and X-linked inheritance has been 
described in certain families. The syndrome has been termed Mendelian susceptibility to 
mycobacterial diseases (MSMD). 
 
Mutations in 5 different genes have been identified: IFN-γR1 and IFN-γR2 (the two chains 
of the IFN-γ receptor), IL-12B, IL-12RB1 (the β1 subunit of the IL-12 receptor) and 
STAT1 (signal transducer and activator of transcription 1), reviewed by Takiff (2007).  
 
1.11.8  Evidence for a tuberculosis susceptibility locus on chromosome 15q 
 
Much of the molecular biology addressing the relationship between infectious disease and 
host genetics started during the course of this PhD project. A possible connection between 
the P gene and TB was suggested (1997) when database searching showed that the genome 
of Mycobacterium tuberculosis contains, not only one, but two P-like genes (Rob Nicholls, 
personal communication). As M.tb is a unicellular organism and does not produce melanin, 
this was an unexpected finding. At the time it led to the question of whether variation at the 
P locus (more particularly, pathogenic variation) might lead to a selective advantage for 
OCA2 heterozygotes. OCA2 is the most common autosomal recessive disorder amongst 
blacks in southern Africa and the carrier frequency has been estimated as 1 in 35. Given the 
climate - hot, with high levels of ionising radiation - it would be easier to appreciate if this 
phenotype had been selected against (in the homozygous state). It has now been shown that 
the P protein is expressed in certain immune tissues (Prof Robert Nicholls, personal 
communication). In these tissues, the P protein does not function in its traditional role as 
part of the melanin biosynthesis pathway, and while its function is unclear, we presume its 
role as a membrane transport channel is required in these tissues. Given this unexpected 
finding, it may be suggested that variation at the P locus might influence an individuals’ 
immune state. Further, if a known mutation caused loss of function of the P gene, might 
carriers of that mutation be either at an advantage (or disadvantage) with respect to an 
infectious disease? 
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The findings of Bellamy et al. (2000), as discussed above, lent strong support to the 
hypothesis that a locus on chromosome 15q11-13 was associated with susceptibility to TB. 
Fine mapping of this region (Cervino et al. 2002), using 10 microsatellites and 5 
polymorphic markers in this 14cM region, showed that a polymorphism in UBE3A is 
significantly associated (p=0.002) with susceptibility to TB. This study did include a P 
gene marker (in IVS13), but it did not show association with TB susceptibility. 
 
Given the fact that work in our laboratory was already being undertaken on the P gene 
(which maps to chromosome 15q12-13) and in light of evidence in the literature that this 
region is likely to be associated with TB susceptibility, it immediately begged the question, 
‘Is the P gene itself involved in host susceptibility to TB?’ Since TB is such a significant 
health burden in this country, this question is not only interesting but also highly relevant.  
 
Aims and Objectives 
 
The initial aim of this project was to screen a cohort of albinism patients for the mutations 
causing their condition. As mentioned, OCA2 is the most common autosomal recessive 
condition in the black population of South Africa. OCA2 is caused by mutations in the P 
gene on chromosome 15q. All patients had previously been screened for the common black 
OCA2 mutation, but 22% of OCA2 gene mutations remained unaccounted for. Given the 
disease prevalence, it was justified that the search for the remaining mutations continues. It 
may have been that a second common mutation could be found or, at least, if family-
specific rare mutations could be identified, this information would be useful to the given 
families. As our patient sample consisted mainly of black individuals, a full P gene exon 
screen was undertaken. The patient sample also included 9 white families – for this 
population group both the P gene and the TYR gene were investigated. 
 
As the mutation screen drew to a close, and very few additional mutations were identified, 
we proposed that some OCA2 and BOCA mutations might lie in the promoter region of the 
P gene and act as down-regulators of P gene expression, rather than severe mutations 
which stop P gene expression altogether. At the time (1997), sequence data for the 5’ 
region of the P gene was not available and so it became another aim of this project to clone 
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and sequence the P gene promoter region. 
 
At about this time the P gene became interesting in a different and somewhat unexpected 
context. A possible link between the P gene region on chromosome 15q and genetic host 
resistance/susceptibility to the infectious disease TB, was suggested in the literature. As our 
research group was already interested in and working on the P gene and secondly, given 
the huge health burden of TB in South Africa, this new angle seemed relevant and 
important to pursue. Consequently, the second major aim of this project became to 
undertake an association study, looking at whether genotypic variation in the P gene region 
on chromosome 15q might be associated with host susceptibility to TB. TB is highly 
prevalent in two South African population groups, namely the black population and the 
Coloured population. The association study involved typing TB patients and unaffected 
controls for DNA variants at 5 loci within the P gene. Statistical analysis of the data – 
looking at whether a certain variant at a given locus may be more or less common in the 
patient versus control group – would lend support to the hypothesis that variation in this 
region of chromosome 15q is associated with host resistance (or susceptibility) to the 
infectious disease, TB. 
 
The aims of this project could therefore be stated as follows: 
 
1. Oculocutaneous albinism mutation screening 
• (a). To screen the P gene coding regions in a cohort of individuals with albinism 
from the black population, who do not carry the common OCA2 mutation (the 2.7 
kb deletion), for the mutation/s causing their condition. 
 
• (b). To screen the P gene and the TYR gene coding regions in a cohort of 
individuals with albinism from the white population for mutations causing their 
condition. 
 
• (c). To clone and sequence the P gene promoter region. 
 
2. To determine whether genotypic variation in the P gene region on chromosome 15q is 
associated with host susceptibility to TB.  
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CHAPTER 2 
SUBJECTS, MATERIALS AND METHODS 
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2.1 Introduction 
 
Albinism is the most common autosomal recessive disorder amongst southern African 
blacks and has been a focus of research interest in the Department of Human Genetics, 
University of the Witwatersrand, for many years. Consequently, a large patient base has 
been identified in South Africa, and DNA samples from affected individuals and their 
families are available in the laboratory. Following the identification of a common black 
OCA2 mutation (the 2.7 kb P gene deletion), it became possible to screen individuals for 
this mutation directly by the polymerase chain reaction (PCR). This mutation however 
accounts for only approximately 78% of black OCA2 mutations, and is very rare in white 
individuals. No other common mutations have been described for either the P gene or the 
TYR gene, in any population group. Therefore, in families where the 2.7 kb P gene deletion 
was not the sole cause of the pathogenicity observed, the unknown mutation/s had to be 
identified through various other methodologies. In this study, mutation detection involved 
two techniques, firstly, single strand conformational polymorphism (SSCP) with 
sequencing of exons showing variation and secondly, Southern blotting. 
 
As an additional point of interest in the study of the genetics of hypopigmentation, the gene 
HERC2 was investigated. This gene, a close neighbour of the P gene, may play a role in the 
aetiology of the hypopigmentation phenotype. A subgroup of the OCA subjects and normal 
controls were investigated at the DNA level by Southern blot analysis. 
 
In order to investigate a possible association between the P gene and the infectious disease, 
tuberculosis (TB), the second part of the project included a group of black and a group of 
mixed-ancestry (so-called ‘coloured’) South African patients with tuberculosis who were 
screened (by PCR) for the 2.7 kb deletion mutation of the P gene. These same TB patients, 
plus random control individuals from the same ethnic groups, were genotyped for alleles at 
an additional four polymorphic intragenic P gene marker loci. The aim was to establish 
whether the P gene may play a role in resistance/susceptibility to infection and disease 
development in tuberculosis. 
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2.2 Subjects 
 
2.2.1 Subjects with albinism 
 
Subjects involved in the screen for OCA-causing mutations had been collected during 
previous research projects conducted at the South African Institute for Medical Research 
(now called the National Health Laboratory Service), and on field trips undertaken to 
Lesotho, Zambia and the Central African Republic (CAR). All subjects with albinism were 
tested for the 2.7 kb P gene deletion mutation prior to the present study. Subjects who were 
shown to be homozygous for the 2.7 kb deletion mutation were not included in the present 
study. Subjects who had one or two undetected mutations (there were 72 of them) were 
then selected for further investigation. 
 
This subject cohort affected with albinism comprised two groups of individuals: 1) subjects 
of black African origin and 2) subjects of white European origin (most South African 
whites are of Dutch, French, German or English descent). These subjects were screened for 
mutations in the two pigment genes most likely to carry OCA mutations in the given 
populations, namely the P gene and the TYR gene. P gene mutations (responsible for 
OCA2) have been found to occur in both black and white populations. TYR mutations 
(responsible for OCA1) have, to date, essentially only been found to occur in white 
populations or populations of mixed ancestry.  
 
2.2.1.1  Subjects with unclassified albinism 
 
During collection of subjects on the various field trips, certain hypopigmented individuals 
were observed. These individuals were all from the black African population, but their 
phenotype was not typical of OCA2, ROCA or BOCA (and could not be classified as 
OCA1 as some pigment production was evident in skin, hair and eyes). These individuals 
were grouped together and termed ‘unclassified black’ for the purpose of this study and as 
published in Kerr et al. (2000).  
 
As the type of OCA can not be determined from phenotypic presentation in the white 
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population (both OCA1 and OCA2 may look similar in this population group), Caucasoid 
individuals with OCA were also termed ‘unclassified’ (unclassified white) in this study and 
as published in Kerr et al. (2000). 
 
A total of 72 individuals with OCA were included in a screen for OCA-causing mutations 
(see Table 2.1). The majority of these subjects (63/72) were of black African origin, as 
would be expected given the relative size of the population and the population frequency of 
OCA2, but a number of white families were also included. Black individuals with the 
classic OCA2 phenotype were only screened for P gene mutations. The albinism phenotype 
shows locus homogeneity in the southern African black population, with all cases showing 
linkage to the P locus (Ramsay et al. 1992, Kedda et al. 1994). While BOCA has also been 
shown to be linked to the P locus in the same sample studied (Manga et al. 2001), black 
individuals with BOCA, as well as those with an unclassified form of albinism, were 
screened for TYR mutations as well as P gene mutations. The intermediate 
hypopigmentation phenotype observed in these two groups of individuals may have been 
caused by epistatic effects, with mutations at two different loci (P and TYR) contributing to 
the phenotype. White individuals were screened for both P and TYR mutations, in an 
attempt to determine which type of albinism was present in a given family.  
 
 
 
SUBJECT GROUP TYPE OF  OCA N % GENE SCREENED FOR MUTATIONS  
Black OCA2 39 54% P 
 BOCA 9* 13% P, TYR 
 Unclassified 15 20% P, TYR 
White Unclassified 9 13% P, TYR 
Total  72 100  
 
N= number of individuals. 
*= In the original BOCA sample collected by P. Manga and in her subsequent publications (Manga et al. 
1995, 1997), 10 BOCA individuals were available for study. DNA on one sample had run out and 
consequently only 9 BOCA individuals were included in the present study. 
 
The majority of subjects were from South Africa, unless otherwise stated: of the 39 black 
OCA2 individuals, 31 were South Africans, 6 were from the CAR and 2 from Zambia; the 
Table 2.1. Albinism subjects involved in a mutation screen for pathogenic variants. 
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9 BOCA individuals were all collected by P. Manga and Professor J. Kromberg on a field 
trip to Lesotho; the 15 black individuals with an unclassified form of albinism included 7 
from the CAR and 8 from Lesotho; and there were 9 white South African OCA individuals. 
The countries of origin of the subjects are shown on the map in Fig. 2.1. All subjects were 
unrelated with the exception of one of the CAR individuals with an unknown form of 
albinism who is the half-sib of an individual with classic OCA2 (both included in this 
study). 
 
 
 
 
Figure 2.1 Map of Africa showing countries from which patient samples were collected. 
The four areas of sampling (Gauteng, South Africa; Lesotho; Zambia and the CAR) are 
highlighted using pink arrows. Lesotho is a land-locked country within South Africa’s 
boarders; the Central African Republic is further north, lying just above the Congo.   
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2.2.2 Subjects with tuberculosis 
 
While OCA is a single gene disorder, the study of host genetic response to an infectious 
disease can be considered a complex trait. When investigating complex diseases, large 
sample sizes are needed to see small effects. Due to the difficulties encountered in 
collecting the black TB patient sample for the present study, smaller numbers than hoped 
for were included, and this work should therefore be considered a pilot study. 
 
In order to address the issue of a possible role for the P gene as a potential 
resistance/susceptibility locus in the aetiology of tuberculosis, blood samples from 
(normally pigmented) black patients with TB were collected in order to determine an 
observed carrier frequency of the 2.7 kb deletion mutation in this sample group and to 
establish whether it differed significantly from the general black population. The black 
population was targeted because this is the only population group in which a common 
OCA-causing mutation has been identified (i.e. the 2.7 kb P gene deletion) and its carrier 
frequency calculated in this population (1 in 40). Therefore, in the South African black 
population, we have figures for an expected carrier frequency to use for comparative 
purposes. Patients were collected from Sizwe Hospital, Charles Hurwitz Hospital and 
Lifemed Hospital (all dedicated TB hospitals in the Johannesburg area), and from the 
Tokoza Clinic (a general out-patient clinic also in the Johannesburg area). Visits to these 
hospitals were made by the writer and a Genetics nurse, Sr Merlyn Glass. The project was 
explained to the patients in as simple a way as possible, questions were encouraged and 
then volunteers were asked to donate blood. Informed consent forms were signed by all 
volunteers. Non-genetic TB susceptibility factors (e.g. HIV infection, diabetes, alcoholism) 
had to be taken into account, and any individual in which active TB disease could be 
attributable to any of these identifiable factors was excluded from the study.  
 
Approval for the collection of samples was obtained from the Committee for Research on 
Human Subjects, University of the Witwatersrand (see Appendix). All samples were coded 
prior to DNA extraction, and research results were not conveyed back to the individual. In 
cases where the HIV status of the patient was not known, an additional blood sample was 
taken and the HIV status established. Only HIV negative subjects were included in the 
study. Due to the extremely high prevalence of HIV in TB patients, over a period of 18 
months, a sample of only 72 black TB patients who were HIV negative was collected, 
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despite seeing over 600 patients in this time. Black controls were random individuals 
referred to the NHLS, Department of Human Genetics, for paternity testing. 
 
In order to extend the study on black patients with TB, a second group was selected. These 
patients were of South African mixed ancestry (so-called ‘coloured’ individuals of 
Khoisan, black and white ancestry) and they were ascertained in the Western Cape 
province. Blood samples were collected from Coloured patients and DNA extracted from 
these samples by the staff of Dr Eileen Hoal-van Helden at Tygerberg Hospital, University 
of Stellenbosch Medical School. The mixed ancestry group of TB patients was not subject 
to the strict selection criteria of the black sample with respect to HIV status – at the time of 
sampling the HIV prevalence in this group was low and HIV status was not used as an 
exclusion criterion. HIV status of the coloured TB patients in this study was unknown. The 
controls were random blood donors, matched for geographic and ethnic origin. DNA 
aliquots were sent to our laboratory for DNA genotyping for the purposes of the present 
study. The subject group then totalled 350 (see Table 2.2). (Note – for the different marker 
assays, results could not always be obtained for all individuals typed due to technical 
difficulties. Therefore, for the different assays, slightly smaller sample sizes are reported 
on.)  
 
 
SUBJECT GROUP N*  % 
Coloured controls 87 25% 
Coloured TB patients 92 26% 
Black controls 99 28% 
Black TB patients 72 21% 
Total 350 100 
 
*N= number of individuals.  
 
In addition to the 2.7 kb deletion mutation, four other P gene polymorphisms were typed, 
both in the cohort of coloured TB patients (plus matched controls) and the cohort of black 
TB patients (plus their matched controls). Three of these were (AC)n repeat microsatellite 
markers and the fourth was a single nucleotide polymorphism (SNP). Two of the AC 
Table 2.2. Subjects involved in a screen of the P gene for association with TB 
susceptibility. 
 81
repeats were identified by searching genomic P gene sequence (downloaded from Celera) 
for stretches of 10 AC repeat units or more. A minimum of 10 repeats was chosen to give a 
greater chance that the repeat would be polymorphic. (Note – The sequence data used for 
this experiment, downloaded from the Celera website (www.celera.com), stretched from 
exon 52 of HERC2 through P and included some 3’ sequence. This work was done in 2001 
before a more complete version of the human genome was publicly available. There were 
gaps in the sequence and exon 1 and 2 of the P gene were not present in the sequence 
download.) Three useful AC repeats were identified – in introns 17, 20 and 24. Information 
on the 3 novel markers and their polymorphic alleles was submitted to the Genome 
Database (GDB) (www.gdb.org) and they were assigned the following ‘D’ numbers:  
D15S1533 (IVS17), D15S1536 (IVS20) and D15S1537 (IVS24). The SNP is a published 
variant, occurring in the coding region (exon 9) of the P gene (Lee et al. 1995). The variant 
is a C to T base change, leading to an amino acid substitution in the P protein (R305W).  
See Figure 2.2 for the relative positions of the 5 markers typed. 
 
 
 
Figure. 2.2. A schematic representation of the genomic region surrounding the human P 
gene, showing the positions of the five intragenic markers used to screen TB patients and 
their appropriate controls. The 2.7 kb deletion mutation spans exon 7, the variant R305W is 
found in exon 9, the three microsatellite markers, D15S1533, D15S1536 and D15S1537, 
are found in introns 17, 20 and 24 respectively. 
 
 P gene exon 
 P gene intron
Extragenic sequence
Position of P gene markers
Position of the last exon of HERC2 
 
40 582 bp 
 
        93         3    7   9         10        15    19        20                      22           24                      25                            
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    2.7 kb del 
 
R305W    D15S1533        D15S1536                            D15S1537 
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2.3 Materials and Methods 
 
All chemical solutions used in this study were made up as described in Sambrook et al. 
(1989). 
 
Methodologies used to screen OCA patients for disease-causing mutations will be 
described in this section (PCR-SSCP analysis and Southern blotting with DNA sequencing 
of variants). Two genes were included in the mutation screen: tyrosinase and the P gene. 
 
Normal sequence data for the region 5’ of P were not available at the commencement of 
this project; hence an attempt was made to clone and sequence the P gene promoter region. 
Two methods were used to try and obtain P gene promoter sequence – subcloning of a 
bacterial artificial chromosome (BAC) known to contain sequence 5’ of P, and inverse 
PCR using primers located immediately 5’ to P gene exon 1.  
 
Methodologies used to type polymorphic markers within the P gene in the subjects with TB 
and their controls will be described below (specific mutation detection as well as 
microsatellite analysis on the ABI 377 sequencer). Five intragenic markers were examined 
to establish whether the P gene may be associated with tuberculosis 
susceptibility/resistance. 
 
2.3.1  Collection and storage of blood samples 
 
Blood samples were collected from all the subjects in either EDTA or ACD tubes, to 
prevent coagulation of the blood. Blood was spun down at 2300rpm for 10 min in order to 
separate the plasma, white blood cells (buffy coat), and red blood cells. The buffy coat was 
aspirated into a 50ml polypropanol tube and the DNA extracted immediately, or the buffy 
coat was stored at -20°C.  
 
DNA was extracted by the salting out procedure, essentially as described by Miller et al. 
(1988). The method involves three basic steps. Firstly, Triton X washes remove unwanted 
red blood cells, secondly, overnight incubation with the enzyme Proteinase K which digests 
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proteins (which are subsequently pelleted and discarded after addition of saturated NaCl) 
and thirdly, precipitation of genomic DNA after addition of 100% ethanol. 
 
If the blood sample volume was very small (< 1 ml), the DNA was extracted using the 
High Pure PCR Template Preparation Kit (Roche Diagnostics).  
 
Following extraction, DNA was dissolved in 1X TE buffer and stored at 4°C or at -80°C 
for long term storage.  
 
2.3.2  PCR 
 
The polymerase chain reaction (PCR) is a technique used to amplify a specific short stretch 
of DNA. Specificity is determined by a set of primers which are designed to flank the 
region of DNA that is to be amplified. Different amplification cycling conditions will be 
optimal for different primer sets. 
 
2.3.2.1  The P gene 2.7 kb deletion PCR assay 
 
Firstly, all the subjects with albinism were tested for the 2.7 kb deletion mutation. A 
PCR assay was designed by Durham-Pierre et al. (1994) which allows rapid detection of 
the mutation. One of the primers (MHB51) has since been redesigned by the same 
authors and was used in this study. Three primers are added to the reaction (see Figure 
2.3), two forward primers, MHB107 and MHB72, and a common reverse primer, 
MHB71.  
 
 
 
 
 
 
 
 
 
 84
 
 
 
 
 
 
Figure 2.3  Diagramatic representation showing the position of the PCR primers used to 
detect the P gene 2.7 kb deletion mutation (Durham-Pierre et al. 1994). 
 
 
If the deletion is not present, MHB107 and MHB71 are too far apart for a PCR product to 
be generated. In this situation (i.e. on a normal chromosome), a product of 240 bp will be 
generated between MHB72 and MHB71. If the deletion is present, then MHB72 would not 
be able to bind and MHB107 and MHB71 would be significantly (2.7 kb) closer and a 
product of 398 bp would be generated between these two primers. The primer sequences 
are given in Table 2.3. 
 
 
 
DIRECTION NAME SEQUENCE 
F MHB107 5’- CAT AGT CTT GGT TTT TGT AGT CCT -3’ 
F MHB72 5’- GCG GTG GCT GTC ATG GC -3’ 
R MHB71 5’- GGA GGG TGC ATT CAT TCT TCA G -3’ 
 
 
 The PCR reaction was carried out in a total reaction volume of 25μl containing 
approximately 100ng DNA, 10pmol each primer, 1 unit Taq DNA polymerase (Boehringer 
Mannheim), 1.25μM each dNTP and 2.5μl 10X PCR buffer. Cycle conditions were 94°C 1 
min, 60°C 1 min, 72°C 1 min for 30 cycles. PCR product was visualised on a 2% or 3% 
agarose gel stained with ethidium bromide.    
 
If an individual affected with OCA2 did not carry the 2.7 kb deletion mutation (i.e. carried 
two unknown mutations), or if they were heterozygotes for the 2.7 kb deletion (i.e. carried 
one unknown mutation), the aim of this study was to identify the unknown mutation/s. 
Table 2.3. Primer sequences used to detect the P gene 2.7kb deletion mutation. 
107 72
71 
Deletion 
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Further, all of the 9 BOCA patients included in this study which had been collected by P. 
Manga (PhD thesis, 1997) were found to be heterozygous for the 2.7 kb deletion. The 
second unknown mutation remained to be identified. 
 
2.3.2.2  P gene PCR 
 
The aim of this part of the study was to identify unknown P gene mutations. Individuals 
affected with OCA2 were selected to include those who did not carry the 2.7 kb deletion 
mutation (i.e. carried two unknown mutations), or were heterozygous for the 2.7 kb 
deletion (i.e. carried one unknown mutation). Further, out of a group of BOCA patients 
collected by P. Manga (Manga et al. 2001), 9/10 were found (by her) to be heterozygous 
for the 2.7 kb deletion and the second unknown mutation remained to be identified. The 
remaining individual did not carry the 2.7 kb deletion on either chromosome. 
 
The P gene has 25 exons which are amplified individually using primers situated in the 
flanking intronic regions. PCR primers and cycling conditions were as described (Lee et al. 
1995) for all exons except exon 16. No amplification was obtained for this exon using the 
published primer sequences and various PCR conditions, thus the primers were redesigned. 
The sequences of these primers are given in Table 2.4.  
 
 
DIRECTION NAME SEQUENCE 
F Primer 16F 5’- CTG CAG AAC TGA AGC ACG AG -3’ 
R Primer 16R 5’- ATG TTC TGC TGC ACA CCA AG -3’ 
 
 
For exon 16, the PCR mix was made up as described, but only 1.25pmol of each primer 
was added in a 12.5μl reaction. Thirty five cycles of amplification were performed with 
denaturation at 95°C for 1 min, annealing at 54°C for 1 min and primer extension at 72°C 
for 1 min.  
 
The exon 25 PCR product was too large for SSCP analysis (574 bp), and was therefore 
Table 2.4. Primer sequences for amplification of exon 16 of the human P gene. 
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digested with either Hinf I or Bst NI before running on a gel.  
 
2.3.2.3  Tyrosinase gene PCR 
 
To date, no common mutation/s have been identified at the TYR locus in any population 
group. Consequently, described TYR mutations are rare, and are largely specific to the 
family in which they occur. Black individuals with classic OCA2 were not included in a 
screen for TYR mutations. Caucasoid individuals with OCA, black individuals with an 
unclassified form of hypopigmentation and black patients with BOCA were screened for 
TYR mutations by SSCP analysis. The TYR gene comprises 5 exons. Exon 1 is too large 
(819 bp) to amplify as a single fragment for PCR-SSCP analysis and is therefore amplified 
in two smaller fragments, termed 1a and 1b (Oetting et al. 1994). The primer sequences 
used to amplify the exons of the TYR gene were all as published (Oetting et al. 1994). 
 
2.3.3 PCR-SSCP analysis  
 
Single strand conformation polymorphism is a method of mutation screening. The 
technique exploits the fact that single stranded DNA will take on a secondary structure 
which is directly determined by the sequence of the DNA strand. Consequently, if a DNA 
sequence variation has arisen, the single stranded DNA fragment containing that variant 
will take on a different secondary structure to that of the normal fragment, resulting in a 
mobility shift when the DNA fragment is run on a gel. Thus, when performing SSCP 
analysis, band patterns (and not band sizes) are compared between individuals. The method 
was first described by Orita et al. (1989a and b). Sensitivity of the technique is not 100%, 
but reportedly has a pick-up rate of 80-90% (Hayashi and Yandell 1993, Sheffield et al. 
1993). Detection rate is improved by varying gel running conditions (e.g. adding glycerol 
to the gel mix, or changing the temperature at which the gel is run) and by keeping the size 
of the DNA fragments run on the gel small, optimally between 100-250 bp. The DNA 
single strands are run on a polyacrylamide gel, which gives better resolution than an 
agarose gel. In the present study two gel conditions were used to run the same sample 
under two different conditions in order to improve the detection rate – gels were made up 
with or without glycerol. 
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2.3.3.1 Radioactive PCR 
 
A given exon was amplified by PCR in a total volume of 12.5μl containing approximately 
100ng of genomic DNA, 5pmol of each primer, 125μM of each dNTP, 1.25μl 10X PCR 
buffer, 0.625μl (32P) dCTP and 0.5 units Taq polymerase (Boehringer Mannheim).  
 
2.3.3.2  Polyacrylamide gel electrophoresis 
 
The radioactive PCR product was denatured by heating at 95°C for 3 minutes, and then 
loaded onto a 6% MDE (Hydrolink) vertical polyacrylamide gel. Each DNA sample was 
run under two different conditions (firstly on a gel containing 10% glycerol and secondly 
on a gel without glycerol) to increase the probability of detecting band shifts reflecting 
DNA variants. Gels without glycerol were run at 28 V/cm for 5-7 hours and gels with 
glycerol were run overnight at 10 V/cm. A fan was directed at the gel to ensure the gel did 
not overheat. This is obviously not a precise method of regulating temperature and 
consistency between gels could not be guaranteed. DNA fragments were visualised 
following autoradiography. If a SSCP variant was detected, the given exon was re-
amplified in the absence of radioactive label, and the PCR product sequenced. 
 
2.3.3.3  Sequencing 
 
Several methods of DNA sequencing are available. In this project, two methods were used: 
manual sequencing and then later, when an automated DNA sequencer became available in 
the laboratory, automated DNA sequencing. Both methods used are based on the Sanger 
method of DNA sequencing where double stranded PCR product is the template DNA for 
the sequencing reaction.  
 
PCR product (non-radioactive) was generated and then run on a 0.8% low melting 
temperature agarose gel. The DNA was extracted from the gel using the QIAGEN Gel 
Extraction Kit. This ensured the DNA fragment to be sequenced was separated from the 
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other PCR reagents (dNTPs and primers) and other possible spurious PCR bands. For 
manual sequencing, the USB sequencing kit for double stranded DNA sequencing (Perkin-
Elmer) was used. Sequencing product generated through manual sequencing incorporated 
the radioactive isotope 35S. This product was run on a 6% denaturing polyacrylamide gel at 
35 V/cm to generate high temperatures, which ensures DNA remains denatured. DNA was 
visualised through autoradiography. For automated sequencing, sequencing product 
generated using the Taq FS dye terminator kit was run through a Centricep column to 
remove unincorporated, fluorescently labeled dNTPs. Samples were dried using an 
Eppendorf 5301 Concentrator. The dried pellet was mixed with 3μl dextran-formamide 
loading dye, denatured for 2 minutes at 95°C, then electrophoresed on a 4.3% denaturing 
polyacrylamide gel (36cm WTR plates at a constant 200W) for 7 hours on an ABI 377 
Automated DNA Sequencer.  Data were analysed using Version 3.4.1 Sequencer Analysis 
Software (ABI). 
  
2.3.4  Southern blotting 
 
This technique was developed in the 1970s by Ed Southern (Southern 1975) and essentially 
ear-marked the beginning of molecular genetic technology. It is a time-consuming 
procedure involving multiple steps and is therefore difficult to trouble-shoot if technical 
difficulties are encountered. Further, many laboratories still make use of radioactivity to 
label probes. For these reasons it is not a method of choice if PCR is a viable alternative. 
However, PCR is limited in the size of DNA fragment that can be analysed, making 
Southern blotting a necessary method for detecting large chromosomal rearrangements, 
deletions or duplications. The process involves restriction of genomic DNA using a 
specific restriction enzyme, separation of the digested fragments by agarose gel 
electrophoresis, denaturation of the DNA in situ, transfer of the single stranded DNA from 
the gel to a nylon membrane, hybridisation of the membrane with a radioactively (or 
biotin) labelled single stranded probe and finally exposure of the membrane to 
autoradiograph film. 
 
While PCR-SSCP analysis was used to detect single base changes or small sequence 
variants, Southern blotting was used to look for large rearrangements firstly within the P 
gene and secondly, in the region immediately 5’ of the P gene (i.e. the HERC2 region). 
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2.3.4.1  Southern blotting for the P gene 
 
2.3.4.1.1  DNA digestion 
 
As an initial trial, human genomic DNA was digested with three enzymes (Bam HI,  
Eco RI and Hind III) in order to look for an enzyme digest suitable for the probe. Results of 
this blot showed Eco RI to be most suitable. This enzyme was chosen as the 2.7 kb deletion 
is contained within an Eco RI fragment, resulting in the presence of a smaller fragment, 
rather than a missing fragment when using a 2.8 kb P gene cDNA fragment as a probe 
(Durham-Pierre et al. 1994). Therefore 2.7 kb deletion heterozygotes and homozygotes can 
act as controls on a blot.  
 
All subjects in this study (N=72) were included in the P gene mutation screen by Southern 
blotting. Genomic DNA (10μl) was run on a 0.8% agarose gel in order to determine DNA 
quality. Some DNA samples had been stored in the laboratory for many years and DNA 
degradation was possible. If DNA was degraded, the sample could not be used for Southern 
blotting. DNA concentration was determined using spectrophotometry. For Southern 
blotting, 5μg genomic DNA was digested with 30 units of Eco RI overnight at 37°C in a 
total digest volume of 50μl. Five microlitres of the digest was run on a 0.8% agarose gel to 
check that the digest has been successful. 
 
2.3.4.1.2  Agarose gel electrophoresis 
 
Agarose was dissolved in 1X TBE buffer by boiling. The gel mix was allowed to cool 
before ethidium bromide was added to a final concentration of 0.3μg/ml, for visualisation 
of DNA. Digested genomic DNA was separated on a 0.8% agarose gel run overnight 
(approximately 20 hours). 
 
2.3.4.1.3  Southern blotting 
 
Following alkali denaturation and neutralisation of the DNA fragments in the gel, DNA 
was transferred from the gel onto a nylon membrane (HybondN, Amersham) by Southern 
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transfer (Southern 1975). DNA was fixed onto the membrane by UV cross-linking or by 
baking at 80°C for 2 hours. 
 
2.3.4.1.4  Radioactive labelling of the probe: pcDNA3-P 
 
The plasmid, pcDNA3-P, contains the complete cDNA sequence of the P gene. This clone 
was originally generated in the laboratory of Professor Richard Spritz (University of 
Wisconsin, Madison, Wisconsin, USA), and was a gift to us from his collaborator, 
Professor Robert Nicholls. The 5.4 kb plasmid vector contains a 2.8 kb Bam HI/Xba I 
fragment insert comprising the full length P gene cDNA. Approximately 10μg of plasmid 
DNA was digested overnight at 37°C with 20 units Bam HI and 20 units Xba I in a total 
volume of 150μl. The digest was run on a 0.8% low gelling temperature agarose gel (FMC 
BioProducts) to separate the vector and insert bands. The 2.8 kb insert band was cut out of 
the gel, and the DNA extracted from the gel using the Gel Extraction kit (QIAGEN). Five 
microlitres of DNA was run on a 0.8% agarose gel to ascertain the concentration of DNA 
recovered. Approximately 50ng of insert DNA was radioactively labeled with 32P dCTP 
using the Megaprime Labeling kit (Amersham). 
 
2.3.4.1.5  Hybridisation and autoradiography 
 
The HybondN membrane, to which the DNA had been fixed, was placed in a glass 
hybridisation tube. All prehybridisation, hybridisation and washing steps were undertaken 
in a Hybaid oven. The membrane was prehybridised with 10ml hybridisation solution at 
65°C for at least 2 hours. The radioactively labelled probe was denatured at 95°C for 5 
minutes and then added to the hybridisation solution. Hybridisation was at 65°C, overnight. 
Following hybridisation, the blot was washed to remove unbound and non-specifically 
bound probe. The blot was washed twice with 2X SSC/0.1% SDS for 15 minutes at room 
temperature, once with 1X SSC/0.1% SDS for 20 minutes at 65°C, and finally, once with 
0.2X SSC/0.1% SDS for 20 minutes at 65°C. The membrane was sealed in a plastic bag 
and then placed in an X-ray cassette (Okomoto) together with Hyperfilm (Amersham) X-
ray film. Following exposure at room temperature for 2-6 days, the film was developed in 
an automatic X-ray developer (Pako 14X). 
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2.3.4.2  Southern blotting for HERC2 
 
The human gene, HERC2, lies immediately 5’ to the P gene on chromosome 15q. Mouse 
studies have shown that variation in this gene can affect coat colour, leading to a 
hypopigmented phenotype. To investigate whether mutations in this gene may influence 
human pigmentation, Southern blot analysis was undertaken to look for large structural 
rearrangements in HERC2 in a subset of the patients involved in this study. Individuals 
with BOCA, unclassified OCA and OCA2 were included in this investigation. The multiple 
enzyme blot used above was stripped by boiling in water for 30 minutes and then 
hybridised with a labelled single stranded probe as described above. The HERC2 probe was 
a 1002 bp PCR product amplified from intron 70. The primer sequences are given in Table 
2.5: 
 
 
DIRECTION NAME SEQUENCE 
F HERC2-E 5’-CGT CTC CGT GCG GTC AGG TAA G-3’ 
R HERC2-F 5’-GTT CAG CAC GGC CCA GAG TAG G-3’ 
 
The PCR reaction was carried out in a total reaction volume of 25μl containing 
approximately 100ng DNA, 10pmol each primer, 1 unit HiFi Taq DNA polymerase (Roche 
Diagnostics), 1.25μM each dNTP, 2.5μl DMSO and 2.5μl 10X PCR buffer (number 2). 
Cycle conditions were 95°C 5 min and then  95°C 1 min 52°C 1 min, 72°C 2.5 min for 30 
cycles. PCR product was run on a 0.8% agarose gel stained with ethidium bromide. The 1 
kb fragment was excised from the gel and purified using the QIAGEN gel purification kit. 
DNA was eluted in 10mM Tris buffer. Five microlitres of recovered fragment was run on a 
0.8% agarose gel to check recovery and to estimate concentration. 
 
Probe labelling and blot hybridisation was as described above. Of the three enzymes tested 
(Bam HI, Eco RI and Hind III), Hind III gave the most clear banding pattern and multiple 
bands were detected per individual. Consequently this enzyme was chosen to digest patient 
DNA samples.    
 
Table 2.5. Primers used to amplify a 1kb fragment from IVS70 of the HERC2 gene. 
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2.3.5  Cloning of the P gene promoter region 
 
Following exon by exon mutation analysis of the P gene by SSCP analysis, it became 
apparent that a large proportion of unidentified mutations did not lie within the coding 
region of the gene. Taking into consideration the BOCA phenotype, which presents with 
intermediate pigmentation, as well as the observation of ‘’mild’’ OCA2 phenotypes, it was 
proposed that P gene mutations may lie in the 5’ control or promoter region of the gene 
(Kerr et al. 2000). These mutations may influence the level of P gene expression, without 
rendering the gene completely non-functional. It was therefore necessary to clone and 
sequence the P promoter region to establish the normal sequence, before variation in this 
region could be detected. Some of the following work was undertaken by the writer in the 
laboratory of Professor Robert Nicholls, Case Western Reserve University, Cleveland, 
Ohio between May and September 1997. The completion of the research was undertaken 
by the writer subsequent to this visit at the University of the Witwatersrand. 
 
2.3.5.1  Identification of a BAC clone 
 
Prior to the writer’s arrival in the laboratory of Professor Robert Nicholls, a Bacterial 
Artificial Chromosome (BAC) clone had been identified (through library screening using 
PCR), which contained the 5’ exons of the P gene, as well as the 3’ region of the gene 
HERC2 (which was then known as ERY-1). Thus, this BAC contained the 5’ upstream 
region of the P gene (see Fig 1.9 for a map of the region). The BAC clone, plate number 
263 022 (Research Genetics), contained at least exons 1-3 of the P gene; P exons 12-25 
were definitely not present in this BAC clone (verified through exon by exon PCR 
amplification using the BAC as a source of template DNA). PCR amplification of exons 4 
– 11 gave inconsistent results. 
 
2.3.5.2  Subcloning the BAC 
 
A number of restriction enzymes that have a 6 bp recognition site were chosen by the 
writer in order to identify a restriction fragment that would be of an appropriate length to 
clone into a plasmid and sequence (about 2-5 kb). For each reaction, 500ng of BAC DNA 
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was digested for 2 hours with 10 units of Bam HI, Dra I, Eco RI, Hind III, Hinf I, Nco I, 
Xba I or Xho I according the manufacturer’s instructions. Digest fragments were separated 
on a 0.8% agarose gel which was run at 45V for 17.5 hours. The DNA was transferred to 
HybondN membrane as described. The blot was hybridised overnight with the P promoter 
fragment probe (see next section) and the final wash was in a 0.1X SSC solution at 56°C. 
Autoradiography was at -80°C for 3-6 hours. A second Southern blot was generated using a 
range of 4 bp restriction enzyme cutters, which generated smaller fragments in the range of 
1-3 kb: Apo I, Bst YI, Msp I, Pst I or Tsp 509I. 
 
2.3.5.3  P gene promoter fragment probe 
 
The fragment used to probe the human P promoter region was a 270 bp Eco RI/Bam HI 
fragment comprising exon 1 of the P gene and 180 bp 5’ of exon 1. The fragment was 
cloned into pBluescriptKSI. The insert was excised from the plasmid by digesting 
approximately 10μg of probe DNA with 25 units Eco RI and 25 units Xba I in a total digest 
volume of 200μl for 2-3 hours. The digest was run on a 3% agarose gel, the 270 bp band 
was excised from the gel, and the DNA recovered using the QIAGEN Gel Extraction kit. 
Approximately 50ng of insert DNA was radioactively labelled with 32P dCTP using the 
Rediprime Labeling kit (Amersham). 
 
2.3.5.4  Preparation of BAC DNA for subcloning 
 
Two restriction fragments were chosen as possible candidates for subcloning: the 2.3 kb   
Tsp 509I fragment, and the 7 kb Xba I fragment. Digestion with Tsp 509I (/AATT) 
produces sticky ends which are clonable into Eco RI (G/AATTC) sites. Since most 
commercially available vectors will contain an Eco RI site in the polylinker, Tsp 509I 
fragments will be amenable to cloning into a number of vectors. Further, the size of the 
fragment made it an ideal candidate for sequencing as it was not too large. However, taking 
into consideration the fact that the Tsp 509I fragment to which the P promoter probe 
hybridised, may equally as likely have comprised sequence which lay 3’ to P exon 1, rather 
than 5’ promoter sequence, it was decided to clone a larger fragment, like Xba I, 
simultaneously.  Approximately 10μg BAC DNA was digested with 40 units of the 
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appropriate enzyme in a 100μl digest volume. Following digestion, the DNA was ethanol 
precipitated (as described, Sambrook et al. 1989) and resuspended in 20μl of dH2O. The 
digests were loaded onto a 1% agarose gel (made up without the addition of ethidium 
bromide) and run at 100V for 5 hours. The 2.3 kb Tsp 509I band and the 7 kb Xba I band 
were cut out of the gel using molecular weight markers as a guide to where these fragments 
would be, and the DNA recovered using the QIAquick gel extraction kit (QIAGEN). 
 
2.3.5.5  Preparation of the cloning vectors 
 
Two different plasmid vectors were used, pZERO and pBluescript. pZERO was the initial 
vector of choice, but when a positive clone failed to be recovered after numerous attempts, 
pBluescript was used as an alternate vector. pZERO is a so-called ‘suicide’ vector where 
the cloning site interrupts a lethal gene so that only vectors which contain an insert will 
survive, vectors which simply re-circularize will necessarily commit ‘suicide’. A few 
micrograms of each plasmid vector were digested with either Eco RI or Xba I. To prevent 
recircularization of pBluescript, the linearised plasmid was treated with Calf Intestinal 
Phosphatase (CIP) according to the manufacturer's instructions. This enzyme 
phosphorylates the 5’ overhang, thereby preventing vector re-ligation. Following digestion, 
the plasmids were run on a 0.8 % agarose gel, and the DNA purified from the gel using the 
QIAquick gel purification kit (QIAGEN). 
 
2.3.5.6  Ligation of vector and insert 
 
Ligation reactions were undertaken in a reaction volume of 20μl, at 14°C overnight. Sticky 
end ligation reactions require an optimal DNA concentration of 20-50μg of DNA (in total) 
per ml of reaction volume, using 2-3 times more insert DNA than vector DNA. Four 
hundred units of T4 DNA ligase (NEB) were added to each ligation reaction. T4 DNA 
ligase requires ATP as an energy source. While ATP is present in the enzyme buffer, it is 
easily destroyed by high temperatures and repeated freeze-thaw episodes. Therefore, 
20mM ATP was also added to the ligation reaction. 
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2.3.5.7  Transformation 
 
Following ligation of the insert DNA into a vector, the DNA was transformed into 50μl 
competent DH5α E. coli cells (GibcoBRL) according to the manufacturer’s instructions, 
and the cells plated onto agar plates containing the appropriate antibiotic. The cells 
transformed with the pZERO vector were plated onto agar plates made up to contain 
kanamycin and IPTG. IPTG induces expression of the ‘suicide’ gene. The cells 
transformed with the pBS vector were plated onto agar plates containing ampicillin and    
Xgal. All antibiotic stock solutions, IPTG and Xgal were made up as described (Sambrook 
et al. 1989). The cloning vector, pBluescript, contains part of the coding sequence of the β-
galactosidase gene (lacZ). The polycloning site of the vector lies within this region. In the 
presence of the chromogenic substrate, Xgal, E.coli transformed by such a vector form blue 
colonies. However, if the vector contains an insert, the foreign DNA will have inserted into 
the polycloning site, and the bacteria carrying recombinant plasmids will therefore not be 
able to form blue colonies, and will appear white. The plates were incubated at 37°C 
overnight. 
 
2.3.5.8  Identification of positive transformants 
 
Two methods were used to check if the transformants contained the correct insert. Firstly, 
individual colonies were picked and grown up overnight in liquid Luria broth (LB) 
containing the appropriate antibiotic. The plasmid DNA was extracted from the host cells 
using the QIAGEN plasmid miniprep kit and then digested with either Eco RI or Xba I to 
check for the presence of, and size of, an insert fragment. Alternatively, colony filter lifts 
were performed, whereby the colonies were transferred to a HybondN membrane by gently 
placing a filter on top of a pre-cooled agar plate, the DNA denatured by floating the filter, 
DNA side up, on denaturing solution for 2 minutes and then neutralised by floating the 
filter on neutralising solution. The DNA was fixed to the membrane by UV cross-linking, 
and the membrane hybridised with the P promoter probe as described. The original plate 
used for the filter lift was either left at room temperature over-night, or at 37°C for a few 
hours to allow regrowth of the colonies. If a positive transformant was identified following 
hybridisation with the promoter probe, that colony was picked, grown up in LB containing 
the appropriate antibiotic, and the DNA extracted using the QIAGEN plasmid miniprep kit. 
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2.3.6  Inverse PCR 
 
In order to determine the normal sequence of the P gene promoter region, the traditional 
method of cloning the area and then sequencing was adopted (see above). As an alternate 
strategy, the technique of inverse PCR (Ochman et al. 1988, Triglia et al. 1988) was 
attempted. This methodology does not involve cloning of the DNA to be sequenced, hereby 
circumventing problems encountered with regions of the genome which prove difficult to 
clone. Fig 2.4 shows a schematic outline of the technique. PCR is used to amplify a region 
of unknown DNA sequence that is adjacent to a region of known DNA sequence. Two 
PCR primers are designed within the region of known sequence, but here they are 
orientated such that chain elongation will proceed outwards, away from each other. The 
DNA fragment containing this region of known sequence is digested with an appropriate 
enzyme to produce a fragment of suitable size for PCR amplification. The ends of the 
fragment are then ligated to form a circle. The primers, when binding to their homologous 
sequence, will now be orientated such that chain elongation will proceed across the region 
of uncharacterised sequence. PCR product generated in this way may then be sequenced. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 Diagram to illustrate the principle of the inverse PCR technique. DNA is 
digested with a given enzyme (digest site in red). DNA fragments are ligated to form 
monomeric circles and this circularised DNA is used as template in a PCR reaction. 
Ligation 
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2.3.6.1  Template digestion 
 
Human genomic as well as cloned (BAC) DNA was used concurrently as template DNA in 
this experiment. BAC DNA was used as this would give a better chance of success due to 
the presence of exponentially more copies of the target for PCR being present. 
 
Bgl II was the enzyme of choice in this inverse PCR reaction: There is a Bgl II site within 
exon 1 on the P gene (see Fig 2.5). The appropriate amount of genomic or  
BAC (263 022) DNA was digested overnight with 30 units (genomic) or 10 units (BAC) of 
Bgl II in a total digest volume of 50μl. Following digestion, the DNA was extracted using 
phenol/chloroform to remove the restriction enzyme (Bgl II cannot be heat inactivated). 
DNA was resuspended in 50 μl dH2O.     
 
2.3.6.2  Ligation   
 
The ligation step requires the DNA to be in a dilute concentration so as to favour the 
formation of monomeric circles. The ligation reaction was set up in a volume of 50μl and 
included 100ng of genomic DNA or 1-5ng of BAC DNA and 400 units of T4 DNA ligase 
(NEB). The ligation reaction took place at 16°C, overnight. The ligase enzyme was 
inactivated by heating at 68°C for 15 minutes. 
 
2.3.6.3  Inverse PCR 
 
The P gene exon 1 forward primer was suitable for use here and the second primer (in the 
reverse orientation) was positioned as shown in Fig 2.5. The sequence of this primer was 
5’-CCACAAAGCTGCCCACATGG-3’.  
 
The concentration of template DNA optimal for inverse PCR is approximately 2 μg/ml of 
genomic DNA or 20 ng/ml of cloned DNA. The inverse PCR reaction was set up on ice 
and included 1-10 μl of the ligation reaction as template DNA, 15 pmoles of each primer 
and   units of Expand HiFi DNA polymerase (Boehringer Mannheim) in a total volume of 
50 μl. The PCR conditions were 94°C for 2 min, then 94°C for 15 sec, 56°C for 30 sec and 
 98
68°C for 4 min for 10 cycles; followed by 94°C for 15 sec, 56°C for 30 sec and 68°C for 4 
min + 20 sec each cycle, for 20 cycles. The final elongation step was 72°C for 7 minutes.  
 
The PCR products were sequenced using the ABI 377 automated sequencer, as described 
above. 
 
 
gi|773301|gb|U19152|HSPPROT01 Human P protein (P) gene, exon 1 
 
gaattcatgccgggggtgcggaacgggcgagctgtgggcggggccatgtgggcagctttgtgggcgtggccgggaggg 
 
gcgtgctacggcgtggccgcactgtgggcggggccgagtggggagtgctgtgggcggggccgggccgggggggtgcc 
 
tgggtggggccgctgcgggagcgccgagctcccTCTGAGTTCTTACTTCGAAGGCTGTGCTCC 
 
GCTCACCATCCAGAGCGGAGGTGCGGACCTTAAACTCACTCCTGGAGAAA/G 
 
ATCTGCAAGTGCGCAGgtaaagtgcacg 
 
Figure 2.5 Nucleotide sequence of exon 1 and immediate upstream region of the human P 
gene (Lee et al. 1995). Uppercase letters denote the exon, primer positions and orientations 
are indicated by arrows and the Bgl II site is highlighted in red. 
 
2.3.7 The P gene and tuberculosis association 
 
This part of the study was aimed at typing five intragenic P gene markers in a group of 
South African black TB patients and a group of Cape Coloured TB patients, plus 
appropriate controls for each group. The five markers typed were the SNP, R305W, the 
common black OCA2 mutation, the 2.7 kb deletion, and three microsatellite markers – 
D15S1533 (IVS17), D15S1536 (IVS20) and D15S1537 (IVS24). 
 
The 2.7 kb deletion was screened for as described above. 
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2.3.7.1  Detection of the R305W polymorphism 
 
The C to T base change in exon 9 of the P gene alters the recognition sequence of the 
enzyme Msp I. Msp I cuts the sequence CCGG and will not cut the sequence CTGG. In 
order to test for this variant, exon 9 of the P gene was amplified by PCR under the 
following conditions: the reaction was carried out in a total volume of 20μl containing 
approximately 100ng DNA, 2pmol each primer, 1 unit Taq DNA polymerase (Roche 
Diagnostics), 1.25μM each dNTP and 2μl 10X PCR buffer. Primer sequences were as 
published (Lee et al. 1995). Cycle conditions comprised an initial denaturation step of 
94°C for 2 min, followed by 35 cycles of  94°C 40 sec, 55°C 1 min, 72°C 1 min. Eight to 
ten microliters of PCR product was run on a 3% HGT agarose gel in order to check that the 
PCR reaction had worked. The remaining 10μl of PCR product was digested with 10 units 
of Msp I (Roche Diagnostics) in a total digest volume of 20μl, for approximately 3 hours. 
The entire digest volume was run on a 4% HGT agarose gel in order to visualise digest 
products. The PCR product was 272 bp and digestion results in two fragments of 190 bp 
and 82 bp. Therefore, following gel electrophoresis of digest products, presence of the R 
allele will result in the two digest products being visible, while presence of the W allele 
will result in the uncut 272 bp band being present.  
 
2.3.7.2 P gene intragenic marker screen 
 
Five marker systems, internal to the P gene, were studied in an attempt to establish whether 
or not the P gene plays a role in susceptibility/resistance to the infectious disease 
tuberculosis. Patients plus ethnically matched controls were typed for alleles at 5 loci: the 
2.7 kb deletion, the R305W polymorphism and the microsatellite (AC)n repeats D15S1533, 
D15S1536 and D15S1537. 
 
2.3.7.2.1 Typing the microsatellite repeats 
 
For markers D15S1533, D15S1536 and D15S1537, DNA was PCR amplified in 25μl final 
reaction volume with 125ng genomic DNA, 1xPCR buffer with MgCl2 (Roche), 5pm of 
each sense and antisense primer, 1.25mM dNTPs, 1unit Taq polymerase (Roche). Primer 
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sequences are given in Table 2.6: 
 
PRIMER NAME FLOURESCENT 
LABEL 
SEQUENCE 
D15-SEG11 F  FAM (blue) 5’-/5FAM/CTT GGC AAC ATC CCT GTA TCA -3’ 
D15-SEG11 R  5’-TGA ATG CCA TTA TTT CAT TCC TT -3’ 
P-IVS20 F HEX (green) 5’-/5HEX/TAA TAC CTG GGT GAC AAA ATA AT -3’ 
P-IVS20 R  5’-ATA GGA GTA AAT AAG ATA GAC -3’ 
P-IVS24 F FAM (blue) 5’-/5FAM/GCC GCA CTC AGC CAG CAT A -3’ 
P-IVS24 R  5’-CAG CAA TCC AGC CCT CTT TAG TTT -3’ 
 
 
A small volume (5μl) of PCR product was run on a 3% agarose gel to check if the PCR 
amplification was successful.  The sample was diluted depending on the concentration of 
the PCR product (estimated from the agarose gel) and 1μl of the diluted PCR product was 
mixed with 2.3μl dextran-formamide loading buffer and 0.2μl internal lane size standard, 
GENESCAN-500 ROX (ABI).  The PCR products, formamide loading dye and internal 
size standard were denatured for 2 minutes at 95°C, then electrophoresed on a 4.3% 
denaturing polyacrylamide gel (36cm WTR) at a constant 200W for 2 hours using a ABI 
model 377 Automated DNA Sequencer. The two markers labelled with FAM (SEG 11/IVS 
17 and IVS 24) could be run on the same gel as the PCR products were of sufficiently 
different sizes. Data were analysed automatically using Version 3.1.2 Genescan and 
Version 2.5 Genotyper Analysis Software (ABI) to produce an electropherogram for each 
sample showing the size (bp) of each amplification product. 
 
2.3.7.3 Statistical tests 
 
Data generated in the TB host susceptibility study was analysed using statistical tests in 
order to establish significance of the results obtained. 
 
 
 
Table 2.6. Primer sequences used to amplify three repeat regions intragenic to the P gene. 
The D15-SEG11 primer pair amplify the D15S1533 repeat segment; the P-IVS20 primer 
pair amplify the D15S1536 repeat segment; and the P-IVS24 primer pair amplify the 
D15S1537 repeat segment. 
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The null hypothesis 
 
The null hypothesis (designated the symbol H0) is a hypothesis of no differences, i.e. that 
there are no differences between, for example, the two sample groups under investigation.  
The null hypothesis is usually formatted for the sole purpose of being rejected but it acts as 
the statement against which the experimenter will test his/her research hypothesis 
(designated the symbol H1). Thus when we want to make a decision about a theory we test 
H0 (the null hypotheses) against H1 (the alternative or test hypothesis). 
 
Level of significance 
 
When can H1 be accepted and H0 be rejected? 
A researcher can reject H0 in favour of H1 if a statistical test yields a valuable whose 
corresponding probability is so small so as to make the probability of H0 being true 
correspondingly small.  The probability associated with the occurrence of a particular value 
is designated the symbol p. This probability is referred to as the level of significance.  
Numerical values for p that are considered statistically significant are arbitrarily chosen but 
common values used are 0.05 and 0.01.  If a significant p value is chosen at p≤ 0.05 then 
the researcher is acknowledging that 5% of the time there will be calculations showing 
differences (just by chance), so the number of differences found must be greater than or 
equal to 5 in 100 in order to be able to reject H0 and accept H1. 
 
2.3.7.3.1 The χ2 Test  
 
The Chi-squared (χ2) test can be used to test whether a significant difference exists between 
an observed number of objects or subjects falling into a category (H1) and an expected 
number deduced from the null hypothesis (H0).  The χ2 methodology is used to test whether 
the observed frequencies are sufficiently close to the experimental ones, in which case the 
H0 holds.  In order to reject the null hypothesis, the observed frequencies need to be 
sufficiently different from the experimental ones.   
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A χ2 value is generated using the following formula:   
 
χ2 =        Σ    
  
 
Where  Oi =  observed number of individuals (specimens/cases) 
 E = expected number of individuals (specimens/cases) 
 Σ = sum of values over all (k) categories 
 
If the observed values (O) are close to the expected values (E) then (Oi – E) will be small 
and consequently χ2 will be small.  Therefore, the larger χ2 is, the more likely it is that the 
observed frequencies are significantly different from the population on which the null 
hypothesis is based.  
 
2.3.7.3.2 Fisher’s exact test 
 
Fisher’s exact test is used as an alternative to the χ2 test and generates a p value. The exact 
test is a statistical significance test used to analyse data when the sample sizes are small. 
When large sample sizes are available for analysis, a χ2 test can be used. However, this test 
is not suitable when the ‘expected’ values in any of the cells in a 2x2 contingency table is 
below 10 and there is only one degree of freedom. 
(Oi – Ei)2 
 
Ei 
k 
i = 1 
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CHAPTER 3 
Results and Discussion:  OCA mutation screen (P and TYR genes) 
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3.1 Results: OCA mutation screen  
3.1.1 Mutation detection in OCA subjects 
3.1.1.1 Detection of the 2.7 kb deletion mutation 
 
All subjects collected for albinism-related research by workers in our laboratory were 
routinely tested for the 2.7 kb deletion mutation. For the present study, a subset of these 
was chosen - that is, subjects who were heterozygous for the deletion or subjects who did 
not carry the deletion on either chromosome. There were 72 such subjects (see Table 2.1). 
The assay was a PCR reaction, the products of which were run on a 2% agarose gel (see 
Fig 3.1). 
 
 
 
 
 
 
Figure 3.1 Agarose gel of PCR products detecting the 2.7 kb P gene deletion mutation. The 
smaller 240 bp fragment represents absence of the deletion (normal allele) and the larger 
398 bp fragment represents presence of the deletion (mutant allele). Marker lane: 1kb 
marker (Roche Diagnostics), Lane 1, individual homozygous for the deletion; lane 2, 
individual does not carry the deletion; lanes 3, 4, 5, individuals are heterozygous for the 
deletion; lane 6, blank PCR control.  
 
 
SUBJECT GROUP TOTAL 2.7kb DELETION STATUS 
  N/N*            N/del* 
Black  OCA 39 13                 26 
          - BOCA 9 0                   9 
          - Unclassified 15 10                   5 
White Unclassified 9 8                   1 
Total 72 31                 41 
 
*N= Normal (absence of the 2.7kb deletion mutation) 
  del= Deletion present 
Table 3.1. Results of the 2.7 kb deletion screen. 
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3.1.1.2 Detection of the R305W variant 
 
The black OCA2 individuals (N=39) and the BOCA individuals (N=9) involved in the 
OCA mutation screen were tested for the R305W polymorphism. Controls for the black 
population were randomly selected black individuals sent into the laboratory for paternity 
testing (N=45). Control figures for the white population had been published (Lee et al. 
1995). The assay was a PCR reaction followed by restriction digestion with Msp I (see Fig 
3.2.). 
 
 
 
 
Figure 3.2 Detection of the R305W P gene variant. The uncut PCR product is 272 bp in 
length. Following digestion with Msp I, the normal sequence is cut and two fragments of 
190 bp and 82 bp are generated. The small 82 bp fragment is often not visible on the gel. 
Presence of the W variant abolishes the restriction site. Digest products were run on a 3 or 
4% HGT agarose gel. Lanes 1, 2, 4, 6, individuals are homozygous for the R allele; lane 3, 
individual is homozygous for the W allele; lanes 5, 7, individuals are heterozygous 
carrying one R and one W allele. Marker: 1 kb marker (Roche Diagnostics). 
 
 
Results of the R305W screen on the subjects in the present study in comparison with those 
presented by Lee et al. (1995) on a cohort of African Americans are given in Table 3.2. 
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POPULATION GROUP n R  W  REFERENCE 
Black OCA2 78 0.42 0.58 This study 
Normal African American 100 0.10 0.90 Lee et al. 1995 
Normal SA blacks  90 0.91 0.09 This study 
Normal Caucasoid 35 0.83 0.17 Lee et al. 1995 
BOCA 18 0.66 0.33 This study 
n=number of alleles  
R= argenine allele frequency 
W= tryptophan allele frequency 
    
The W variant occurs at a frequency of 0.58 (45/78 chromosomes) in the black OCA2 
sample in the present study. This is significantly different from the frequency in normally 
pigmented African-American individuals (0.90) as reported by Lee et al. (1995). In order to 
determine whether the frequency of this variant is different to normally pigmented southern 
African blacks, 45 such individuals were screened for the R305W variant. It was found that 
8/90 chromosomes (0.09) carried the tryptophan (W) variant. The frequency of this amino 
acid substitution in a normal Caucasoid population sampled by Lee et al. (1995) is 0.17. 
Six out of the nine BOCA patients were heterozygous for the R305W variant. Out of a 
sample of eight previously studied individuals homozygous for the 2.7 kb deletion (Stevens 
et al. 1995), six were found to be homozygous for the R305W variant, one was 
heterozygous and one did not carry the W allele at all (i.e. 13/16 chromosomes carrying the 
2.7 kb deletion also carried the R305W variant). It would appear that the 2.7 kb deletion 
mutation and the R305W tryptophan (W) allele are co-segregating much of the time, i.e. 
they are in linkage disequilibrium.   
 
3.1.1.3  PCR-SSCP analysis 
 
Denatured, radioactively labelled PCR product was run on MDE polyacrylamide gels, 
made up with or without glycerol, in order to identify possible sequence variants between 
PCR fragments amplified from different individuals. All subjects involved in the OCA 
mutation screen were screened for P gene mutations. A subset of these subjects, namely the 
Caucasoid subjects (N=9), the black subjects with an unclassified form of OCA (N=15) 
and the BOCA subjects (N=9) were screened for TYR mutations in addition to P gene 
Table 3.2 Frequencies of the R305W variant in various population samples. 
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mutations. Examples of SSCP autoradiographs are given in Fig 3.3. 
 
Figure (a) 
 
Figure (b) 
 
Figure 3.3 Examples of autoradiographs of SSCP gels. PCR product was radioactively 
amplified from TYR exon 1B. The same products were run on MDE gels with (Fig a) or 
without (Fig b) glycerol. Note that the two different gel conditions produce different band 
patterns. For this particular PCR product, band shifts are seen only in the gel made up with 
glycerol. In Fig (a), lanes 1, 2, 3, 5, 7, 8, 9, 10 and 13 show SSCP variant type 1, lane 11 
shows SSCP variant type 2 and lane 12 shows SSCP variant type 3.  
 
 
DNA from individuals in whom band shifts were detected was then sequenced in order to 
determine if one or more sequence variants were present in this exon. It is possible that 
band shifts are seen on SSCP gels, with no corresponding sequence variation. Using the 
example above, sequencing of variants using the ABI 377 sequencer gave the following 
results: 
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Figure 3.4 Sequencing of exon 1B of the TYR gene shows that SSCP variant type 3 
represents the normal published sequence (a), variant type 2 is heterozygous for the Y192S 
(TAT→TCT) polymorphism (b) and variant type 1 represents an individual homozygous 
for the Y192S polymorphism (c). (The database reference sequence is TAT. The TCT 
variant is, however, more common in this population and is actually the wild-type 
sequence.)     
(a) 
(b) 
(c) 
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3.1.1.3.1 SSCP analysis for the P gene 
 
A total of 72 individuals were screened for mutations using the method of SSCP analysis 
following PCR amplification of each of the 25 P gene exons. Ten mutations (not counting 
the 2.7 kb deletion mutation) which are likely to be pathogenic were found, nine of which 
are novel. 
 
In the group of black OCA2 patients, four mutations which are likely to be pathogenic were 
found: A334V, 614delA (in a CAR individual), 683insT and 727insG (Table 3.3, Fig 3.5). 
614delA, 683insT and 727insG are all frame-shift mutations. The 614delA mutation causes 
a premature STOP codon in exon 20 and both the 683insT and the 727insG mutations 
result in premature STOP codons in exon 22, leading to a truncated P protein. Mutations 
were identified in four individuals with an unusual hypopigmentation phenotype. E678K 
was found in the homozygous state in an individual from the CAR with very light coloured 
skin and hair (a light tan colour). A second individual was found to be a compound 
heterozygote for the I370T and the L688F mutations. Phenotypically, this individual has 
light brown eyes and very light coloured hair (yellowish-white). A third individual was 
found to be heterozygous for the I370T mutation. His skin was a reddish-brown colour, like 
that of an individual with ROCA. He had tested negative for TYRP1 mutations (Manga, 
1997). The fourth individual is the half-sib of an OCA2 individual. The OCA2 patient is a 
compound heterozygote for the 2.7kb deletion and the mutation, 614delA. The half-sib 
with an unusual phenotype has green-blue eyes and brown skin, much lighter than that of 
the parents or the unaffected sibs. This individual is heterozygous for the 614delA 
mutation. In the case of patients 3 and 4, it is assumed that a second mutation is present but 
could not be identified. This assumption is based on the fact that OCA is an autosomal 
recessive condition and it has been shown that carriers do not exhibit a significant 
reduction in skin pigmentation (Roberts et al., 1986).  
 
Three P gene mutations were found in the Caucasoid sample (Table 3.3; Fig 3.5): IVS 14-2 
(a→g), a splice site mutation, V350M and P743L (the latter previously reported as a 
pathogenic mutation by Lee et al. (1994), in an African American individual). The A334V, 
V350M, I370T, E678K, L688F and P743L mutations are considered to have a high 
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likelihood of being pathogenic, as the normal amino acid residue shows high cross-species 
conservation (Table 3.3) and the variant alleles were not detected by Lee et al. (1995) in a 
control group of normally pigmented individuals. (Local controls were not screened for any 
of these mutations, but this would be something to consider including in a future study.)  
 
No further BOCA mutations (besides the deletion mutation) were identified.  
 
 
Table 3.3 Putative pathogenic P gene mutations identified in this study in OCA individuals 
from Sub-Saharan Africa.  
 
Pathogenic  
variant 
Position in 
protein 
Cross-species 
conservation1 
Population group  
(present study) 
Geographic 
origin 
Reference where first 
described 
2.7 kb deletion Truncated after 
2nd TM domain 
 Black OCA2, 
BOCA, Black 
unclassified OCA  
South Africa, 
CAR, Zambia 
Durham-Pierre et al. (1994) 
A334V 2nd TM domain H, M, MtbA, 
MtbB, Mlep 
Black OCA2 Zambia This study 
V350M Cytoplasmic 
loop 
H, M, MtbA, 
MtbB, Mlep 
Caucasoid 
unclassified OCA 
South Africa This study 
I370T 3rd TM domain H, MtbA, Mlep, 
Syn 
Black unclassified 
OCA 
CAR This study 
IVS 14-2 (a→g) Splice mutation  Caucasoid 
unclassified OCA 
South Africa This study 
614delA Truncated after 
8th TM 
 Black OCA2, 
Black unclassified 
OCA 
CAR This study 
E678K Cytoplasmic 
loop 
H, M, MtbA, 
MtbB, Mlep 
Black unclassified 
OCA 
CAR This study 
L688F 9th TM domain H, M, MtbA, 
MtbB 
Black unclassified 
OCA 
CAR This study 
683insT Truncated after 
9th TM 
 Black OCA2 South Africa This study 
727insG Truncated after 
9th TM 
 Black OCA2 Zambia This study 
P743L Cytoplasmic 
loop 
H, M, MtbA, 
MtbB, Mlep 
Caucasoid 
unclassified OCA 
South Africa Lee et al. (1994) 
 
1Human (H), Mouse (M), Mycobacterium tuberculosis (has two homologues of the P gene, designated MtbA and MtbB), Mycobacterium 
leprae (Mlep) and Synechosystis (Syn). 
 
The 2.7 kb deletion was found in the heterozygous state in 27 Black OCA2 individuals, in 
8 BOCA individuals, in 5 Black Unclassified individuals and in one Caucasoid unclassified 
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individual. All the other mutations listed in Table 3.3 were found in the heterozygous state 
in one individual only, except for: I370T which was found in two CAR individuals; 
614delA which was found in two black individuals, one Black OCA2 and one Black 
unclassified OCA; E678K which was found in the homozygous state in a CAR individual; 
and 683insT which was found in two Black OCA2 individuals. 
 
 
 
 
 
Figure 3.5 Diagrammatic representation of the P gene cDNA showing positions of variants. 
Non-pathogenic variants are labelled above the diagram and pathogenic mutations below 
the diagram. TM=transmembrane domain. 
 
A large number of non-pathogenic variants were identified in both the black (data 
summarized in Table 3.4) and Caucasoid (Table 3.5) groups. In this study, 27 non-
pathogenic sequence variants were identified, of which 7 are novel (the remainder had been 
previously reported by Lee et al., 1995). Most of these variants are silent, or occur within 
intronic sequence, and so are unlikely to affect protein structure or function.  
 
Besides the R305W variant, the other amino acid substitution mutation which was 
classified as non-pathogenic is I722T. This amino acid residue is not conserved 
evolutionary, and the variant allele occurs in both the Caucasoid (0.26) and American black 
(0.07) populations (Lee et al. 1995). 
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NON-PATHOGENIC 
VARIANTS 
 OCA2 
(n=78) 
BOCA  
 
(n=18) 
UNKNOWN 
OCA 
(n=30) 
NORMAL1 REFERENCE 
IVS 5-18 (c→t) 1 (0.01) 0 0 (0.02) Lee et al. 1995 
IVS 5-39 (t→c) 1 (0.01) 0 0  This study 
R305W (CGG→TGG) 45 (0.58) 6 (0.33) 7 (0.23) (0.9)2 Lee et al. 1995 
G321G (CAG→CAA) 0 1 (0.05) 0  This study 
A336A (GCC→GTC) 3 (0.04) 1 (0.05) 0  This study 
Y342Y (TAC→TAT) 3 (0.04) 1 (0.05) 0 (0.01) Lee et al. 1995 
A355A (GCG→GCA) 7 (0.09) 7 (0.39) 5 (0.17) (0) Lee et al. 1995 
IVS 12+19 (g→a) 1 (0.01) 0 0  This study 
IVS 11-4 (a→g) 39 (0.50) 11(0.61) 12 (0.40) (0.38) Lee et al. 1995 
IVS 13+4 (c→a) 1 (0.01) 0 0 (<0.01) Lee et al. 1995 
IVS 13+26 (a→g) 11(0.141) 0 1 (0.03) (0.33) Lee et al. 1995 
IVS 13-15 (t→c) 30(0.385) 0 3 (0.10) (1.0) Lee et al. 1995 
IVS 14+5 (g→a) 14(0.179) 0 0  This study 
C517C (TGC→TGT) 0 0 2 (0.07) (0.20) Lee et al. 1995 
IVS 16-49 (c→a) 1 (0.01) 0 0  This study 
IVS 16-47 (g→a) 24 (0.31) 5 (0.28) 5 (0.17) (0.06) Lee et al. 1995 
V629V (GTG→GTT) 3 (0.04) 1 (0.05) 1 (0.03) (0.07) Lee et al. 1995 
IVS 18+24 (c→g) 1 (0.03) 1 (0.05) 1 (0.03)  This study 
A686A (GCA→GCC) 5 (0.06) 6 (0.34) 3 (0.10) (0.29) Lee et al. 1995 
IVS 21+22 (a→t) 1 (0.01) 4 (0.22) 2 (0.07) (0.03) Lee et al. 1995 
S736S (TCG→TCA) 2 (0.03) 2 (0.11) 0 (0.07) Lee et al. 1995 
I722T (ATA-ACA) 4 (0.05) 2 (0.11) 0 (0.07) Lee et al. 1995 
IVS 22+18 (a→g) 0 0 1 (0.03) (0.07) Lee et al. 1995 
IVS 22+25 (g→c) 1 (0.01) 0 0 (0) Lee et al. 1995 
A776A (GCT→GCC) 27 (0.35) 8 (0.44) 3 (0.10) (0.69) Lee et al. 1995 
G780G (GGC→GGT) 8 (0.10) 10(0.56) 4 (0.13) (0.07) Lee et al. 1995 
S788S (TCG→TCA) 4 (0.05) 5 (0.28) 2 (0.07) (0) Lee et al. 1995 
n=number of chromosomes 
1Frequencies in unaffected individuals reported by Lee et al. 1995. 
2This is the figure for unaffected African-Americans. The writer found the frequency of the variant allele to 
be (0.09) in normally pigmented black Africans. 
 
Table 3.4. Non-pathogenic sequence variants of the human P gene in black individuals. 
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NON-PATHOGENIC 
VARIANTS 
UNKNOWN OCA 
(n=18) 
NORMAL1 REFERENCE 
R305W (CGG→TGG) 3 (0.17) (0.17) Lee et al. 1995 
A355A (GCG→GCA) 20 (0.66) (0.93) Lee et al. 1995 
IVS 11-4 (a→g) 16 (0.88) (0.91) Lee et al. 1995 
C517C (TGC→TGT) 4 (0.22) (0.63) Lee et al. 1995 
IVS 16-47 (g→a) 11 (0.61) (0.13) Lee et al. 1995 
V629V (GTG→GTT) 2 (0.11) (0) Lee et al. 1995 
IVS 22+25 (g→c) 4 (0.22) (0.28) Lee et al. 1995 
A776A (GCT→GCC) 3 (0.17) (0.36) Lee et al. 1995 
G780G (GGC→GGT) 8 (0.44) (0.27) Lee et al. 1995 
S788S (TCG→TCA) 4 (0.22) (0.09) Lee et al. 1995 
 
n=number of chromosomes 
1 Figures from unsffected Caucasoid individuals as reported in Lee et al. 1995  
 
 
3.1.1.3.2 SSCP analysis for TYR 
 
 A total of 33 individuals with albinism were screened for TYR mutations, (15 black 
individuals with an unclassified form of albinism, 9 BOCA individuals and 9 Caucasoid 
individuals). All 5 TYR exons (the first exon in two pieces), were analysed by PCR-SSCP 
analysis. Four mutations were identified, all in the Caucasoid group. One individual was 
found to be a compound heterozygote for the mutations, E294K and A490D. Compound 
heterozygosity in a second individual was also shown upon identification of the P431T 
mutation and the T373K mutation. Three of these variants have been previously reported in 
the literature and are classified as pathogenic (see Table 3.6). The variant A490D has not 
been previously reported. However, variation at this specific codon has been shown to be 
pathogenic – the mutation A490G was reported by King et al. (2003). Three 
polymorphisms were identified, Y192S, L279L and R402Q, one of which (L279L) is novel 
(see Table 3.6). 
 
 
Table 3.5. Non-pathogenic sequence variants of the human P gene in Caucasoid 
individuals. 
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VARIANT POSITION POPULATION GROUP CLASSIFICATION REFERENCE 
E294K Exon 2 Caucasoid Pathogenic Gershoni-Baruch et al. 
1994 
T373K Exon 3 Caucasoid Pathogenic Spritz et al. 1990 
P431T Exon 4 Caucasoid Pathogenic Spritz et al. 1993 
A490D Exon 5 Caucasoid Pathogenic This study 
     
Y192S Exon 1 Caucasoid Non-pathogenic Giebel and Spritz 1990 
L279L Exon 2 BOCA,  
Black unclassified OCA 
Non-pathogenic This study 
R402Q Exon 4 Black unclassified OCA,   
Caucasoid 
Non-pathogenic Tripathi et al. 1991 
   
All the pathogenic mutations listed in Table 3.6 were found only once and were present in 
the heterozygous state in each individual. 
 
A listing of all published variants (both pathogenic and non-pathogenic) for both the P 
gene and TYR is available on the Albinism Database website 
(http//albinismdb.med.umn.edu). 
 
3.1.1.4 Southern blotting 
 
3.1.1.4.1 Southern blotting for the P gene 
 
Three different genomic DNA enzyme digests were initially undertaken as a trial to 
ascertain which enzyme might be most suitable to use to screen the cohort of patients for 
mutations in the P gene (see Fig 3.6). 
 
 
Table 3.6 Variants in the TYR gene identified in this study in OCA individuals.  
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Figure 3.6 Autoradiograph of a Southern blot using 3 different enzymes to digest genomic 
DNA which was probed with a 2.8 kb fragment comprising the full length P gene cDNA. 
Lanes 1-5 Bam HI digests; lanes 6-10 Eco RI digests, lanes 11-15 Hind III digests. In each 
set of digests, the first three lanes contain DNA from normally pigmented control 
individuals, the fourth lane contains DNA from an individual homozygous for the 2.7 kb P 
gene deletion mutation and the fifth lane contains DNA from an individual heterozygous 
for the 2.7 kb P gene deletion mutation.  
 
It can be seen that the 2.7 kb deletion is contained within an Eco RI fragment – the 5.7kb 
band, present in normal controls, is missing in the homozygous deletion patient. This 
patient carries an additional 3 kb band when compared to normal controls. (This smaller 
band is seen more clearly on Figure 3.7 which has a darker exposure.) In heterozygous 
individuals, both bands will be seen – the 5.7 kb fragment representing the normal allele 
and the 3 kb fragment representing the deleted allele.  
 
For reasons discussed in the methods section, Eco RI was selected as the enzyme of choice 
for the subject screen. See Fig 3.7. 
 
 
5.7 kb 
 
 
 
 
 
 
 
 
3 kb 
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Figure 3.7 Portion of an autoradiograph of a Southern blot used to screen OCA patients for 
P gene mutations. Lane 1, 2.7 kb deletion homozygote control; lane 2, 2.7 kb deletion 
heterozygote control, lanes 3-7, subject DNA. 
 
 
Using the method of Southern blot analysis, where subject genomic DNA had been 
digested with EcoRI, no major mutations or rearrangements within the P gene were found 
in any of the population groups tested. 
 
 
 
 
 
 
 
 
 
 
 
5.7 kb 
 
 
 
 
 
 
 
 
 
 
 
 
3 kb 
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3.1.1.4.2 Southern blotting for HERC2 
 
 
 
 
 
Figure 3.8 Autoradiograph of a Southern blot used to screen OCA patients for HERC2 
mutations. Lane 1, 2 control individuals for the P gene blot; lanes 3-22, patient DNA. Lane 
10 shows possible variation, with absence of the 1.8 kb and 2.6 kb fragments but presence 
of a larger fragment of approximately 2.7 kb. DNA in lane 10 was from an individual 
affected with BOCA. 
 
Using the method of Southern blot analysis, where subject genomic DNA (from all BOCA, 
unclassified black and black OCA individuals) had been digested with Hind III and probed 
with a DNA fragment which hybridised to the 3’ end of the gene, a possible rearrangement 
within HERC2 was found in an individual with brown OCA (see Fig. 3.8, lane 10). 
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3.1.2 Sequencing of the P gene promoter region 
3.1.2.1 Sub-cloning the BAC 
Two initial Southern blots were undertaken in order to identify a restriction fragment of the 
BAC insert that would be of an appropriate length to subclone into a plasmid and sequence. 
A blot of multiple enzymes which are 6 bp cutters and a blot of multiple enzymes which 
are 4 bp cutters were generated (results not shown). Enzymes with 6 bp recognition 
sequences were Bam HI, Dra I, Eco RI, Egl II, Hind III, Hinf I, Nco I, Xba I and Xho I. 
Enzymes with 4 bp recognition sequences, producing smaller digest fragments, were Apo I, 
Bst YI, Msp I, Pst I, Sac I, Tsp 509I. A subset of these enzymes was chosen and a second 
blot subsequently undertaken. This blot is shown in Fig 3.9. 
 
 
 
Figure 3.9 Autoradiograph of a Southern blot where different enzymes were used to digest 
BAC DNA. Digest fragments were probed with the P promoter fragment probe. 
 119
 
Due to its’ appropriate size (2.4 kb), the Tsp 509I fragment was chosen as a suitable 
fragment for subcloning. A larger fragment, namely the Xba I fragment (6.1 kb), was also 
included in the subcloning experiment as a back-up (discussed in Methods section). 
 
No positive results were obtained from these experiments, despite several different cloning 
vectors being used. No positive transformants were recovered from the initial plasmid of 
choice, pZERO, and so an alternate cloning vector was attempted (namely, pBluescript). 
No positive transformants were recovered when using this plasmid. It seemed that the 
fragment we were trying to clone could not be contained within a plasmid vector and 
produce viable plasmids. The fragment appeared deleterious to the plasmids used and 
therefore unclonable in these vectors. The use of another type of vector, namely lambda 
phage, produced similar results with no positive transformants recovered.  
 
  
3.1.2.1.1 BAC clone 263 022 appears unstable 
 
As work with the BAC progressed, it appeared that different preparations of BAC DNA 
were giving inconsistent results. In order to establish whether this was the case, three 
different DNA preparations were used in an experiment. Sample 1 was BAC DNA 
extracted in Rob Nicholls’ lab at CWRU and brought back to South Africa by the writer. 
Sample 2 was BAC DNA extracted in Rob Nicholls’ (RN) lab by Nancy Rebert (a staff 
member in RN lab) and sent to South Africa. Sample 3 was BAC DNA extracted in South 
Africa from bacteria containing clone 263 022 sent to South Africa in a stab from RN lab. 
The three different preparations were digested with various enzymes and the digest 
products run on a 0.8% agarose gel. The agarose gel as well as the Southern blot showed 
that all three DNA samples were giving different digest patterns (see Fig 3.10). 
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                                                     Figure (a)                              Figure (b) 
 
Figure 3.10 The BAC 263 022 appears to be unstable. Three different BAC DNA 
preparations were digested with Bam HI, Bgl II, Eco RI, Sac I or Xba I. The agarose gel 
(Fig a) was blotted and probed with the human P gene promoter fragment. The 
autoradiograph is shown (Fig b). Theoretically, all three preparations should give identical 
results. 
 
3.1.2.2 Inverse PCR 
 
As it was not possible to subclone the 5’ region of the P gene into a plasmid vector, 
possibly due to instability of the region, another approach to gaining sequence data for the 
region was undertaken. Both BAC DNA and human genomic DNA were used as template 
DNA in an inverse PCR experiment. See Fig 3.11. 
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Figure 3.11 PCR fragments generated in an inverse PCR experiment. Marker lane (1 kb marker), 
Lane 1, 3, 6 empty lanes; Lane 2, genomic DNA used as template, Lanes 4, 5, 7 and 8, BAC DNA 
used as template. The 1.2 kb band in all lanes was cut out as well as the larger brightest band in the 
genomic DNA sample (approximately 4 kb) and the DNA purified from the gel. Purified DNA was 
used as template for sequencing. The sequencing primer was PE1F. 
 
Genomic DNA (both the 1.2 kb and 4 kb templates) gave no results on sequencing, 
probably due to low recovery after gel extraction and subsequent weak concentration for 
sequencing reaction.  
 
BAC DNA gave good sequencing results and clear sequence could be read. Analysis of this 
sequence data using BLAT (part of the University of California at Santa Cruz, UCSC, 
suite) shows the fragment generated in the inverse PCR experiment maps within intron 2 of 
the P gene. 
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3.2 Discussion: OCA mutation screen 
3.2.1 Mutation detection in OCA patients 
 
OCA is the most common single gene disorder in southern Africa. OCA1 is caused by 
mutations at the TYR locus and OCA2 is caused by mutations at the P locus. In this study 
we investigated the P gene and the TYR gene in an attempt to define further variation at 
these loci in our local population groups. 
3.2.1.1 The P gene 
 
3.2.1.1.1 The R305W variant 
 
The R305W variant has been previously described and reported to occur at very high 
frequencies in African-Americans (0.9) (Lee et al. 1995). It was suggested that this variant 
may play a role in normal pigment variation since its frequency was dramatically lower in 
Caucasoids (0.17). In the present study, the frequency of the W allele in normally 
pigmented black Africans was found to be 0.09. The contrary results of the Lee et al. 
(1995) study might be due to sample bias. Alternatively, the allele may have reached such 
high frequencies by random drift or the bottle-neck phenomenon created by the bringing of 
the early African slaves to America. The frequency of this variant in OCA2 individuals 
(0.58) is significantly higher (p<0.001) than the frequency observed in a sample of 
normally pigmented black Africans (0.09). Since the R305W variant is much more 
common in black African OCA2 individuals compared with normally pigmented 
individuals from the same population, it may be postulated that the R305W variant is in 
linkage disequilibrium with decreased skin pigmentation. This is in keeping with the 
observation that the R305W variant and the 2.7 kb deletion mutation are co-segregating 
much of the time. The R305W mutation may be an ancient mutation and the original 2.7 kb 
deletion mutation may have arisen on a chromosome carrying the W variant. As the 
association between R305W and the 2.7 kb deletion mutation is not absolute, it may be 
postulated that discrepancies have arisen over evolutionary time due to mechanisms such as 
cross-over events or the possibility of more than one origin for the deletion mutation.  
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3.2.1.1.2 Detection of unknown mutations by SSCP analysis 
 
Numerous synonymous codon mutations were detected and all scored as neutral, non-
pathogenic changes (G321G, A336A, Y342Y, A355A, C517C, V629V, A686A, S736S, 
A776A, G780G and S788S). It is interesting to bear in mind that specific examples have 
been cited in which apparently ‘neutral’ variants have been shown to be responsible for 
disease phenotype (Akli et al. 1990, Li et al. 1995, Richard and Beckmann 1995, Liu et al. 
1997). These mutations all result in either the creation or abolition of a splice site and lead 
to aberrant RNA processing. These types of mutations are obviously difficult to find, 
requiring appropriate tissue from each patient and subsequent testing for illegitimate RNA 
transcription products. The synonymous amino acid mutations described here do not appear 
to lead to the gain or loss of putative splicing consensus sites. 
 
The difficulty of assigning non-pathogenic status to a variant just because it is polymorphic 
in a population is again exemplified by the findings of Fukai et al. (1995) who described 
two patients with autosomal recessive ocular albinism – each was a compound 
heterozygote for a different pathogenic mutation and the ‘normal’ tyrosinase polymorphism 
arg402gln. Here, ocular albinism appeared to be a clinically mild form of OCA1. 
 
Relatively few mutations were found during this screen. The technique of SSCP analysis 
does not detect all small mutations, but reportedly has a sensitivity rate of 80-90% 
(Hayashi and Yandell 1993, Sheffield et al. 1993). Of the 39 OCA2 patients, 26 were 
heterozygous for the 2.7kb deletion and 13 had no identifiable mutation. Therefore of the 
78 OCA2 alleles, 52 could not be accounted for by the deletion mutation. Mutations could 
be identified in four (0.077) of these. As non-2.7 kb deletion genes account for 23% of 
black OCA2 genes in southern Africa, these additional four mutations account for 1.7% 
(7.7% of 23%) of OCA2 genes in the overall population group. However, many 
nonpathogenic variants and polymorphisms were detected, making it unlikely that the lack 
of mutation detection was a technical problem.  
 
It is proposed that some of these unidentified mutations may lie in the promoter or control 
regions of the gene or in intronic regions. Further, mutations which affect the regulation of 
the P gene may play an important role in the aetiology of BOCA, and the promoter region 
may well house mutations which down-regulate the P gene without rendering it non-
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functional, hereby causing the intermediate phenotype seen in individuals with BOCA, and 
possibly other milder hypopigmentation phenotypes as exemplified by the CAR family 
described in this study.  
 
It is worth bearing in mind that an individual with OCA type 1A has been reported (Oetting 
and King 1991) who was found to be a compound heterozygote for a substitution mutation 
in exon 1 of tyrosinase and a promoter mutation at –199 that altered the CCAAT box 
(CCAATTC→CCAATTA). This promoter mutation obviously rendered the tyrosinase 
allele non-functional and did not merely down-regulate transcriptional activity. Therefore, 
it may well be that certain elusive OCA2 mutations are to be found in the P promoter 
region, and not only possible BOCA mutations. 
 
3.2.1.1.3 Mutation detection by Southern blotting 
 
While SSCP methodology is useful in detecting small DNA variation of the order of a few 
base pairs, large scale deletions, insertions or rearrangements, of the order of several 
hundred or thousand base pairs, will only be detected using Southern blot analysis. When 
looking for a known mutation, Southern blotting is obviously an extremely useful tool, but 
when screening for unknown mutations the technique possesses something of a ‘shot in the 
dark’ quality. If the appropriate enzyme for genomic DNA digestion is not chosen, in 
conjunction with the appropriate probe, the mutation may well be missed. Also, Southern 
blotting will miss heterozygote deletions if there is no fragment size change. In this study, 
only one restriction enzyme (Eco RI) was used in Southern blot analysis due to a restriction 
on material (DNA) and economic resources. If further enzymes had been used, a mutation/s 
may well have been identified using this technique. Due to the fact that Southern blotting is 
labour intensive, slow to yield results, costly and usually involves the need to work with 
radioactivity, it is now seldom used as a method of mutation screening. SSCP analysis, 
protein truncation tests or, more recently, direct sequencing (Oetting et al. 2005) are the 
methods of choice for mutation detection.  
 
3.2.1.2 Epistasis 
 
While it is immediately obvious in a mutation detection experiment to look within or near 
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the disease locus for pathogenic variation, the possible epistatic effects of other genes 
should not be ignored. Epistasis is a situation where the alleles in one gene cover up or alter 
the expression of alleles at another gene. As discussed in this thesis, variation at the 
HERC2 locus may possibly influence P gene expression. 
 
3.2.2 Sequencing the P promoter region 
3.2.2.1 Cloning 
 
While areas such as promoters or enhancers are immediately recognisable as control 
elements, it is becoming increasingly more apparent that the regulatory organisation 
leading to correct gene expression involves these plus more complex factors. The 
assumption for this section of the project was that the P gene promoter lies in the 
immediate 5’ region of the first exon of P. As will be discussed, this is not always the case, 
but where no other information is available, this is the only premise with which to start. In 
this study, traditional cloning techniques failed to produce results, and a viable clone 
containing the area 5’ of P could not be generated, despite several different approaches. It 
seems likely that this region contains a DNA element (or elements) that, when cloned into a 
vector, interferes with the vectors’ functioning to such an extent so as to render the vector 
non-viable and the region of DNA to be cloned essentially ‘unclonable’. 
 
This phenomenon, whereby short stretches of eukaryotic DNA show instability when 
propagated in prokaryotic hosts, is not uncommon. There are no obvious ‘rules’ allowing 
recognition of a DNA sequence as unstable (prone to rearrangement). However, high AT-
content or the presence of multiple repeats in a DNA segment may result in non-clonability 
of a sequence (Razin et al. 2001). Both of these phenomena are exemplified in the recent 
(January 2007) cloning of a portion of chromosome 22q11 – a region located within one of 
the remaining unclonable gaps from the Human Genome Project (Kurahashi et al. 2007). 
This region is notoriously rearrangement-prone with breakpoints of several constitutional 
translocations clustering here. Kurahashi et al. (2007) identified a 595-bp palindromic AT-
rich repeat (PATRR) within the region and propose these repeat units lead to unusual DNA 
secondary structure with subsequent double-strand-breakage within the palindrome 
followed by nonhomologous end-joining rather than homologous recombination. 
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A second problem in trying to clone the promoter region of a gene is being able to identify 
and locate the actual promoter. The simplistic assumption that each gene has its own 
promoter/enhancer and that these lie immediately 5’ of the gene does not always hold. Cis-
regulatory regions can be much larger than expected, extending over hundreds of kb of 
DNA. Certain genes, for example the chicken lysozyme locus, have more than one 
enhancer region (namely, three) and all three need to be in their correct spatial orientation 
for appropriate gene expression (Bonifer et al. 1994; Jägle et al. 1997). Correct gene 
expression implies appropriate tissue specification, appropriate developmental regulation 
and appropriate expression levels. Other genes, for example genes in the β-globin gene 
cluster, may share a control region – each gene in the locus has its own promoter, but all 
genes share a major regulatory element, the LCR (Milot et al. 1996, Bungert et al. 1995). 
Another interesting phenomenon illustrated by the β-globin cluster - and also seen in the 
Hox gene cluster (Kmita et al. 2000) – is that spatial orientation and gene order of genes is 
important in determining their regulation. Here the most 5’ gene in the cluster is expressed 
first during development. Further, when looking at DNA sequence it is important to 
remember that DNA in vivo is wrapped around nucleosomes, which brings transcription 
factor binding sites together, that on 2-D sequence information will seem further apart. 
Besides chromatin architecture, chromosomal environment will also affect gene expression 
– genes may be localised in heterochromatic or euchromatic regions and epigenetic 
phenomena such as methylation, phosphorylation or acetylation will also affect their 
regulatory status. 
 
All these phenomena contributing to gene expression make characterisation of the P gene 
regulatory machinery extremely difficult. Some of the issues discussed above may 
influence expression at the P locus, but this can only be tested by performing transfection 
experiments, generating transgenic mice where the p gene plus differing amounts of 
flanking sequence are subject to gene transfer experiments in mice. The influence of 
different cis-DNA regions co-transfected with p can then be assessed with respect to their 
influence on p expression.    
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3.2.2.2 Inverse PCR 
  
The inverse PCR experiment, using BAC DNA as template, generated a clear band of 1.2 
kb. Sequencing this 1.2 kb fragment showed it mapped to intron 2 of the P gene. The 
sequencing primer used was the P gene exon 1 forward primer. Thus, even though clean 
PCR product was generated, this product was produced by illegitimate primer binding – the 
PCR primers bound to a fragment from intron 2 and not to the ligated fragment containing 
P exon 1. Although initially exciting, it is however not surprising that the PCR product 
maps to the 5’ region of the P gene, given that the template DNA was not genomic, but a 
BAC containing the DNA region stretching from the 3’end of HERC2 to the 5’region of 
the P gene. 
 
3.2.2.3 Sequence analysis of the 5’ region of the P gene  
 
One of the main aims of this project was to identify pathogenic mutations in a cohort of 
subjects with OCA2. As relatively few mutations were detected (screening all 25 exons, 
plus exon/intron boundaries), it was postulated that some of the unidentified mutations 
might lie in the P gene promoter region. However, little upstream sequence of P exon 1 
was available at that time (1996) - only approximately 200 bp - and consequently another 
aim of this project became the cloning and sequencing of the region immediately 5’of P. 
Using various methodologies, cloning of this region was unsuccessful. Now (2007), the 
Human Genome Project being essentially complete, DNA sequence of the 5’region of P is 
available. Bioinformatic analysis was undertaken to investigate this region and to attempt 
to identify the important regulatory elements - which would then be a target region in 
future mutation detection studies, and/or any motifs that might have rendered this region 
‘unclonable’ by the methods used in this study.  
 
The sequence 5’of P was identified and analysed using Ensembl, looking for CpG islands, 
repeats and regulatory features. Analysis using the Mammalian Promoter Database site, 
looked for Hpa II restriction sites which predict methylation status, CpG islands (see 
below) and predicted transcription factor binding sites. Dot plots were generated using the 
dottup programme, part of the EMBOSS suite. Note: The P gene is transcribed on the 
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reverse strand (i.e. in the direction chr 15q ter → 15q cen). 
 
3.2.2.3.1 Promoter motifs 
 
A promoter is the region of an operon or gene that acts as the initial binding site for RNA 
polymerase. Proteins known as transcription factors (TFs) bind to the promoter DNA 
sequences and facilitate the recruitment of RNA polymerase, the enzyme that synthesises 
RNA from the coding region of the gene. Promoter motifs like a CCAAT-box, an E-box 
and a TATA-box present near the transcription start site and are necessary for full promoter 
activity and are highly conserved. Promoters work together with enhancers, silencers and 
other regulatory elements to control the level of transcription of a gene. While prokaryotic 
promoters are easily identifiable, eukaryotic promoters are more complex, more diverse 
and often difficult to characterise. 
 
CpG islands  
 
CpG islands are regions of the genome where a large number of cytosine and guanine 
residues are found. In general, the CpG dinucleotide is generally under-represented in the 
vertebrate genome. DNA methylation occurs only at CpG sites. However, methyl cytosines 
are not stable and usually mutate to thymine over evolutionary time (CpG→ TpG) leading 
to the situation where CpGs are approximately five times less frequent than expected 
(Jones et al. 1992).  
 
The 5’ regions of active genes – house-keeping genes and regulated genes which are being 
expressed – are not methylated and the absence of methylation slows CpG decay. DNA 
methylation represses transcription by physically inhibiting the binding on transcription 
factors and also by recruiting methyl-CpG-binding proteins which alter chromatin structure 
(Jirtle and Skinner 2007). Approximately 56% of human genes are associated with CpG 
islands (Antequera and Bird 1993) and the CpG island often includes the promoter and 
extends approximately 1 kb downstream into the transcription unit. Therefore, 
identification of a CpG island helps to define the 5’ limit of a gene and would help define 
the region in which the promoter is likely to be found (and therefore the target region for 
future mutation detection experiments). 
 
 129
CCAAT-box, TATA-box and E-box 
 
A CCAAT-box is a eukaryotic promoter element, located approximately 75 – 80 bp 
upstream of the start site of transcription. CCAAT-boxes are generally associated with non-
house-keeping genes, i.e. with genes under regulatory control and this element seems to be 
necessary for the transcription of sufficient protein product. Deletions or mutations of the 
CCAAT-box lead to a significant decrease in gene expression – the factor that binds to the 
CCAAT-box confers substantial transcriptional activity to the promoter. Also, any 
alteration in methylation status of the CCAAT-box abolishes factor binding. 
 
The consensus recognition sequence of the TATA-box, TATAAA, binds a TATA binding 
protein, which assists in the formation of the RNA polymerase transcription complex. The 
TATA-box typically lies very close to the transcription start site (often within 50 bases). 
 
A third motif is the so-called E-box, having the consensus sequence CANNTG, where the 
‘N’ bases are specified according to the transcription factor. An E-box binds transcription 
factors which contain a basic-helix-loop-helix motif (bHLH). 
 
3.2.2.3.2 Ensembl output (www.ensembl.org) 
 
Input sequence was 20 kb (P gene exon 1 plus 10 kb upstream and 10 kb downstream). 
Sequence release: 44, April 2007.  
 
 
 
 
 
 
 
 
 
 
Figure 3.12 Ensembl annotation of a 20 kb region on chromosome 15q which includes the 
first exon of the P gene (nucleotide coordinates 26 007 362 – 26 027 361). 
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Ensembl annotation of this region (Fig 3.12) shows: 3 CpG islands in close proximity to 
exon 1; a large number of repeats in the exon 1 region; and no prediction of any obvious 
regulatory features.  
 
3.2.2.3.3 MPromDb output (www.bioinformatics.med.ohio-state/MPromDb) 
 
When using an annotation programme which looks more specifically at promoter motifs 
(MPromDb), the following output was generated (Fig 3.13): 
Figure 3.13 MPromDb annotation of a 20 kb region which includes the first exon of the P 
gene (the same sequence data input as for the Ensembl analysis). 
 
The results from the mammalian promoter database are in agreement and validate the 
Ensembl results - the first exon of the P gene is predicted to be CpG related. Additional 
information gained indicates the presence of multiple transcription factor binding sites and 
several Hpa II restriction enzyme sites, used to determine methylation status of the region. 
 
In order to look in more detail at the repeat areas detected by the Ensembl annotation, a dot 
plot of this 20 kb region was generated.  
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3.2.2.3.4 Dottup output (www.ebi.ac.uk/emboss) 
 
Dot plots are a means of nucleic acid sequence analysis, which search out regions of 
similarity between two sequences. These two sequences may be generated in one of two 
ways –  
• Two different sequences may be compared to each other in order to identify 
regions of potential homology, or 
• A sequence may be compared to itself in order to find regions of similarity within 
the molecule, i.e. repeats. 
 
A dot plot comparing two sequences (or one with itself) is generated by sliding a window 
of a size (defined by the user) along both sequences. If the sequences within that window 
match with sufficient precision (again, set by the user), a dot is placed in the middle of the 
window signifying a match. If a window size of 10 is defined, then the programme will 
read the sequence in blocks of 10 nucleotides; if the mismatch limit is set at 2, then up to 2 
out of the 10 bases may mismatch and the window will still be classified as a match. 
Therefore, the larger the window of comparison, and the lower the mismatch limit, the 
more stringent the comparison. 
 
The 20 kb region around P gene exon 1 was analysed using dottup (part of the EMBOSS 
suite). The window size was set at 15 and mismatch limit was set at 0. See Fig 3.14a and b. 
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Figure 3.14a Dot plot analysing a 20 kb region around P gene exon 1, comparing this 
sequence to itself in order to identify areas of repetitive DNA. 
 
This dot plot output shows two regions containing repetitive DNA, the first just upstream 
of exon 1 and the second approximately 6 kb upstream of exon 1. (Exon 1 is located 
approximately mid-way through this sequence input, i.e. at about position 10 000 bp.) 
Zooming in on the region immediately around exon 1 (input 2 kb only), clearly shows a 
highly repetitive region of about 800 bp in length, approximately 1 kb upstream of exon 1 
(see Fig 3.14b). 
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Figure 3.14b Dot plot analysing the 2 kb region upstream of P gene exon 1. 
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Actual sequence data for this region was downloaded from the University of California at 
Santa Cruz website (http://genome.ucsc.edu): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15 Nucleotide sequence data is now available for the 5’region of the P gene. 
(Sequence downloaded from UCSC site.)  An area of repetitive G/C-rich DNA is found 
upstream from exon 1 (approximately -500 bp to -1 250 bp upstream). Putative promoter 
elements, CCAAT-box and E-box, are highlighted in green.  
 
 
The block of repetitive DNA in close proximity to exon 1 may certainly have been a 
confounding factor in attempts to clone this DNA segment into plasmid vectors. A 
CCAAT-box sequence and an E-box sequence (CACGTG) were identified in the exon 1 
>hg17_knownGene_NM_000275 range=chr15:25673628-26020061 5'pad=0 3'pad=0 
revComp=TRUE strand=- repeatMasking=none 
ggacacatagatttggctcacccgagccagtccctggcatggaagttggg 
tttcctccattactgtggccactcagggtctatccctggagctggggtag 
ggttgctccttccccatacattcagcagttacacaaaaacaactgtgacc 
tgcaaggcacagagagccacacgcttggccgcagctgtcctgctggcgtt 
tcaaagcccgcatttcgacagatctgcgtgcacaccaagagccttctgcc 
cactcagggagcctcccccgggctctgtgccccagccccttcccgccctg 
taacagtgtccctgaggcactgggaggggagcaggtgcagtgatgagcga 
ggaggagacagtatttctgggacgggaactggtgcatcggtggtcacagg 
ctccctggagccgccatcccacaaggatgggggtcaccatgcaggctgct 
tgccagccatatccacacctaacgcacacggcggtctgaactgaggggtc 
tgcacatgcgacagtgaatgtggtctcagagatctcgggctctcctgctg 
tcagggccctggctgggaacttcagtgtcctggagcctgccatgccgagg 
acatcctcggtccctgctaccagggcaacccctggcccaccctgtggctg 
tgcaatgtgctctgttataaggcatgagatctctttcagctctgctgtta 
cactgtggatggagcctcttacttcctgccaattcctgtgcagggcctgg 
ccactgcagctgtgtgtgtgtctgtagctgtgttgtctccatgtgtttgt 
gcgtgtatctgtgtgtgtgtctgtatctgtgtgtgtatctgtgtgtgtct 
gtgcgtatatctgtgtttgtatatctgtatatgtgtatctgcgtgtgtgt 
ctgtgcatgtatctgtgtgtgtgtctgtatgtgtctatgtatctgtgtat 
ctctgtgtctgcgtatctgtgtgtctgtgtatctctgtgtgtagatctct 
gtatctgtgtgtatctgtgcatgtgtgtatctgtgtgtctgtatctgtgt 
gcctgtgtatatctgtgtctgtgtatctctgtgtgtgtccgtgtgtgtat 
ctgtgtgtgtctctgtatctctgtatctgtatgtatctctgtatctgtat 
ctgtgtgtctgtacctgtgtctgtgtatctgtgtctgagtatctgtatat 
atttgtgtgtgtctgtgtatctgtgtctgtgtgtatatctgtgtatctgt 
gtgtatctctgtgcctgtgtgtgtgtctctgtgtatctgtgcatgtgtct 
gtgtgtatctgtgtatgtgtgtctgtgtatctgcatgtgtccttgtgtgt 
catctgtgtatctgtgtcctgtatctgtgtgtctgtgtattgctgtgtct 
ctgtgtgtgtctctgtgtatgtgtatctgtgtatctgtgtctgtgtatat 
cgtgtctatctctgtatctgtgtgtgtgtctgtgtgtatctgtgtgtgtc 
tgtgtatctgtgtgtgtctgtgtatctcgtgtgtgtgtctgtgctgcagg 
aggggctgtcggcaagtgtaaccttggcgtcctagctggagggcctctca 
gtgcccgctgggagagctctgaagggaacagaatgttcactgagcatttc 
cccgttcttgttcatagggaaaagcctgtccgcagtcctgggccgcctct 
ttagaggtaaagctggaaactatccccgcggagagcgctgtcggggacgc 
cggggcggcgtggccttagacggagctgctctcagcccgcgccgccgggg 
gctggggagctgaggggccgggggtgcggagcgggcgagctgtgggcggg 
gccatgtgggcagctttgtgggcgtggccgggaggggcgtgctacgggcg 
tggccgcactgtgggcggggccgagtggggagtgctgtgggcggggccgg 
gccgggggcgtgcctgggtgggggacccgctgcgggagcgccgagctccc 
TCTGAGTTCTTACTTCGAAGGCTGTGCTCCGCTCACCATCCAGAGCGGAG     Exon 1 
GTGCGGACCTTAAACTCACTCCTGGAGAAAGATCTGCAAGTGCGCAGgta 
aagtgcacgtgctccgcggtcgggaggaaggaggcgaggagccagactag 
- 1500 bp 
 
 
 
 
 
 
 
- 1000 bp 
 
Highly 
Repetitive 
Region 
 
 
 
- 500 bp 
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region, at -1272 bp and +9 bp, respectively. These motifs are not in recognised positions, 
but are still worth taking into account in future mutation detection exercises. They 
essentially define a region of approximately 1.3 kb around exon 1 which may putatively be 
described as the P gene promoter region.  
 
3.2.3  Possible involvement of HERC2 in pigmentation 
 
In mice it has been found that mutations in the gene which lies immediately adjacent to the 
p gene, Herc2, can produce a partial pigment phenotype (Walkowicz et al., 1999; Lehman 
et al., 1998). Three hypotheses that may explain the hypopigmentation phenotype seen in 
these mice are: hypopigmentation could result from loss of a DNA element controlling p 
gene expression; Herc2 itself could play a role in pigmentation; or a second intronic gene 
which affects pigmentation may be present within the Herc2 locus. If conserved in humans, 
this region could also play a role in unknown OCA2 or BOCA phenotypes. Mutations that 
affect the regulation of the P gene may play an important role in the aetiology of BOCA, 
and the promoter or other regions may well house mutations that down-regulate P gene 
expression without rendering it non-functional. This could result in the intermediate 
phenotype seen in individuals with BOCA. In support of this theory is identification of 
DNA variation in this study at the HERC2 locus, as detected by Southern blot analysis, in a 
BOCA individual. Down-regulation of normal expression may possibly lead to other 
milder hypopigmentation phenotypes, as exemplified by the CAR family described in this 
study.  
 
HERC2 mutation screening in this study was very limited, comprising only Southern 
blotting with one enzyme and one probe. The investigation as to the possible involvement 
of HERC2 in pigmention is an important and interesting issue, and could certainly be 
expanded in future studies. 
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3.2.4 Some thoughts on tyrosinase 
3.2.4.1 A confounding factor in TYR mutation detection – TYRL 
 
At the time of cloning the human tyrosinase gene (chromosome 11q14-21), a tyrosinase-
related ‘gene’ containing only the last two exons, exons 4 and 5, of the primary locus was 
also identified in the region 11p11.2-cen (Barton et al. 1998, Giebel et al. 1991).  Giebel et 
al. (1991) suggest the tyrosinase-like segment was duplicated from the original tyrosinase 
gene approximately 24 million years ago. When undertaking mutation detection for the 
TYR gene it is obviously important to consider the presence of this pseudogene. As it shares 
98% identity with the 3’ region of TYR, variants identified in this region could actually be 
in the TYR-like gene, TYRL (Ray et al. 2007). Also, if a patient had a deletion in this region 
of TYR, this could be masked by presence of normal sequence at the TYR-like locus.   
 
3.2.4.2 TYR mutations are rare in black individuals 
 
In the literature, only four cases of black individuals with classic OCA1 have been 
described (Spritz et al. 1991; Oetting et al. 1993; King et al. 2003; Badens et al. 2006). In 
the experience of our laboratory, no South African black person with OCA1 has ever been 
seen, either in the field or in the Genetic Counselling Clinic.  The individuals presented by 
Spritz et al., Oetting et al., and King et al., were all African-American. African-Americans 
carry a large percentage of white admixture and it may be hypothesized that TYR mutations 
were introduced into this population group via this route. The individual described by 
Badens et al. (2006) is the first report of a black African with classic OCA type 1A. The 
proband, a 34 year old Cameroonian black male of the Bamileke ethnic group, presented 
with a very severe phenotype, including snow white hair, milky white skin and grey-blue 
irides. Interestingly, the subject also presented with clearly demarcated darkly pigmented 
patches (ephelides) on his forehead, ear and cheek. To date, ephelides have only ever been 
reported in association with OCA type 2 (P gene mutations). Mutation analysis showed the 
patient was a compound heterozygote for two exon 1 mutations: a 4 bp deletion (del 
AACT) at nucleotide 781, and a transition (T→C) resulting in the substitution mutation, 
C89R.      
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3.2.5 Future approaches to mutation detection 
 
 
Technical difficulties and limitations must be seen as the major limitation of this study. 
Methodologies used for mutation screening (Southern blotting and SSCP analysis) are now 
out-dated in most circumstances and newer techniques are available for the detection of 
larger deletions, chromosomal rearrangement events or alterations in expression patterns. 
These techniques include DNA microarray technology and MLPA (Multiplex Ligation-
dependant Probe Amplification). 
 
A DNA microarray comprises a solid support, usually a glass slide, onto which hundreds or 
thousands of known DNA gene sequences have been dotted by robotic machinery. mRNA 
is extracted from tissue to be tested, subject to rtPCR (using one fluorescently labelled 
primer) in order to produce cDNA. The cDNA is then hybridised to the microarray and will 
bind to complementary DNA sequences on the slide. Computer analysis detects specific 
spots to which test cDNA has bound.  Microarrays can be used to determine which genes 
are being expressed in a single test sample or can be used to compare gene expression in 
two different cell types or tissue samples. Fluorescence intensity can also be measured in 
order to determine gene copy number. Direct mutation detection of known mutations or 
SNPs can also be carried out – here the microarray will be specifically designed to carry 
target DNA from only the gene of interest, each spot containing a different SNP or known 
mutation. 
 
MLPA is a variation of the polymerase chain reaction. The two probes (equivalent to 
primers) are designed such that each contains a portion complementary and specific to the 
target sequence, called the hybridisation sequence. The two probes are designed such that 
they will bind to target DNA immediately next to each other. Each probe consists of a 
second sequence, the primer sequence. In addition, one probe will contain a stuffer 
sequence – an arbitary piece of DNA but of specific length. The stuffer sequence and the 
primer sequences do not bind to the target. When the probes correctly hybridise to the 
target, they are ligated by a thermo stable enzyme. The PCR primers then exponentially 
amplify the ligated probes. Separation of the amplification products is achieved by running 
on a sequence type gel. MPLA involves designing different length stuffer sequences for 
each different hybridisation sequence. In this way the technique could be used for fast, 
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cheap and easy screening of known mutations – up to 40 in a single reaction.  
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CHAPTER 4 
Results and Discussion:  TB and host genetic susceptibility 
 140
4.1 Results: TB and host genetic susceptibility 
4.1.1  The 2.7 kb deletion mutation 
 
The genotype frequencies and the allele frequencies of the 2.7 kb deletion mutation in the 
black TB patient group and the coloured TB patient group together with their controls are 
given in Table 4.1 and Table 4.2 respectively. 
 
 
SUBJECT GROUP N (ind) N/N N/D D/D 
Black TB  70 0.943 (66) 0.057 (4) 0 
Black Controls 99 0.960 (95) 0.040 (4) 0 
Coloured TB  92 0.989 (91) 0.011 (1) 0 
Coloured Controls 87 0.977 (85) 0.023 (2) 0 
 
N (ind) = number of individuals 
N/N = number of individuals with normal/normal genotype w.r.t. 2.7 kb deletion 
N/D= number of individuals heterozygous for 2.7 kb deletion 
D/D = number of individuals homozygous for 2.7 kb deletion 
 
 
 
SUBJECT GROUP n (chr) Del Non-del 
Black TB  140 0.0285 (4) 0.9710 (136) 
Black Controls 198 0.0200 (4) 0.9800 (194) 
Coloured TB  184 0.0050 (1) 0.9950 (183) 
Coloured Controls 174 0.0115 (2) 0.9885 (172) 
n (chr) =  number of chromosomes 
Del = proportion carrying the 2.7 kb deletion (number of chromosomes) 
Non-del = proportion of non-deletion subjects (number of chromosomes) 
 
 
Using the χ2 test, no significant differences were seen between controls and patients for 
either population group. Presence or absence of the 2.7 kb deletion mutation does not 
Table 4.1 Genotype frequencies of the 2.7 kb P gene deletion mutation. 
Table 4.2 Allele frequencies of the 2.7 kb P gene deletion mutation 
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appear to influence susceptibility to TB in either the black or Coloured population samples 
studied here. 
 
4.1.2  The R305W polymorphism 
 
Genotype frequencies and allele frequencies of the R305W variant in the black and 
coloured TB patient group together with their control groups are given in Table 4.3 and 
Table 4.4.  
 
Throughout this section, significant p values (for p≤0.05) are highlighted in red. 
 
 
SUBJECT GROUP N (ind) C/C C/T T/T Hardy-Weinberg  
(p values) 
Black TB  68 0.676 (46) 0.221 (15) 0.103 (7) 0.0099 
Black Controls 97 0.866 (84) 0.124 (12) 0.010 (1) 0.4496 
Coloured TB  78 0.847 (66) 0.141 (11) 0.013 (1) 0.4136 
Coloured Controls 75 0.854 (64) 0.133 (10) 0.013 (1) 0.3716 
N = number of individuals 
C/C = homozygous for cytosine allele at codon 305 (i.e. R allele) 
C/T =heterozygous for cytosine and thymidine at codon 305 (i.e. R and W alleles) 
T/T = homozygous for thymidine allele at codon 305 (i.e. W allele) 
 
 
SUBJECT GROUP n (chr) C T 
Black TB  136 0.816 (111) 0.184 (25) 
Black Controls 194 0.919 (178) 0.081 (16) 
Coloured TB  156 0.918 (143) 0.082 (13) 
Coloured Controls 150 0.920 (138) 0.080 (12) 
 
n = number of chromosomes 
C = cytosine (i.e. proportion carrying the R (argenine) allele) 
T = thymidine (i.e. proportion carrying the W (tryptophan) allele). 
 
Table 4.3 Genotype frequencies for the R305W variant. 
Table 4.4 Allele frequencies for the R305W variant. 
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The genotype distribution in the black control, coloured control and coloured TB samples 
was found to be in accordance with Hardy-Weinberg equilibrium. The genotype 
distribution in the first subject group (black TB patients) shows that this group is not in 
Hardy-Weinberg equilibrium (p=0.0099), suggesting that selection for a certain allele has 
taken place. 
 
Genotypes were further analysed by comparing individuals with C in their genotype (C/C 
plus C/T individuals) and without C in their genotype (T/T individuals) and then 
individuals with T in their genotype (C/T plus T/T individuals) and without T in their 
genotype (Table 4.5). 
 
 
SUBJECT GROUP N (ind) 
 
+ C - C  + T - T 
  C/C + C/T T/T  C/T + T/T C/C 
Black TB  68 0.897 (51) 0.103 (7)  0.324 (22) 0.676 (46) 
Black Controls 97 0.990 (96) 
 
0.010 (1)  0.134 (13) 0.866 (84) 
Coloured TB  78 0.988 (77) 0.013 (1)  0.154 (12) 0.846 (66) 
Coloured Controls 75 0.987 (74) 
 
0.013 (1)  0.146 (11) 0.854 (64) 
N= number of individuals 
 
In order to test whether there was a significant difference in the genotype clusterings 
between patients and controls, the exact test was performed on the above data.  (Table 4.6) 
 
 
 BLACK TB vs BLACK CONTROLS COLOURED TB vs C CONTROLS 
+ C vs - C 0.009 0.742 
+ T vs - T 0.003 0.541 
 
The ‘T’ allele is significantly more common in black TB patients when compared to the 
Table 4.5 Genotype clusterings for the R305W variant. 
Table 4.6 p values generated using Fisher’s exact test on genotype clustering data. 
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black control group. There is no significant difference between the Coloured TB group and 
their control group.  
 
4.1.3  Analysis of 3 P gene microsatellite markers 
 
4.1.3.1  D15S1533 (IVS17) 
 
The frequencies of the different alleles at the D15S1533 locus are given in Table 4.7 and 
graphically depicted in Figure 4.1. 
 
 
 B TB PATIENTS B CONTROLS  C TB PATIENTS C CONTROLS 
Allele (n=72) (n=99)  (n=92) (n=87) 
16  0.005    
17      
18 0.097 0.091  0.321 0.333 
19  0.015 (3)  0.043 (8) 0.017 (3) 
20  0.005 (1)  0.071 (13) 0.017 (3) 
21 0.104 (15) 0.061 (12)  0.038 (7) 0.052 (9) 
22 0.111 0.111  0.054 0.063 
23 0.028 (4) 0.045 (9)  0.071 (13) 0.115 (20) 
24 0.257 0.278  0.185 0.201 
25 0.097 0.101  0.098 0.080 
26 0.139 0.126  0.071 0.075 
27 0.104 (15) 0.091 (18)  0.078 (14) 0.029 (5) 
28 0.028 0.035  0.016  
29 0.014 0.010   0.006 
30     0.006 
31 0.014 0.020  0.005 0.006 
32 0.007 0.005    
 
 
Table 4.7. Allele frequencies D15S1533 (IVS17) 
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Figure 4.1 Microsatellite allele frequencies at the D15S1533 (IVS17) locus. 
 
Tests of significance (Fisher’s exact test) were performed for each allele size where there 
appeared to be an interesting difference in allele frequencies between the control and the 
patient group for each population.  
 
For the D15S1533 marker, alleles 19, 20, 21, 23 and 27 were investigated. p values were 
generated using Fisher’s exact test (see Table 4.8): 
 
 
MARKER ALLELE BLACK COLOURED 
  p values 
(B controls vs B TB patients) 
p values 
(C control vs C TB patients) 
D15S1533 19 0.192 0.125 
 20 0.579 0.011  
 21 0.092 0.352 
 23 0.289 0.091 
 27 0.404 0.033  
 
 
 
Alleles 20 and 27 show significantly different allele frequencies between patients and 
Table 4.8. p values for allele frequencies at D15S1533. 
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controls in the Coloured sample. (Differences between allele frequencies should also be 
noted for allele 21 in the black population and allele 23 in the Coloured population – while 
these differences are not significant at the p ≤ 0.05 level, they are however significant at p 
≤ 0.10.) 
 
Also note – for certain alleles, clear population differences for allele frequencies can be 
seen. For example, allele 18 is more common in the Coloured population than it is in the 
black population (0.333 vs 0.091) and allele 24 is more common in the black population 
than it is in the Coloured population (0.278 vs 0.201). 
 
 
4.1.3.2  D15S1536 (IVS20) 
 
The frequencies of the different alleles at the D15S1536 locus are given in Table 4.9 and 
graphically depicted in Figure 4.2. 
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 B TB PATIENTS B CONTROLS  C TB PATIENTS C CONTROLS 
Allele (n=72) (n=99)  (n=92) (n=87) 
11    0.005 0.006 
12 0.236 0.212 (42)  0.337 (62) 0.230 (40) 
13 0.014 0.015  0.033 0.029 
14 0.014 0.010    
15 0.132 0.152  0.082 0.092 
16 0.125 (18) 0.126 (25)  0.098 (18) 0.138 (24) 
17 0.104 (15) 0.086 (17)  0.071 (13) 0.115 (20) 
18 0.201 (29) 0.086 (17)  0.071 (13) 0.098 (17) 
19 0.014 (2) 0.030 (6)  0.016 0.023 
20 0.076 0.086  0.120 0.149 
21  0.050  0.033 0.057 
22 0.014 (2) 0.045 (9)  0.043 0.029 
23  0.015  0.005  
24 0.021 0.015  0.022 0.011 
25  0.005  0.011  
26 0.021 0.035  0.033 0.011 
27 0.028 0.015  0.022 0.011 
28  0.010    
29      
30      
31  0.005    
 
Table 4.9. Allele frequencies D15S1536 (IVS20) 
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Figure 4.2. Microsatellite allele frequencies at the D15S1536 (IVS20) locus. 
 
 
Tests of significance were performed for alleles 12, 16, 17 and 18 and the results are shown 
in Table 4.10. 
 
 
MARKER ALLELE BLACK p VALUES 
(B TB PATIENTS  vs B CONTROLS) 
COLOURED p VALUES 
(C TB PATIENTS vs C CONTROLS) 
D15S1536 12 0.320 0.003  
 16 0.558 0.138 
 17 0.340 0.091 
 18 0.001 0.221 
 
Allele 12 shows significantly different allele frequencies between the patient and control 
group in the Coloured population and allele 18 shows significantly different allele 
frequencies between the patient and control group in the Black population for p values ≤ 
0.05. (When using the less stringent critical value for p, where p ≤ 0.10, allele 17 is then 
significantly more common in the Coloured control group than in the TB patient group.)  
 
 Table 4.10. p values for allele frequencies at D15S1536. 
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4.1.3.3  D15S1537 (IVS24) 
 
The frequencies of the different alleles at the D15S1537 locus are given in Table 4.11 and 
graphically depicted in Figure 4.3. 
 
 
 
 B TB PATIENTS B CONTROLS  C TB PATIENTS C CONTROLS 
Allele (n=72) (n=99)  (n=92) (n=87) 
7    0.005  
8     0.006 
12 0.014 (2) 0.020 (4)  0.005 (1) 0.040 (7) 
13 0.097 (14) 0.101 (20)  0.049 (9) 0.161 (28) 
14 0.111 (16) 0.136 (27)  0.098 (18) 0.057 (10) 
15 0.056 (8) 0.066 (13)  0.103 (19) 0.201 (35) 
16 0.070 (10) 0.045 (9)  0.228 (42) 0.098 (17) 
17 0.021 0.020   0.027 0.046 
18 0.049 0.051  0.033 0.011 
19 0.007 0.010  0.027 0.006 
20 0.083 (12) 0.071 (14)  0.071 (13) 0.029 (5) 
21 0.034 (5) 0.384 (76)  0.179 (33) 0.132 (23) 
22 0.069 (10) 0.045 (9)  0.071 0.063 
23 0.028 0.020  0.049 0.052 
24 0.028 (4) 0.020 (4)  0.022(4) 0.086 (15) 
25  0.010  0.016 0.006 
26 0.014   0.011 0.006 
27    0.005  
 
 
Table 4.11. Allele frequencies D15S1537 (IVS24) 
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Figure 4.3. Microsatellite allele frequencies at the D15S1537 (IVS24) locus. 
 
Tests of significance were performed for alleles 12, 13, 14, 15, 16, 20, 21 and 24 (for 
which frequencies appeared to differ between the subject and control groups), and the 
results are shown in Table 4.12. 
 
 
MARKER ALLELE BLACK p VALUES 
(B CONTROLS vs B TB PATIENTS) 
COLOURED p VALUES 
(C CONTROL vs C TB PATIENTS) 
D15S1537 12 0.500 0.027  
 13 0.531 <0.001  
 14 0.285 0.100 
 15 0.440 0.003  
 16 0.229 <0.001  
 20 0.403 0.052 
 21 <0.001  0.115 
 24 0.455 0.005  
 
Alleles 12, 13, 15, 16 and 24 show significantly different allele frequencies between the 
patient and control group in the Coloured population sample. For allele 12, fewer patients 
have this allele than do controls; for allele 13, fewer patients have this allele than do 
Table 4.12 p values for allele frequencies at D15S1537. 
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controls; for allele 15, fewer patients have this allele than do controls; for allele 16 fewer 
controls have this allele than do patients and for allele 24, fewer patients have this allele 
than do controls. 
 
Allele 21 shows significantly different allele frequencies between the patient and control 
group in the black population sample. Far fewer patients carry this allele as compared to 
the control group. 
 
4.1.4  Considering the 5 markers as a haplotype 
 
Although haplotype data could not be unambiguously established, as the sample groups 
comprised individuals and not families, haplotypes were estimated and data analysed using 
the software package, Arlequin. 
 
Table 4.13. Exact p values generated when performing pairwise comparisons between all 5 
marker loci simultaneously (Arlequin), i.e. considering the 5 markers as a haplotype. 
 
 C CONTROLS C TB PATIENTS B CONTROLS 
C TB patients 0.533   
B Controls 0.077 0.118  
B TB patients 0.223 0.498 0.479 
 
No significant differences were seen between either patient and their respective control 
group. However, as might be expected, the p value for comparison of black controls vs 
Coloured controls (0.077) is almost significant, a reflection of population differences. 
4.1.5  Summary 
 
In order to summarise the results in this chapter, probability values (Fisher’s exact test) 
were generated for pairwise comparisons for individual loci (Table 4.14).  
 
Table 4.14 p values genetated using Fisher’s exact test for pairwise comparisons for 
individual P gene loci.  
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 2.7 kb del R305W D15S1533 D15S1536 D15S1537 
C C vs C TB 1 1 0.239 0.419 <0.001  
B C vs B TB 1 0.0019  0.962 0.036  0.952 
C C vs B C 1 1 <0.001  0.360 <0.001  
C TB vs B TB 1 0.0119  <0.001  0.003  <0.001  
 
Highly significant differences are seen between the Coloured control and patient group at 
the D15S1537 locus.  
 
Highly significant differences are seen between the black control and patient group at the 
R305W locus and at the D15S1536 locus. 
 
When comparing the black and Coloured control groups to each other and when comparing 
the black and Coloured patient groups to each other, several loci show significant 
differences in allele frequencies (R305W, D15S1533 and D15S1537). These differences 
are population differences, and they are not considered relevant to the TB susceptibility 
study.  
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4.2 Discussion: TB and Host Genetic Susceptibility  
 
While infectious disease genetics is not a new area of study – some of the largest twin 
studies were performed more than 50 years ago (Puffer 1946, Stocks 1928, Frost 1933) – 
the current attention being afforded host genetics and susceptibility to infectious disease 
reflects the recent increase in power of new molecular approaches being used to identify 
susceptibility and resistance genes. The number of candidate genes being proposed as 
potential susceptibility genes is rapidly increasing. Moreover, genome-wide linkage 
analysis is beginning to reveal regions of the human genome which harbour further 
susceptibility or resistance loci. In this study the P gene was investigated as a possible 
candidate falling within a region on human chromosome 15q previously identified as being 
associated with susceptibility to TB. 
 
4.2.1 OCA2 heterozygotes and a selective advantage for TB 
 
At the outset of this study it was tempting to postulate that the P gene, shown unexpectedly 
to be expressed in certain immune tissues, might have a function other than its role in 
melanin production. If the P protein functions as a part of the immune system then it would 
be feasible to postulate that this locus would find itself subject to selective pressure in the 
presence of infectious disease and it would therefore be expected that heterozygote P 
mutation carriers would have a selective advantage over non-mutation carriers. To test this 
theory, the only known common P gene mutation, the 2.7 kb deletion mutation, was 
screened for in a group of black TB patients and a group of Coloured TB patients, plus 
their respective ethnically and geographically matched controls.  
 
The frequency of the 2.7 kb deletion was not significantly different between patients and 
controls in both the Black and Coloured groups tested. It can be concluded that this 
mutation is unlikely to play a major role in either resistance or susceptibility to TB disease. 
It should be noted that the sample sizes are small. Given the low frequency of the mutant 
relative to the normal allele, significant differences in allele frequencies may be detected 
only in a much larger sample. 
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 4.2.2 The R305W polymorphism 
This SNP is considered a non-pathogenic variant as it is polymorphic in many populations 
(Lee et al. 1995). It could, however, have some functional significance given that it leads to 
an amino acid change in the P protein.  
 Black TB patients have a significantly higher frequency of the T (W) allele when 
compared to the black control group. It may be suggested that the T allele is a susceptibility 
allele (or is in linkage disequilibrium with a susceptibility allele) in this population group 
and individuals with the genotypes that include a ‘T’ allele are more likely to develop TB 
disease. Grouped genotype comparisons support this, i.e. genotype frequencies with T (C/T 
and T/T) or without T (C/C) are significantly different between patients and controls in the 
black population samples tested here. 
 
 The frequency of the C and T alleles is not significantly different in the Coloured patient 
versus control group. 
  
4.2.3  Analysis of 3 P gene microsatellite markers 
 
For the marker, D15S1533 (IVS 17), allele 20 and allele 27 are significantly more common 
in Coloured TB patients than in Coloured controls. These may be possible susceptibility 
alleles for this population group. No significant differences in allele frequencies in the 
black sample are seen.  
Allele 18 is more common in the Coloured group as compared to the black group of 
individuals, suggesting this may be a Caucasoid allele introduced through population 
admixture. 
 
 
For the marker, D15S1536 (IVS 20), allele 12 is significantly more common in Coloured 
TB patients than in Coloured controls. Allele 18 is significantly more common in Black TB 
patients than in the Black control group. These may be susceptibility alleles in their 
respective population groups. 
 
For the marker, D15S1537 (IVS 24), alleles 12, 13, 15 are significantly more common in 
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the Coloured control group than in the Coloured patients. These may be protective alleles 
in this population. Allele 16 is more common in Coloured patients than in Coloured 
controls, suggesting it may be a susceptibility allele. 
 
4.2.4  The 5 markers as a ‘haplotype’ 
 
Since families were not tested, it was not possible to deduce haplotypes. Some attempt was, 
however, made to infer haplotypes using the Arlequin package. Based on inferred 
haplotypes, there is no significant difference between the TB patient and control groups in 
either population. This would indicate that the region covered by the ‘haplotype’ is not 
associated with host resistance/susceptibility to TB. However, given that several loci within 
this region individually show significant association to either resistance or susceptibility to 
TB, we can conclude that, while the P gene itself may not be directly involved in TB 
susceptibility, genetic variants close to P, could still be significant in host susceptibility to 
this infectious disease. Further, the markers D15S1533, D15S1536 and D15S1537 used in 
this study are microsatellite markers and it should be borne in mind that microsatellites are 
less stable than SNPs (due to slippage). Consequently, given sufficient time, microsatellite 
haplotypes may decay, making the interpretation of haplotype experiments more 
complicated. 
  
Since the original paper by Bellamy et al. (2000) describing linkage of a region of 
chromosome 15q to TB susceptibility, and subsequent fine mapping of the region (Cervino 
et al. 2002), no further literature investigating this genomic region has been published. The 
study undertaken here supports these earlier findings, with significant associations being 
found in both the South African black and Coloured population groups with alleles in the P 
gene. In the black population, the T allele of the R305W polymorphism and allele 18 at the 
D15S1533 locus are significantly associated with susceptibility to TB. In the Cape 
Coloured population, alleles 20 and 27 at the D15S1533 locus, allele 12 at the D15S1536 
locus and allele 16 at the D15S1537 locus are associated with susceptibility to TB. Further, 
in the Coloured population alleles 12, 13 and 15 at the D15S1537 locus showed significant 
association with normal controls and may be classified as protective or resistance alleles. 
Unpublished data from the laboratory of Professor Rob Nicholls shows that the P protein is 
expressed in lymph tissue in the chicken. Expression of this protein in a tissue involved in 
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immunity is suggestive of another role for P, besides its classic function in the pigment 
pathway.    
 
4.2.5 Reconciling apparently contradictory findings in the literature 
 
There is now a substantial body of work looking for the genes responsible for susceptibility 
to mycobacterial infections. Many genes have been tested for association with 
susceptibility to TB, in many diverse populations and using a variety of study designs.  
 
Besides the clear findings of studies on the genes involved in extreme susceptibility to 
mycobacterial disease, inherited in a Mendelian fashion, other studies have left us with 
results that are sometimes contradictory. Takiff (2007) argues that the accumulated 
literature on host genetic susceptibility to TB is “often contradictory” and can be 
“inconclusive”. While a given polymorphism in a certain gene may show association with 
TB susceptibility in one population, a study undertaken in another population group may 
show no association. How is this possible? One explanation might be: Given that numerous 
genes are necessarily involved in determining susceptibility, the subset of these genes 
exerting their cumulative effect may be different in different populations (Hill 2006). 
Another explanation might be: If a major determinant of susceptibility is present in a 
particular ethnic group, another ethnic group may well have a different major determinant 
of susceptibility (for example the HLA allele DQB1*0503 is a major determinant of 
susceptibility in Cambodians (Goldfeld et al. 1998), but has not been reported in any other 
population). A third argument, put forward by Casanova and Abel (2007), proposes that 
much of TB susceptibility may be determined, not by the small effects of many genes, but 
by the large effects of fewer, as yet unidentified, dominant genes – a scenario exemplified 
by the results of the Baghdadi study of Moroccan families (Baghdadi et al. 2006).  
 
It is also essential to take into account the important differences of intensity of exposure 
within a population, strain virulence, length of time the individual has been exposed to the 
pathogen and environmental factors when interpreting molecular studies. Rigorous criteria 
for the selection of both cases and controls helps to minimize these variables which could 
easily modify effects and lead to confounding results. Also, a study (such as this one) 
which analyses small individual allele effects in what is most likely a complex multi-locus 
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interaction will always be limited. When investigating the genetics of complex diseases 
there is a need for large multi-locus studies which are sufficiently powered.   
 
4.2.6  Third world resources  
 
An important issue is brought into question by Takiff (2007): “Will identifying genetic 
determinants of susceptibility contribute to the control of TB?” Given that TB is endemic 
in poorer countries with limited health care resources, would it not be more practical (even 
more ethical?) to concentrate rather on diagnosing, effectively treating and improving local 
control programs? Certainly socioeconomic conditions and TB control programs can 
modify, and in extreme circumstances, override, the effects of host genetics in determining 
susceptibility to this infectious disease.  
 
Given the emergence of increasingly virulent, multi-drug resistant strains of 
M. tuberculosis and the severity of the problem this presents (Raviglione 2006), it may well 
become necessary to target chemotherapy and possibly vaccines, prophylaxis and control 
programs to the genetic composition of the individual, family or ethnic group. In 
populations where certain loci have been found to be highly associated with TB (e.g. in 
Cambodians [Goldfeld et al. 1998] and in Moroccans [Baghdadi et al. 2006]), a cost-
benefit analysis would certainly be feasible. The identification of host susceptibility alleles 
responsible for cases of MSMD has, and will continue to, contribute to knowledge 
regarding the functional elements of the human immune system with respect to 
mycobacterial infection. Given that TB, together with AIDS and malaria, are the three 
major killers among infectious diseases, new approaches to preventing, diagnosing and 
curing TB are needed – which in turn depend on a better understanding of the 
mycobacterium as well as the host.    
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Chapter 5 
Conclusions 
 
 158
 Conclusions 
 
OCA mutation detection 
 
The mutation screen in subjects with albinism identified several mutations, but many 
remain elusive. Limitations of this study are due to the approach used, which could not 
detect rearrangements, mutations hidden in the regulatory region/s, intron mutations, or 
single-exon, multi-exon or whole gene deletions on one chromosome. In OCA1, partial 
deletions of the 3’region of the gene may have gone undetected due to the presence of the 
TYR-like pseudogene. 
 
Further, we should bear in mind that mutations influencing the OCA2 phenotype may not 
necessarily be restricted to the P gene, and similarly, the OCA1 phenotype may be 
modified by loci other than TYR. A mutation may be present in another gene whose product 
participates in the melanin metabolic pathway. The interaction of pigment proteins is 
clearly illustrated by a family described by Manga et al. (1997). Two sibs from the black 
African population were described with an atypical form of OCA – the phenotype was 
essentially an intermediate form between OCA2 and ROCA. The individuals presented 
with hair similar to that of OCA2 individuals, but reddish and skin much lighter but still 
red-yellow in colour which is typical of the ROCA phenotype. Mutation analysis revealed 
the individuals were compound hetrozygotes for two TYRP1 mutations (i.e. they were 
affected with ROCA), but in addition were heterozygous for the 2.7 kb deletion mutation at 
the P locus. This scenario of phenotypic variation of the ROCA phenotype by mutation at 
the P locus highlights the importance of considering the interaction of gene products in the 
pigment biosynthesis pathway. Further, (although the presence of a second P mutation 
could not be ruled out in these individuals) it seems that heterozygosity for a P mutation is 
sufficient to influence phenotype when occurring together with mutation/s at another 
related locus. 
 
Epigenetic phenomena in the P gene region revisited 
 
Epigenetic imprinting characterises the genes which cause Prader Willi Syndrome (PWS) 
and Angelman Syndrome (AS). Interestingly patients with PWS and AS often present with 
hypopigmentation relative to other family members. PWS and AS are developmental 
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disorders associated with specific, but different, imprinted regions on chromosome 15q. In 
both of these syndromes, dysregulation of the methylation status of the PWS or AS loci, 
close to P, alters (down-regulates) P gene expression. Although isolated OCA2 carrier 
status does not usually lead to hypopigmentation, the heterozygous loss of P gene 
expression in PWS and AS patients more often translates into a phenotype. It may be 
possible that methylation changes at the PWS or AS loci somehow affect the surrounding 
DNA, by altering DNA methylation status or by altering chromatin structure through 
histone acetylation or methylation, and the syntenic CpG island associated with the P gene 
may become dysregulated. Why heterozygous loss of function of P is sufficient to cause a 
hypopigmentation phenotype for this classic autosomal recessive locus in these syndromes 
remains an intriguing question. 
 
The function of the P protein 
 
The function of the P protein remains unclear – its role in pigment is undisputed, although 
its precise mode of action has yet to be elucidated. Mouse studies show that in cells null for 
the p protein, melanosomal ultrastructure is abnormal, the localisation and trafficking of 
tyrosinase is altered and the transport of other melanosomal proteins into the melanosome 
fails (Manga et al. 2001a). This function of the P protein as a transport channel may be 
important in a context other than pigment production. As discussed in chapter 1, the 
genome of M. tuberculosis contains two P-like genes. In this unicellular organism which 
does not produce pigment, the requirement for the P protein is presumably in context of its 
function as a trans-membrane channel, or it may have another, as yet, unidentified function.  
 
It is proposed that any selection taking place at the P locus is associated with another 
function of the P protein, perhaps related to host immunity. This “other” function of the P 
protein may also be related to the high carrier status of OCA2 heterozygotes in Africa.  
 
Further, it is unlikely that the selective agent is only the TB pathogen. It could be other 
pathogens, since TB infection in the black African population is a relatively recent 
phenomenon which occurred less than 200 years ago. TB is unlikely to have been acting 
long enough or to have had a strong enough selective pressure to have attained the high P 
gene mutation frequency observed in sub-Saharan Africans.  
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TB and host susceptibility: The bigger picture will emerge  
 
Host susceptibility is a complex genetic trait involving many host genes (some having 
greater and some lesser effects), many pathogen genes (conferring greater or lesser 
virulence) and these are all influenced by other environmental factors. The picture is a 
detailed puzzle of which small pieces are now becoming apparent (see Fig 5.1).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1  Host susceptibility to infectious disease may be considered a complex genetic 
trait, with multiple genes involved and environmental conditions having significant 
influence. TB susceptibility is a sum of many different parts. In the last decade, small 
pieces of the puzzle have become visible, as depicted in A, but the bigger picture, B, has 
yet to emerge.  
 
The tremendous public health problem presented by TB persists, despite the widespread 
use of the BCG vaccine and antibiotic therapy. The vaccine is variable in the protection it 
provides and the antibiotics in current use are losing their efficacy in the face of emerging 
drug resistance. To develop new prevention and treatment strategies the field of molecular 
genetics must address the following questions: Why is it that not all individuals exposed to 
M. tuberculosis will become infected by the pathogen?; Once they infect an individual, 
how do these bacteria evade the host defence system to survive, sometimes for years? Why 
is it that only 10% of those infected will go on to develop TB disease?; Why are some 
  
A       B 
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strains of M. tuberculosis more virulent than others?; and How does M. tuberculosis react 
to the host at different stages of infection? Successful research in these areas will aid in the 
design of novel TB therapies, a global health issue whose requirement is becoming 
increasingly urgent.  
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